Company Announcements

Marico Limited

BSE: 531642
NSE: MARICO
Latest Announcements
2
Press Release / Media Release (13 Nov 2026, 6:51 pm)

Marico Ltd rebrands flagship CSR education initiative as Nihar Shanti Mazbooti Ki Paathshala

Marico Ltd has announced a renewed identity for its flagship education-focused CSR initiative, renaming 'Nihar Shanti Paathshala Funwala' to 'Nihar Shanti Mazbooti Ki Paathshala'. The rebranding aligns the initiative with the company's unifying belief, 'Mazboot Faislon Se Banta Hai Mazboot Bhavishya'. The program, which focuses on foundational learning and numeracy, has cumulatively trained over 1.26 lakh teachers and impacted approximately 12.69 lakh students. In FY2025-26 specifically, it benefited over 3,500 children aged 3-6, 260 Anganwadi workers, and 1,500 parents. This strategic shift underscores the company's commitment to empowering women and children through long-term educational impact.

Corporate Social Responsibility Update

Marico Limited has announced a rebranding of its flagship CSR education initiative. The programme, previously known as 'Nihar Shanti Paathshala Funwala', will now be called 'Nihar Shanti Mazbooti Ki Paathshala'.

This transition is designed to align the initiative with the unifying belief, 'Mazboot Faislon Se Banta Hai Mazboot Bhavishya' (Strong decisions lead to a strong future). The company stated that this evolution reflects a shift from creating 'moments of fun' to fostering meaningful, long-term impact on foundational learning and educational outcomes.

Cumulative Program Impact

The initiative focuses on Foundational Literacy and Numeracy (FLN) in line with the National Education Policy (NEP). Cumulative performance metrics reported include:

MetricReach
Teachers Trained1.26 lakh+
Students Benefited12.69 lakh+

Recent Operational Reach (FY2025-26)

During the most recent financial year, the programme's footprint included:

  • Children (3-6 years): 3,500+
  • Anganwadi Workers and Helpers: 260
  • Parents: 1,500+

Management Perspective

Amit Bhasin, Chief Legal Officer & Group Counsel and Secretary, CSR Committee, Marico Limited, noted that the initiative aims to empower children through accessible, high-quality education, while celebrating women who make strong decisions for their families.

Investor Takeaway

This announcement is a routine update regarding the company's CSR strategy and branding. It does not carry financial implications or material changes to the company's business operations.

7
Acquisition (6 Nov 2026, 10:51 pm)

Marico Ltd to acquire 51% stake in Bonorizon Consumer Ventures for up to Rs 35 crore

Marico Ltd has signed definitive agreements to acquire a 51% equity stake in Bonorizon Consumer Ventures Private Limited for an aggregate cash consideration of up to Rs 35 crore. The acquisition aims to strengthen the company’s international growth strategy by focusing on its digital growth engine. The transaction is expected to close within 90 days, subject to customary conditions. Marico also secured rights to purchase the remaining stake after three years, contingent on performance milestones.

Transaction Overview

Marico Limited has entered into definitive agreements to acquire a 51% equity stake in Bonorizon Consumer Ventures Private Limited. The venture is designed to bolster Marico’s global business strategy by accelerating its digital growth engine in international markets.

Key Deal Terms

MetricDetails
Target EntityBonorizon Consumer Ventures Private Limited
Stake Acquired51% equity share capital and voting rights
ConsiderationUp to Rs 35 crore (Cash)
Completion TimelineWithin 90 days from the date of signing definitive agreements
Regulatory ApprovalsNone required

Strategic Rationale

The acquisition is part of Marico’s broader strategy to evolve into a well-rounded Indian multinational FMCG enterprise. By leveraging the capabilities of the target entity, the company aims to enhance its presence and growth opportunities in international markets.

Future Control Rights

In addition to the immediate 51% stake, Marico has secured the right to acquire the remaining equity share capital and voting rights in Bonorizon. This option is exercisable after three years from the date of signing the definitive agreements, subject to the achievement of specific milestones, requisite approvals, and compliance with the terms of the agreements.

Watch Points

  • Execution: Investors should track the completion of the acquisition within the indicated 90-day timeline.
  • Integration: As the target entity (incorporated on October 22, 2026) has no reported turnover, successful scaling of the business will be key to realizing the intended strategic benefits.
  • Future Acquisition: The potential for acquiring the remaining stake after three years will depend on performance milestones being met.
6
Acquisition (6 Nov 2026, 10:46 pm)

Marico Ltd Increases Stake in Cosmix Wellness to 80% with Rs 113.65 Crore Acquisition

Marico Ltd has acquired an additional 20% stake in Cosmix Wellness Private Limited for Rs 113.65 crore in cash, increasing its total shareholding from 60% to 80%. This follows the company's initial entry into the Bengaluru-based functional wellness brand earlier in 2026. Marico has also secured rights to acquire the remaining stake after FY29, contingent upon milestone achievements. The acquisition is classified as an arm's length related-party transaction.

Acquisition of Additional Stake in Cosmix Wellness

Marico Limited has completed the acquisition of an additional 20% stake in Cosmix Wellness Private Limited for a cash consideration of Rs 113.65 crore. This transaction increases Marico's total shareholding in the entity from 60% to 80%. The company had previously acquired a 60% stake in February 2026.

Key Highlights

FeatureDetails
Target EntityCosmix Wellness Private Limited
IndustryHealth & Wellness
Transaction TypeAcquisition of additional 20% stake
ConsiderationCash
Investment AmountRs 113.65 crore
Total Shareholding80% (increased from 60%)
Completion DateNovember 6, 2026

Target Entity Performance

Cosmix Wellness, based in Bengaluru, operates in the premium food and nutrition categories. Below are the historical turnover figures reported by the company:

YearTurnover (Rs Crores)
FY 2025–2691.53
FY 2024–2547.25
FY 2023–2424.32*

*Calculated as per Indian GAAP. The company also reported a Last 3 months Annual Recurring Revenue (ARR) of Rs 170+ crore as per Ind AS.

Strategic Context

This follow-on investment continues Marico's strategy to expand its presence in the digital-first functional wellness space. The current transaction is classified as a related-party transaction conducted at arm's length, and the promoters have no interest in the deal.

Future Outlook

Marico has secured the right to acquire the remaining stake in Cosmix Wellness after the completion of FY29. This future acquisition remains subject to the achievement of specified milestones, as well as necessary approvals and the terms defined in the definitive agreements.

8
Earnings Call Transcript (6 Nov 2026, 10:28 pm)

Marico Ltd Q2 FY27 Earnings Call: Consolidated Revenue Grows 13% YoY, EBITDA Up 27%

Marico Ltd reported a strong Q2 FY27 with consolidated revenue rising 13% and EBITDA increasing 27%, driven by 10% volume growth in India and 13% constant currency growth in international markets. Management upgraded the full-year EBITDA growth guidance to mid-twenties, citing better visibility and improved portfolio profitability. The company expects to cross INR 15,000 crore in annual revenue and maintains its long-term goal of reaching INR 20,000 crore by FY30. Key focus areas remain premium personal care, foods, and digital-first brands, bolstered by the GTM transformation under Project SETU.

Key Highlights

MetricPerformance/Value
Consolidated Revenue13% Growth YoY
India Volume Growth10%
EBITDA27% Growth YoY
PAT31% Growth YoY
EBITDA Margin18.2% (+200 bps YoY)
Gross Margin~600 bps Expansion YoY

Financial Snapshot

Marico delivered a robust performance in Q2 FY27, characterized by double-digit growth across its core business engines. Consolidated revenue grew 13%, with the India business contributing 10% volume growth and the international business achieving 13% constant currency growth. Profitability metrics were particularly strong, with EBITDA growing 27% and PAT rising 31%. For the first half of FY27, revenue, EBITDA, and PAT increased by 18%, 26%, and 28% respectively.

Profitability and Margin Analysis

The company reported a significant gross margin expansion of approximately 600 basis points year-on-year, attributed to favorable portfolio mix, improved profitability in new growth engines, and softer copra prices. Despite a 44% increase in advertising and promotion expenditure, the EBITDA margin expanded by 200 basis points to 18.2%.

Business and Operational Performance

  • Parachute: Delivered 13% volume growth (highest in 22 quarters) and gained 570 basis points in volume market share to reach 60%.
  • Value-Added Hair Oil (VAHO): Achieved 21% value growth, marking the sixth consecutive quarter of stellar growth.
  • Foods: Grew 45% with an annualized revenue run rate crossing INR 1,500 crores.
  • Digital-First Brands: The portfolio has scaled to approximately INR 1,150 crores. Beardo is expected to cross INR 400 crores in revenue this year.
  • Project SETU: The GTM transformation has resulted in a 1.5x increase in direct reach and the doubling of rural stockists. The company is now initiating SETU 2.0 with a focus on AI and tech-led smarter growth.

Management Commentary and Guidance

Management has improved its annual outlook, now expecting teens revenue growth and confirming it will comfortably cross the INR 15,000 crore revenue mark. The full-year EBITDA growth guidance has been upgraded to mid-twenties, up from an earlier estimate of ~20%. The long-term vision remains to reach INR 20,000 crores in revenue by FY30. For the medium term, management anticipates mid-teens EBITDA growth.

Concerns and Watch Points

  • Commodity Prices: While copra prices have remained rangebound, crude-linked derivatives and vegetable oils have risen, presenting potential inflationary pressure.
  • Demand Uncertainty: Management noted potential headwinds from deficient rainfall in certain states, which requires monitoring regarding the demand environment.
  • Execution Dependence: Future growth aspirations are contingent on successful execution, specifically the scaling of new growth engines like digital-first brands and premium personal care.

Investor Takeaway

Marico’s Q2 performance reflects resilience and successful execution of its diversification strategy. The combination of volume-led growth in the core business and rapid scaling of new ventures, supported by improved EBITDA guidance, suggests strong operational health. Investors should monitor the progress of Project SETU 2.0, the scaling of digital-first brands, and the management's ability to navigate commodity price volatility.

4
Postal Ballot (6 Nov 2026, 5:37 pm)

Marico Ltd issues Postal Ballot notice to appoint Mr. Rohit Jawa as Independent Director

Marico Limited has issued a Postal Ballot notice seeking shareholder approval for the appointment of Mr. Rohit Jawa as an Independent Director. The appointment is effective January 1, 2027, for a term of five consecutive years, concluding on December 31, 2031. Mr. Jawa, formerly the Managing Director and CEO of Hindustan Unilever Limited, brings over 38 years of leadership experience in consumer goods. Shareholders may cast votes via remote e-voting, which commences on November 8, 2026, and concludes on December 7, 2026. Results are expected by December 9, 2026.

Key Highlights

ItemDetails
AppointeeMr. Rohit Jawa
RoleIndependent Director
Term5 years (Jan 1, 2027 – Dec 31, 2031)
Approval ModePostal Ballot (Special Resolution)
Remote E-voting StartNovember 8, 2026 (9:00 a.m. IST)
Remote E-voting EndDecember 7, 2026 (5:00 p.m. IST)
Results DeclarationOn or before December 9, 2026

Board Appointment Details

Marico Limited has proposed the appointment of Mr. Rohit Jawa as an Independent Director of the company. The board, following the recommendation of the Nomination and Remuneration Committee, approved this appointment effective from January 1, 2027, subject to the approval of members via special resolution. Mr. Jawa has submitted his declaration of independence and confirms that he meets the criteria for the role under the Companies Act, 2013, and SEBI Listing Regulations.

Background of Appointee

Mr. Rohit Jawa holds over 38 years of leadership experience in building and transforming consumer businesses. His background includes:

  • Former Roles: Managing Director & CEO of Hindustan Unilever Limited (June 2023 – July 2025) and President, Unilever South Asia.
  • Prior Experience: Led end-to-end transformation programs for Unilever as Chief of Transformation in London; served as Executive Vice President, North Asia, and Chairman of Unilever China.
  • Expertise: Global business, brand building, digital skills, retail, and business strategy.

Voting and Timeline

The company is conducting the approval process exclusively through remote e-voting as per MCA circulars. Physical ballot papers are not being distributed. The voting window is open from November 8, 2026, to December 7, 2026. Results will be declared by December 9, 2026, and will be available on the company website and at the stock exchanges.

2
Analyst / Investor Meet (5 Nov 2026, 10:59 pm)

Marico Ltd Announces Schedule of Upcoming Analyst and Investor Conferences for November 2026

Marico Ltd has formally intimated its upcoming participation in two analyst and investor conferences scheduled to take place in Mumbai in November 2026. The management team will engage in one-on-one and group meetings at the Avendus Spark INDX and the JM Financial Annual India Conference. The company confirmed that no unpublished price-sensitive information (UPSI) will be disclosed during these sessions. Furthermore, the standard presentation utilized for such interactions is available on the company's official website. This remains a routine procedural filing required under SEBI listing regulations.

Key Highlights

ItemDetails
Primary CompanyMarico Ltd
EventsAvendus Spark INDX; JM Financial Annual India Conference
DatesNovember 16, 2026; November 17, 2026
LocationMumbai
Meeting TypeOne-on-One / Group
PurposeInvestor Interaction

Schedule of Investor Meetings

Marico Ltd management has confirmed participation in the following industry conferences:

  • Avendus Spark INDX: Scheduled for Monday, November 16, 2026, in Mumbai.
  • JM Financial Annual India Conference - India Xchange 2026: Scheduled for Tuesday, November 17, 2026, in Mumbai.

The events will involve one-on-one and group meetings with various institutional investors and analysts. The company has indicated that the schedule remains subject to change based on exigencies concerning the organizers or the company management.

Compliance and Transparency

In accordance with standard regulatory practices and SEBI listing obligations, Marico Ltd has explicitly stated that no unpublished price-sensitive information (UPSI) will be shared during any of these interactions. The company has also noted that the standard presentation materials used for these meetings are accessible to the public via the Investor Relations section of its official website.

2
Newspaper Publication (3 Nov 2026, 9:59 pm)

Marico Ltd - Announcement of Newspaper Publication of Financial Results

Marico Ltd has published the newspaper extract of its un-audited consolidated financial results for the quarter and half-year ended September 30, 2026, in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. These results were approved by the Board of Directors on November 2, 2026, and the notices appeared in Financial Express, Free Press Journal, and Navshakti on November 3, 2026. Investors are directed to the company's website or stock exchange portals for the complete filing and detailed financial information.

Publication Details

Marico Ltd has published the newspaper extracts of its un-audited consolidated financial results for the quarter and half-year ended September 30, 2026. The publication was carried out in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Publication Summary

AttributeDetails
Reporting PeriodQuarter and half-year ended September 30, 2026
Board Approval DateNovember 2, 2026
Publication DateNovember 3, 2026
Newspapers UsedFinancial Express (English), Free Press Journal (English), Navshakti (Marathi)

Regulatory Context

As per SEBI LODR Regulations, companies are mandated to publish their financial results in at least one English language national daily newspaper circulating in the whole or substantially the whole of India and in one daily newspaper published in the language of the region, where the registered office of the company is situated. This notice serves as confirmation of such compliance.

What Shareholders Should Know

The full version of the financial results is accessible on the following platforms:

Shareholders and investors are advised to refer to these official channels for detailed financial statements.

3
Audio Recording (3 Nov 2026, 2:07 am)

Marico Ltd - Disclosure of Audio Recording of Earnings Conference Call for Quarter Ended September 30, 2026

Marico Ltd has released the audio recording of its earnings conference call held on November 2, 2026, covering the company's unaudited financial results and operational performance for the quarter and half-year ended September 30, 2026. The recording is available on the company's official investor relations website. The company also stated that a written transcript of the conference call will be prepared and filed with the stock exchanges in the future. This disclosure is in compliance with SEBI regulatory requirements.

Earnings Call Disclosure

Marico Ltd has formally disclosed the availability of the audio recording for the earnings conference call conducted on November 2, 2026. The call addressed the company's unaudited financial results and operational performance for the quarter and half-year ended September 30, 2026.

Key Highlights

ItemDetails
EventEarnings Conference Call Audio Recording
Date of CallNovember 2, 2026
Period CoveredQuarter and Half-Year ended September 30, 2026
StatusRecording available on company website
Next StepTranscript to be published subsequently

The audio recording is accessible via the company's investor relations portal at https://marico.com/india/investors#quarterly. The company has confirmed that a written transcript of the call will be intimated to the stock exchanges and uploaded to the website in due course. This filing serves as a standard administrative update pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

6
Change in Directorate (2 Nov 2026, 9:23 pm)

Marico Ltd appoints Mr. Rohit Jawa as Additional Independent Director

Marico Ltd has appointed Mr. Rohit Jawa as an Additional Director in the capacity of Independent Director, effective January 1, 2027, for a five-year term ending December 31, 2031. The board approval occurred on November 2, 2026, and is subject to shareholder approval via postal ballot. Mr. Jawa, a seasoned business leader with over 38 years of experience, previously served as the MD & CEO of Hindustan Unilever Limited until July 2025. He brings expertise in emerging markets, digital transformation, and premiumization. The company confirmed he holds no other directorships.

Board Appointment

The Board of Directors of Marico Ltd, at its meeting held on November 2, 2026, has approved the appointment of Mr. Rohit Jawa as an Additional Director. He will serve in the capacity of an Independent Director for a term of five consecutive years, beginning January 1, 2027, and ending December 31, 2031. This appointment remains subject to the approval of shareholders, which will be sought via a postal ballot. The company will communicate the process and timelines for this ballot in due course.

Profile Overview

Mr. Rohit Jawa brings over 38 years of experience in leading and transforming consumer businesses. His background spans India, South-East Asia, and North Asia, with core expertise in international growth, brand building, digitalization, and premiumization.

Notably, Mr. Jawa previously served as the Managing Director and Chief Executive Officer of Hindustan Unilever Limited until July 2025, where he was also a member of the Unilever Leadership Executive. Prior to that role, he led transformation programs for Unilever in London and served as Chairman of Unilever China. He holds an MBA from the Faculty of Management Studies (University of Delhi) and has completed executive programs at IMD Business School and Harvard Business School.

Governance and Compliance

The company has confirmed that Mr. Rohit Jawa is not related to any existing members of the Board and is not debarred from holding the office of Director by virtue of any SEBI order or other regulatory authority. Additionally, it was disclosed that Mr. Jawa does not currently hold any directorships or memberships in Board Committees of any other company.

9
General (2 Nov 2026, 9:17 pm)

Marico Ltd Reports Q2 FY27 Consolidated Revenue Growth of 13% and 31% Increase in PAT

Marico Ltd announced strong Q2 FY27 results, with consolidated revenue rising 13% to Rs 3,897 crore and PAT growing 31% to Rs 550 crore. EBITDA margins expanded 200 bps to 18.2%, marking the company's highest performance in 50 quarters. Domestic volume growth stood at 10%, with the international business delivering 13% constant currency growth. Management emphasized a shift toward premium, digital-first categories and a long-term goal of Rs 20,000 crore revenue by 2030. Key growth drivers include the Foods and Premium Personal Care portfolios, supported by the new Project SETU 2.0 initiative.

Key Highlights

MetricValue / Status
Consolidated RevenueRs 3,897 crore (13% YoY)
EBITDARs 709 crore (27% YoY)
EBITDA Margin18.2% (+200 bps)
Reported PATRs 550 crore (31% YoY)
Domestic Volume Growth10%
International CCG13%

Financial Snapshot

ParticularsQ2 FY27Q2 FY26Change (%)H1 FY27H1 FY26Change (%)
Revenue from Operations3,8973,45013%7,8546,67118%
EBITDA70956027%1,5281,21526%
EBITDA Margin (%)18.2%16.2%200 bps19.5%18.2%130 bps
PBT67455023%1,4641,20621%
Reported PAT55042031%1,18092428%

Note: All values in Rs Crore unless specified otherwise.

Business Performance

India Business

The India business recorded 10% revenue growth to Rs 2,916 crore, driven by robust volume growth. Key developments included:

  • Parachute Rigids: Sustained momentum with 13% volume growth, its highest in 22 quarters. It reached a 60% volume market share.
  • Value-Added Hair Oils: Achieved 21% value growth, marking the sixth consecutive quarter of growth.
  • Saffola Edible Oils: Reported 6% revenue growth, with the premium range growing ahead of the overall portfolio.
  • Foods: Grew by 45%, crossing an annualised revenue run rate of Rs 1,500+ crore.
  • Premium Personal Care (PPC): Including digital-first brands, this segment reported an annualised revenue run rate of Rs 500+ crore, with the broader digital-first portfolio at ~Rs 1,150 crore.

International Business

International operations maintained steady momentum with 13% constant currency growth (CCG) and 23% revenue growth in INR terms.

  • Vietnam: Delivered 22% CCG.
  • Bangladesh: Reported 5% CCG.
  • MENA: Delivered 15% CCG.
  • South Africa and NCD & Exports: Registered 15% and 17% CCG, respectively.

Outlook and Strategic Roadmap

Management maintains a positive outlook, backed by a clear strategy to shift the portfolio toward higher-margin, premium categories.

  • FY27 Target: Mid-teens revenue growth, surpassing Rs 15,000 crore revenue, and mid-twenties EBITDA growth.
  • Vision 2030: Aiming for a Rs 20,000+ crore topline, with a mid-teen EBITDA CAGR.
  • Strategic Priorities: The company is launching 'Project SETU 2.0', focusing on AI-led capabilities for assortment selling and sales-force enablement to drive further distribution expansion.

Concerns and Watch Points

  • Inflation: Management continues to monitor geopolitical volatility and weather-related risks impacting crude and vegetable oil prices.
  • Input Costs: While copra prices were 35% below peak levels, vegetable oil and crude-linked derivative costs have shown inflationary trends.

Investor Takeaway

Marico's Q2 performance demonstrates effective execution in both core and emerging segments. The combination of strong volume growth, margin expansion (highest in 50 quarters), and a clear, multi-year strategic roadmap for the 'Vision 2030' target provides a constructive outlook for shareholders. Monitoring the progress of the 'SETU 2.0' project and the company's ability to maintain premiumization amidst fluctuating commodity costs remains essential.

6
Outcome of Board Meeting (2 Nov 2026, 9:11 pm)

Marico Ltd Reports Consolidated Net Profit of Rs 558 Crore for Quarter Ended September 30, 2026

Marico Ltd announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Consolidated revenue from operations stood at Rs 3,897 crore for the quarter, compared to Rs 3,450 crore in the corresponding period of the previous year. Consolidated net profit grew to Rs 558 crore from Rs 432 crore in the same period. The company also appointed Mr. Rajan Bharti Mittal as Lead Independent Director. Additionally, Marico entered into an agreement to acquire a majority stake in Satiya Nutraceuticals Private Limited (Plix).

Financial Performance Summary

Marico Ltd reported consolidated revenue from operations of Rs 3,897 crore for the quarter ended September 30, 2026, marking an increase from Rs 3,450 crore in the same quarter last year. The consolidated net profit for the period rose to Rs 558 crore, compared to Rs 432 crore in the corresponding quarter of the previous year.

For the half-year ended September 30, 2026, consolidated revenue stood at Rs 7,854 crore, up from Rs 6,671 crore in the half-year ended September 30, 2025. Consolidated net profit for the half-year period was Rs 1,210 crore, compared to Rs 945 crore in the prior-year period.

Corporate Developments

The Board of Directors has approved the appointment of Mr. Rajan Bharti Mittal (DIN: 00028016) as the Lead Independent Director of the company, effective November 2, 2026.

Strategic Acquisition

Subsequent to the quarter end, Marico entered into a definitive agreement on October 5, 2026, to acquire an additional 38.18% stake in Satiya Nutraceuticals Private Limited ("Plix"). This transaction, executed in tranches, brings the company's total stake in Plix to 84.09% on a fully diluted basis. The acquisition of the remaining 14.09% stake is scheduled for completion in July 2027, subject to the terms and conditions of the agreement.

Notes on Financials

The company noted an intra-group restructuring involving the integration of the business of Zed Lifestyle Private Limited ("Beardo") into Marico on a going concern basis, effective June 29, 2026. Additionally, the company performed a retrospective reclassification of certain customer-related advertisement and promotional expenses, netting them off against Revenue from Operations. This change did not impact profit before tax, net profit, EPS, or total equity for the comparative periods.

7
Financial Results (2 Nov 2026, 9:08 pm)

Marico Ltd Reports Q2 FY27 Consolidated Financials; Announces Strategic Stake Increase in Plix and Governance Changes

Marico Limited reported consolidated revenue from operations of Rs 3,897 crore for the quarter ended September 30, 2026, marking an increase from the restated Rs 3,450 crore in the same quarter last year. Net profit for the period stood at Rs 558 crore, compared to Rs 432 crore in the year-ago period. The company also announced the appointment of Mr. Rajan Bharti Mittal as Lead Independent Director. Strategic highlights include a post-quarter increase in stake in Satiya Nutraceuticals Private Limited (Plix) to 84.09% and the earlier acquisition of Skinetiq in Vietnam.

Financial Performance

Marico Limited's consolidated financial results for the quarter ended September 30, 2026, show steady performance against the previous year.

Consolidated Financial Snapshot (Rs in crore)

MetricQ2 FY27 (Sept 30, 2026)Q2 FY26 (Sept 30, 2025) (Restated)
Revenue from Operations3,8973,450
Profit before tax674550
Net Profit for the period558432
EPS (Basic) (Rs.)4.243.24

Strategic Developments

Acquisitions and Restructuring

  • Satiya Nutraceuticals Private Limited (Plix): Subsequent to the quarter, on October 5, 2026, Marico entered into a definitive agreement to acquire an additional 38.18% stake in Plix. This takes the company's total stake to 84.09% on a fully diluted basis. The remaining 14.09% is expected to be acquired in July 2027.
  • Skinetiq (Vietnam): The company acquired a 75% stake in Skinetiq, a Vietnam-based entity owning the digital-first skincare brand "Murad," effective April 2, 2026.
  • Internal Restructuring: The company completed the integration of "Just Herbs" (effective October 1, 2025) and "Beardo" (effective June 29, 2026) through voluntary liquidation and distribution of business undertakings to the company.

Accounting and Governance

Accounting Policy Change

  • The Group reclassified certain customer-related advertisement and promotional expenses. These amounts, previously included in "Advertisement and Sales Promotion expenses," are now netted off from "Revenue from Operations." This change was applied retrospectively to comparative periods and does not impact the profit before tax, net profit, or EPS.

Governance Update

  • The Board of Directors appointed Mr. Rajan Bharti Mittal (DIN: 00028016), an Independent Director, as the Lead Independent Director, effective November 2, 2026.

What Looks Positive

  • The company reported a year-over-year increase in both consolidated revenue and net profit for the quarter.
  • Continued execution of the growth strategy through targeted acquisitions in the wellness and skincare segments.

Watch Points

  • Integration Risks: As the company integrates various business units like Plix, Skinetiq, Just Herbs, and Beardo, investors should monitor the realization of expected synergies.
  • Future Obligations: The acquisition of the remaining stake in Plix is scheduled for July 2027 and is subject to the terms and conditions of the agreement.
3
Press Release / Media Release (22 Oct 2026, 5:06 pm)

Marico Reports 89.3% Reduction in Operational Emissions Intensity Since FY13

Marico Limited announced progress on its ESG 2030 Roadmap, achieving an 89.3% reduction in Scope 1 and Scope 2 GHG emissions intensity against its FY13 baseline. The company also recorded a 29.95% reduction in Scope 3 emissions intensity compared to its FY19 baseline. During FY2025-26, 77.3% of Marico's operational energy consumption was derived from renewable sources. The firm reiterated its Net Zero ambitions, targeting Indian operations by 2030 and global operations by 2040. These disclosures were released on the International Day of Climate Action.

Climate Action Progress

Marico Limited has highlighted significant advancements in its decarbonisation efforts, aligning with its ESG 2030 Roadmap. The company aims for Net Zero emissions in its Indian owned manufacturing units by 2030 and across its global operations by 2040. The current progress is attributed to a mix of renewable energy adoption, energy-efficiency measures, process optimization, and the transition to lower-carbon energy sources.

Key ESG Figures

MetricPeriod/BaselineValue
Scope 1 & 2 Emissions Intensity ReductionSince FY1389.3%
Scope 3 Emissions Intensity ReductionSince FY1929.95%
Renewable Energy in Ops Energy ConsumptionFY2025-2677.3%
Scope 1 & 2 Emissions IntensityFY2025-260.84 tCO₂e/crore revenue
Targeted Scope 1 & 2 Reduction by 2030vs FY1393%

Strategic Outlook

As part of its decarbonisation roadmap, Marico is targeting a 93% reduction in Scope 1 and Scope 2 emissions by 2030 compared to its FY13 baseline. The company intends to address residual emissions through carbon sequestration initiatives and verified carbon offsets. The company's Climate Transition Plan aims to integrate these environmental initiatives with its overall business strategy, supply chain management, and long-term growth planning to strengthen business resilience.

Management Commentary

Amit Bhasin, Chief Legal Officer, Group General Counsel and Secretary, CSR Committee of Marico Limited, stated that climate action is an integral component of the company's business strategy. He emphasized that building a future-ready organization requires sustainability to be embedded across operations, supply chains, and decision-making processes.

5
Audio Recording (15 Oct 2026, 4:31 pm)

Marico Ltd to hold Q2FY27 earnings conference call on November 2, 2026

Marico Ltd has scheduled an investor and analyst conference call for Monday, November 2, 2026, at 6:00 p.m. IST. The session follows the company's Board meeting and announcement of financial results for the quarter and half-year ended September 30, 2026. Management, including MD & CEO Saugata Gupta and Group CFO & CEO (International Business) Pawan Agrawal, will discuss the company's financial performance and operations. An audio recording and transcript will be made available on the company's website after the call.

Key Highlights

ItemDetails
EventQ2FY27 Earnings Conference Call
DateMonday, November 2, 2026
Time6:00 p.m. IST
Reporting PeriodQuarter and half-year ended September 30, 2026
Management AttendeesSaugata Gupta (MD & CEO), Pawan Agrawal (Group CFO & CEO - International Business)
Call LeaderSaurabh Khaitan

Conference Call Details

Marico Ltd has organized a conference call to discuss its financial results for the quarter and half-year ended September 30, 2026. The call is scheduled for November 2, 2026, following the Board of Directors' meeting on the same day.

Participation and Access

Investors and analysts can participate via the provided dial-in numbers or register via a "diamond pass" link to bypass the queue. A live webcast option is also available for those wishing to listen online. An audio recording and transcript of the call will be published on the company's website shortly after the event concludes.

What This Means for Investors

This announcement serves as a schedule update for upcoming financial results. Investors should anticipate the release of the official financial statements on November 2, 2026, prior to the call. The conference call will provide management's perspective on the company's operational performance, market dynamics, and outlook for the period.

Investor Takeaway

This is a standard procedural filing confirming the date and time for Marico's Q2 earnings call. No financial information was disclosed in this notice.

2
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 (9 Oct 2026, 8:49 pm)

Marico Ltd - Filing of Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations for Quarter Ended September 30, 2026

Marico Ltd has submitted the quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the period ended September 30, 2026. The certificate, issued by the Registrar and Share Transfer Agent, MUFG Intime India Private Limited, confirms that all securities received for dematerialization during the quarter were processed, verified, and listed according to regulatory mandates. This filing represents standard regulatory compliance and contains no changes to company operations or financial status.

Compliance Certificate Filing

Marico Ltd has filed the compliance certificate for the quarter ended September 30, 2026, pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

Key Details

  • Filing Date: October 9, 2026
  • Reporting Period: Quarter ended September 30, 2026
  • Registrar and Share Transfer Agent (RTA): MUFG Intime India Private Limited

Regulatory Confirmation

The certificate issued by the RTA confirms that for the securities received for dematerialization during the quarter:

  1. The securities comprised in the certificates have been listed on the stock exchanges where the earlier issued securities are listed.
  2. The security certificates received for dematerialization were confirmed/rejected to the depositories.
  3. The security certificates were mutilated and cancelled after due verification by the depository participant.
  4. The name of the depositories has been substituted in the register of members as the registered owner within the prescribed timelines.

What This Means for Investors

This filing is a mandatory administrative requirement for listed companies to ensure that the dematerialization process is handled correctly by the RTA and that securities are properly listed. It provides assurance regarding the integrity of the share dematerialization process but does not influence the company's fundamental performance or outlook.

3
Board Meeting (9 Oct 2026, 8:24 pm)

Marico Ltd Schedules Board Meeting for November 2, 2026

Marico Ltd has notified the exchanges that its Board of Directors will meet on November 2, 2026. The primary agenda is to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2026. In compliance with internal code of conduct regulations, the company has also announced that the trading window for dealing in its securities remains closed from September 26, 2026, through November 4, 2026, inclusive.

Board Meeting Notice

Marico Ltd has officially informed the exchanges that a meeting of its Board of Directors is scheduled for Monday, November 2, 2026. The meeting will be held to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, along with the Limited Review Report of the Auditors thereon.

Trading Window Closure

The company has confirmed that the trading window for dealing in Marico Ltd's shares is closed effective from September 26, 2026, until November 4, 2026, inclusive. This closure is a standard procedural requirement in advance of the financial results announcement to prevent insider trading.

7
Acquisition (6 Oct 2026, 1:44 am)

Marico Ltd Increases Stake in Satiya Nutraceuticals to 84.09% in Rs 1,012 Crore Deal

Marico Ltd has acquired an additional 24.09% stake in Satiya Nutraceuticals, the owner of the 'PLIX' brand, for Rs 1,012.03 crore. This transaction increases Marico's aggregate stake in the subsidiary to 84.09% on a fully diluted basis. The company further plans to acquire the remaining 14.09% stake in July 2027 for a base consideration of up to Rs 592 crore, subject to milestone conditions. The investment aligns with Marico's strategy to strengthen its footprint in the rapidly growing health, wellness, and personal care segments.

Key Highlights

ItemDetails
CompanyMarico Ltd
Target EntitySatiya Nutraceuticals Private Limited (Brand: 'PLIX')
ActionAcquisition of 24.09% stake
StatusCompleted (October 5, 2026)
InvestmentRs 1,012.03 crore
Post-Deal Stake84.09% (fully diluted)
Future PlanAcquisition of remaining 14.09% in July 2027

Transaction Details

Marico Ltd has entered into definitive agreements to acquire a 38.18% stake in Satiya Nutraceuticals from its founders and other shareholders. As a first step, the company has completed the acquisition of 24.09% of this stake, moving its aggregate holding from 60% to 84.09% on a fully diluted basis.

The current tranche of acquisition involved a cash consideration of Rs 1,012.03 crore. The aggregate consideration for the 84.09% stake stands at Rs 1,392.07 crore.

Marico is scheduled to acquire the remaining 14.09% stake in July 2027. This final tranche will have a base consideration of up to Rs 592 crore, with additional payments subject to specific milestones and terms defined in the agreements.

Target Company Performance

Satiya Nutraceuticals is headquartered in Mumbai and operates in the health, wellness, and personal care segments. The company's consolidated turnover over the last three fiscal years is as follows:

Financial YearConsolidated Turnover (Rs crore)
FY 2025-26864.31
FY 2024-25432.84
FY 2023-24155.32

Strategic Rationale

The acquisition is part of Marico's strategy to expand its total addressable market in value-added foods and nutrition. By increasing its stake, Marico aims to cement its presence in the rapidly growing personal care and wellness categories where 'PLIX' operates.

Governance and Related Parties

Marico disclosed that the acquisition involves founders and related entities of Satiya Nutraceuticals, classifying it as a related party transaction. The company confirmed that the transaction is conducted at arm's length, and the Promoter/Promoter Group of Marico has no interest in the entity being acquired.

What This Means for Investors

For shareholders, this transaction demonstrates Marico's active capital allocation strategy towards high-growth, modern consumer segments. The clear roadmap for the remaining acquisition suggests a phased integration plan. Investors should monitor the performance of the 'PLIX' brand and its contribution to the consolidated financial results in upcoming quarters.

8
General (5 Oct 2026, 2:11 pm)

Marico Ltd Expects Double-Digit Revenue Growth in Q2 FY27; Anticipates Surpassing Guidance

Marico Limited provided a pre-earnings update for Q2 FY2026-27, reporting strong domestic demand with double-digit underlying volume growth. The company expects consolidated revenue to grow in double digits, with operating profit projected to grow in the mid-twenties. Key drivers include robust performances in Parachute Coconut Oil and Value Added Hair Oils, alongside teens growth in international markets. Marico indicated it is likely to surpass its near-term financial guidance, supported by favorable portfolio mix and copra price tailwinds, despite higher investment in brand building initiatives.

Key Highlights

  • Consolidated Outlook: Expecting double-digit revenue growth.
  • Operating Profit: Projected to grow in the mid-twenties.
  • Domestic Performance: Underlying volume growth reached double digits.
  • Guidance: Company expects to surpass near-term financial targets.

Business Performance

The India business demonstrated robust momentum in Q2 FY27:

  • Parachute Coconut Oil: Sustained strong performance with volume growth in the early teens.
  • Saffola Oils: Delivered mid-single digit price-led growth, though volumes declined due to focus on maintaining threshold profitability and supply rationalization.
  • Value Added Hair Oils: Reported growth in the twenties for the sixth consecutive quarter, supported by 'Project SETU' and expansion in the Almond category.
  • International Business: Achieved constant currency growth in the teens, driven by strong performance in Vietnam, the Middle East, and South Africa. Bangladesh saw marginal sequential improvement.

Cost Dynamics and Margins

  • Input Costs: Crude-linked derivatives prices continued to rise.
  • Copra Prices: Remained rangebound at approximately 35% below peak levels, providing a tailwind.
  • Margins: The company expects a strong acceleration in gross margins YoY, aided by a favorable portfolio mix and copra price stability.
  • Investments: ASP (Advertising and Sales Promotion) investments increased significantly to support brand building and growth initiatives.

Management Commentary

Marico noted that with a strong performance in the first half of the year, it is likely to surpass its near-term guidance across key financial parameters. The company maintains its aspiration for sustainable, profitable, volume-led growth over the medium term.

What This Means for Investors

The update signals a positive trajectory for Marico, characterized by strong volume growth in core portfolios and improved profitability. The expectation of mid-twenties operating profit growth suggests effective margin management despite increased marketing investments. Investors should monitor the sustainability of the domestic volume growth in subsequent quarters and the impact of persistent inflation on consumer demand.

2
Change in Directorate (1 Oct 2026, 8:41 pm)

Marico Ltd Announces Retirement of Independent Director Rajeev Vasudeva

Marico Limited announced the retirement of Mr. Rajeev Vasudeva as an Independent Director, effective at the end of the day on October 31, 2026, due to increased professional commitments. Following his departure, Mr. Rajeev Vasudeva will also step down as the Chairman of the Nomination and Remuneration Committee. Concurrently, the company has announced the appointment of Mr. Bhaskar Bhat as the new Chairman of the Nomination and Remuneration Committee, effective November 1, 2026. This transition constitutes a routine board-level change.

Board and Governance Update

Marico Limited has officially announced the retirement of Mr. Rajeev Vasudeva from his position as an Independent Director. In a disclosure to the stock exchanges, the company confirmed that Mr. Vasudeva will not seek re-appointment upon the conclusion of his current term. This decision is attributed to his increasingly onerous professional commitments, both in India and overseas.

The retirement is scheduled to be effective from the end of the day on October 31, 2026. Consequently, Mr. Vasudeva will also cease his role as the Chairman of the Nomination and Remuneration Committee as of the same date.

Leadership Succession

The Board has approved the appointment of Mr. Bhaskar Bhat as the new Chairman of the Nomination and Remuneration Committee. This appointment is scheduled to take effect on November 1, 2026.

Change DescriptionDetails
Departing DirectorMr. Rajeev Vasudeva
Effective Retirement DateOctober 31, 2026
Former Committee RoleChairman, Nomination and Remuneration Committee
Incoming Committee ChairMr. Bhaskar Bhat
Effective Appointment DateNovember 1, 2026

This update is a procedural governance matter and does not impact the company's financial results or operational activities.

3
General (18 Sept 2026, 11:05 pm)

Marico Ltd reports unsolicited ESG rating of 76 by Niche

Marico Ltd informed the stock exchanges that it received an unsolicited ESG score of 76 from Niche Ninety Nine Capability and Certifications (OPC) Private Limited, categorizing the company as a 'Leader' under the agency's methodology. The disclosure was made following an intimation via the System Driven Disclosure mechanism from the BSE. Marico explicitly clarified that it did not engage Niche for this assessment, and the rating was determined independently by the ESG rating provider. This update serves as a routine procedural filing regarding third-party ESG assessments.

ESG Rating Disclosure

Marico Ltd has informed the stock exchanges regarding an ESG rating notification received from the BSE via the System Driven Disclosure (SDD) mechanism.

Rating Overview

ItemDetails
Rating ProviderNiche Ninety Nine Capability and Certifications (OPC) Private Limited
ESG Score76
CategoryLeader
Engagement StatusNot engaged by the Company (Independent)

Management Clarification

Marico Ltd explicitly clarified that it has not engaged Niche for the purpose of this ESG assessment. The company stated that the rating was determined independently by the rating provider.

Investor Takeaway

This filing is procedural in nature, fulfilling the requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Investors should note that the assessment was not commissioned by the company.

2
Analyst / Investor Meet (10 Sept 2026, 11:51 pm)

Marico Ltd Announces Schedule of Analyst and Investor Conferences for September 2026

Marico Ltd has disclosed its participation in two upcoming investor conferences scheduled for September 2026. The company will attend the 2026 Jefferies India Forum in Gurgaon on September 17, 2026, and the J.P. Morgan India Conference in Mumbai on September 22, 2026. Management has clarified that these interactions will not involve the sharing of any unpublished price-sensitive information, and standard corporate presentation materials are available on the company's website. This filing is a routine procedural update regarding investor engagement activities in compliance with SEBI regulations.

Investor Meeting Schedule

Marico Ltd has filed an intimation regarding its participation in upcoming investor conferences scheduled for September 2026. The management team is set to engage with investors and analysts at the following events:

Event NameDateLocation
2026 Jefferies India ForumSeptember 17, 2026Gurgaon
J.P. Morgan India ConferenceSeptember 22, 2026Mumbai

Disclosure and Compliance

The company confirmed that these meetings will be conducted in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Marico Ltd stated that no unpublished price-sensitive information (UPSI) will be shared with attendees. Interested stakeholders can access the presentation materials typically used by company officials during such interactions on the official Marico investor relations website.

3
Allotment of ESOP / ESPS (8 Sept 2026, 10:05 pm)

Marico Ltd Allots 18.01 Lakh Equity Shares Under ESOP 2016

Marico Ltd has allotted 18,00,600 equity shares of face value Re 1 each under its ESOP 2016 scheme. The allotment includes 1,800,000 shares issued to the Welfare of Mariconians Trust (WEOMA Trust) for the implementation of cashless exercise facilities and 600 shares to an eligible grantee upon the exercise of stock options. Following this issuance, the company's total paid-up share capital has increased to 1,30,01,88,450 equity shares. The newly allotted shares will rank pari-passu with existing equity shares.

Allotment Details

On September 8, 2026, the Securities Committee of the Board of Directors of Marico Ltd approved the allotment of 18,00,600 equity shares of face value Re 1 each under the Marico Employee Stock Option Plan, 2016 (ESOP 2016). The allotment consists of two tranches:

  • WEOMA Trust: 1,800,000 equity shares issued to the Welfare of Mariconians Trust, represented by IDBI Trusteeship Services Limited, to facilitate the cashless exercise of stock options by employees.
  • Employee Grantee: 600 equity shares issued to an eligible employee pursuant to the exercise of stock options under the ESOP 2016 scheme.

Capital Structure Impact

As a result of this allotment, the company's paid-up share capital has increased. The comparative figures are as follows:

ItemPre-AllotmentPost-Allotment
Total Equity Shares1,29,83,87,8501,30,01,88,450
Face ValueRe 1Re 1

Pricing and Terms

  • Trust Issuance: The shares allotted to the WEOMA Trust were issued at an issue price of Rs 802.50 per share (comprising a premium of Rs 801.50 per share).
  • Grantee Exercise: The shares allotted to the eligible employee grantee were issued at an exercise price of Rs 545.34 per share (comprising a premium of Rs 544.34 per share).
  • Ranking: All newly allotted equity shares rank pari-passu with the existing equity shares of the company.

Compliance

The disclosure is made in accordance with Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

3
General (4 Sept 2026, 1:18 am)

Marico Ltd Receives 'Leader' ESG Rating of 79 for FY 2026

Marico Ltd has been assigned an ESG rating of 79 for FY 2026 by NSE Sustainability Ratings & Analytics Limited, placing it in the 'Leader' category. The company clarified that this assessment was conducted independently by the rating agency without prior engagement from Marico. This disclosure fulfills the requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Investors may note this recognition of the company's performance across environmental, social, and governance parameters.

ESG Rating Update

Marico Ltd has been assigned an ESG rating of 79 for the financial year 2026 by NSE Sustainability Ratings & Analytics Limited. This rating places the company in the "Leader" category according to the assessment parameters set by the agency, reflecting the company's performance across environmental, social, and governance criteria.

Key Clarification

The company explicitly clarified that it did not engage NSE Sustainability for the purpose of this specific ESG assessment. The rating was determined independently by the agency.

What This Means for Investors

This development serves as an external validation of the company's ongoing ESG efforts. For shareholders, such recognition may contribute to the company's profile regarding sustainability and corporate governance, which are increasingly important factors in modern investment analysis. However, as this is an independently assigned rating, it remains an assessment by a third party rather than a direct operational or financial metric.

This intimation was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

4
Credit Rating (3 Sept 2026, 1:50 am)

Marico Ltd - 531642 - Reaffirmation of Credit Ratings by CRISIL

Marico Ltd announced that CRISIL Ratings Limited has reaffirmed its credit ratings for the company's bank facilities. The long-term bank loan facilities continue to be rated at CRISIL AAA/Stable, while the short-term bank loan facilities are rated at CRISIL A1+. This reaffirms the company's existing credit profile, including its ESG evaluation. The disclosure is a routine procedural update regarding the agency's periodic review of the company's creditworthiness.

Credit Rating Update

Marico Ltd informed the stock exchanges on September 2, 2026, that CRISIL Ratings Limited has completed its review and reaffirmed the company's credit ratings.

Rating Details

The rating action covers the company's various bank facilities:

FacilityRating
Long-term bank loan facilitiesCRISIL AAA/Stable (Reaffirmed)
Short-term bank loan facilitiesCRISIL A1+ (Reaffirmed)

Investor Takeaway

This disclosure represents a reaffirmation of the company's existing credit standing. The "AAA/Stable" and "A1+" ratings indicate the highest degree of safety for long-term and short-term debt servicing, respectively, according to CRISIL's rating definitions. Investors should note this update as a confirmation of stability in the company's financial profile.

2
Analyst / Investor Meet (2 Sept 2026, 1:10 am)

Marico Ltd to Participate in Non-Deal Roadshow in London on September 7-8, 2026

Marico Limited has announced that its management will participate in one-on-one and group meetings with investors in London. These meetings are scheduled for September 7 and September 8, 2026, as part of a Non-Deal Roadshow organized by Goldman Sachs (India) Securities Private Limited. The company explicitly stated that no unpublished price-sensitive information will be shared during these interactions. The company's standard investor presentation remains accessible on its official website. This disclosure is a routine regulatory compliance intimation regarding planned investor relations activities.

Investor Interaction Details

Marico Limited has informed the stock exchanges of an upcoming Non-Deal Roadshow in London. The company's management will conduct a series of one-on-one and group meetings with investors.

  • Event: Non-Deal Roadshow
  • Organizer: Goldman Sachs (India) Securities Private Limited
  • Location: London
  • Dates: September 7, 2026, to September 8, 2026

Regulatory and Compliance Disclosure

The company confirmed that these meetings will be conducted in compliance with regulatory standards. Specifically, Marico noted that no unpublished price-sensitive information (UPSI) will be shared during these interactions. Interested parties may access the company's standard investor presentation, which is publicly available on its website.

2
Newspaper Publication (28 Aug 2026, 11:30 pm)

Marico Ltd - Public Notice Regarding Transfer of Unclaimed Dividends and Shares to IEPF

Marico Limited has published a public notice in accordance with the IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, and SEBI regulations. The company is notifying shareholders that the 1st Interim Dividend for the financial year 2019-20 has remained unclaimed for seven consecutive years. Consequently, the unpaid dividend and the underlying shares are due to be transferred to the Investor Education and Protection Fund (IEPF). Shareholders are advised to lodge their claims with the company's Registrar and Transfer Agent by November 23, 2026, to avoid the transfer of these assets to the IEPF authority.

Publication Details Marico Limited has issued a public notice regarding the transfer of equity shares and unpaid dividends to the Investor Education and Protection Fund (IEPF). This action is taken in compliance with the IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice appeared in the August 28, 2026, editions of Business Standard (English) and Navshakti (Marathi). ## Important Dates * Publication Date: August 28, 2026 * Deadline for Claims: November 23, 2026 ## Shareholder Instructions Shareholders who have not claimed their 1st Interim Dividend for the financial year 2019-20 for seven consecutive years are urged to lodge their claims immediately. Failure to do so by the specified deadline will result in the transfer of both the dividend amount and the underlying shares to the IEPF. Shareholders may contact the Company or its Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited, for assistance. Claims can also be processed post-transfer through the IEPF Authority via the Form IEPF-5 process. ## Regulatory Context This notice follows the statutory requirement under the Companies Act, 2013, read with the IEPF Rules, which mandates the transfer of dividends and shares that have remained unclaimed for a period of seven consecutive years to the IEPF. ## What Shareholders Should Know Existing shareholders with unpaid dividends or physical shares should check their records and, if eligible, comply with the RTA's documentation requirements before the November 23, 2026 deadline to ensure their holdings remain within their own demat or physical folios.

3
Press Release / Media Release (27 Aug 2026, 11:19 pm)

Marico Ltd Reports 547 Crore Litres of Cumulative Water Conservation Potential under Jalashay Programme

Marico Ltd announced its progress in water stewardship for FY26, reporting a cumulative 547 crore litres of water conservation potential through its Jalashay Programme. The initiative covers operations in Maharashtra, Gujarat, Tamil Nadu, and Pondicherry. Key operational milestones include a 24% reduction in water consumption intensity compared to the FY22 baseline, achieving Zero Liquid Discharge (ZLD) status at facilities in Perundurai and Puducherry, and certifying 25% of its manufacturing footprint in water-stressed zones as water neutral. The company continues to advance its ESG 2030 roadmap and sustainability goals.

Water Stewardship Progress

Marico Limited has reaffirmed its commitment to its ESG 2030 roadmap by detailing the achievements of its flagship 'Jalashay Programme' during World Water Week 2026. The company has focused on water stewardship by partnering with local communities and stakeholders.

Key Operational Achievements

  • Water Conservation Potential: The company reported a cumulative creation of 547 crore litres of water conservation potential through the Jalashay Programme as of FY26.
  • Operational Efficiency: The company achieved a 24% reduction in water consumption intensity in FY26 compared to the FY22 baseline.
  • Certification and Infrastructure:
    • 25% of the company's manufacturing footprint in water-stressed zones has been certified as water neutral.
    • The manufacturing facilities at Perundurai, Tamil Nadu, and Puducherry have achieved Zero Liquid Discharge (ZLD) status.

Geographic and Strategic Scope

The Jalashay Programme operates across four states: Maharashtra, Gujarat, Pondicherry, and Tamil Nadu. One highlighted intervention area is Jalgaon, Maharashtra, where the initiative has created 70 crore litres of water potential, benefiting more than 4,000 farmers across seven villages.

ESG 2030 Roadmap

Water stewardship is a foundational pillar of Marico's broader sustainability agenda. The company aims to achieve water neutrality certification across 100% of its manufacturing units located in water-stressed zones as part of its long-term strategic goals.

Investor Takeaway

This announcement serves as a progress update regarding Marico's ESG initiatives. For existing shareholders, it underscores the company's efforts to align its operational growth with environmental sustainability targets. While these metrics reflect positive corporate governance and long-term risk mitigation regarding resource availability, they are standard operational updates and do not represent a change in the company's financial or near-term commercial trajectory.

5
AGM (26 Aug 2026, 1:40 am)

Marico Ltd Holds 38th AGM; Management Reaffirms Vision 2030 and FY27 Growth Aspirations

Marico Ltd held its 38th Annual General Meeting on August 6, 2026, where the company highlighted its FY26 performance and strategic roadmap. The company reported a consolidated revenue of Rs 13,611 crore, up 26% year-on-year, and a recurring consolidated profit after tax of Rs 1,762 crore. Management reaffirmed its Vision 2030 target of achieving Rs 20,000 crore in revenue, with a near-term aspiration of crossing Rs 15,000 crore in FY27 with high-teen EBITDA growth. The Q&A session addressed investor queries regarding bonus issues, inorganic growth, and product innovations, with the management noting requests for bonus shares for future consideration.

Key Highlights

Marico's 38th Annual General Meeting focused on reviewing the company’s FY26 performance and outlining the strategic path toward its Vision 2030 goals. Management emphasized resilience in a volatile environment, marked by input cost inflation and geopolitical challenges, while highlighting progress in portfolio transformation and digital enablement.

Financial Snapshot

MetricFY26 ValueGrowth (YoY)
Consolidated RevenueRs 13,611 crore26%
Recurring Consolidated PATRs 1,762 crore11%
India Business TurnoverRs 10,348 crore28%
  • Operating Margin: The operating margin stood at 17.1%, representing a decline of 265 bps compared to the previous year due to significant input cost inflation.

Vision and Growth Targets

Management reiterated its medium-term and long-term aspirations:

  • Vision 2030: Achieve Rs 20,000 crore in revenue.
  • FY27 Aspiration: Achieve Rs 15,000 crore in revenue with high-teen EBITDA growth.

Business and Operational Performance

  • Segments: The Foods business crossed Rs 1,000 crore in revenue. Premium Personal Care achieved an annualised revenue run-rate (ARR) of over Rs 1,100 crore by year-end.
  • Digital & Quick Commerce: Digital salience reached 20% of the India business. Quick Commerce salience increased to ~5%.
  • Distribution: Project SETU is on track to achieve ~1.5x direct reach by FY27.

Management Q&A Highlights

QueryManagement Response
Bonus IssueNoted the request; the Board will consider it at an appropriate time.
Inorganic GrowthThe company evaluates both organic and inorganic opportunities guided by a defined framework.
New Products25 new products launched in India (17 globally) in FY26, contributing ~5% to consolidated revenues.
CounterfeitingMarico has a dedicated Brand Protection team that conducts market surveys and initiates legal proceedings.
Board DiversityAim to achieve 30% gender diversity in leadership roles by 2030.

Concerns and Watch Points

  • Input Costs: Crude-linked input costs remain a monitorable risk, which the company intends to manage through calibrated pricing and cost initiatives.
  • Competition: The competitive landscape in both offline and online marketplaces remains intense, requiring consistent brand investment and innovation.

Investor Takeaway

The AGM underscored Marico's focus on maintaining double-digit revenue growth and enhancing its digital-first portfolio. While the company faces margin pressures from input costs, its long-term strategic roadmap (Vision 2030) remains the key focus for future value creation. Shareholders should monitor the company's ability to scale high-growth adjacencies and maintain its leadership position in core categories.

3
General (20 Aug 2026, 11:57 pm)

Marico Ltd Receives 'Strong' ESG Rating from ESG Risk Assessments & Insights Limited

Marico Ltd has informed the exchanges that it has been assigned an ESG score of 68, classified as 'Strong,' by SEBI-registered provider ESG Risk Assessments & Insights Limited. The company noted that it did not commission this assessment and that the rating was determined independently by the provider. This filing is a routine disclosure under SEBI listing regulations and carries no direct financial implications for the company.

ESG Rating Disclosure

Marico Limited has informed stock exchanges that it has been assigned an ESG score of 68 by ESG Risk Assessments & Insights Limited, a SEBI-registered ESG Rating Provider. The provider has categorized this score as 'Strong' based on its internal methodology.

Clarification on Engagement

Marico Limited explicitly clarified that it had not engaged ESG Risk Assessments & Insights Limited for the purpose of this ESG assessment. The rating was determined independently by the agency.

Investor Takeaway

This intimation is a routine regulatory compliance filing under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It serves as public disclosure of an unsolicited third-party assessment of the company's ESG performance.

8
Earnings Call Transcript (12 Aug 2026, 1:19 am)

Marico Limited Reports Strong Q1 FY27 Results with 23% Consolidated Revenue Growth

Marico Limited delivered a robust start to FY27, reporting 23% consolidated revenue growth and a 25% increase in both EBITDA and PAT for the quarter ended June 30, 2026. This marks the company's highest profit growth in 28 quarters. The India business achieved 11% volume growth and 21% revenue growth, supported by core business resilience in Parachute Rigids and VAHO. New growth engines, including the Foods and Premium Personal Care portfolios, continue to scale, with significant annualized revenue run rates achieved. Management remains optimistic, targeting double-digit revenue growth to exceed ₹15,000 crore for the full year.

Key Highlights

ItemDetails
Consolidated Revenue Growth23%
EBITDA Growth25%
PAT Growth25%
India Business Volume Growth11%
EBITDA Margin20.7%

Financial Snapshot

Marico delivered a strong start to the year, with consolidated revenue growing 23% and both EBITDA and PAT rising 25%. This represents the highest profit growth for the company in 28 quarters. India business performance was a significant driver, delivering 11% volume growth and 21% revenue growth, reflecting resilience in the core portfolio and successful scale-up of new growth engines.

Margin Analysis

EBITDA margin improved 40 basis points year-on-year to 20.7%. Gross margin expanded 30 basis points, aided by softer copra prices and a favorable portfolio mix. Management also noted a 25% growth in advertising and sales promotion (A&P) expenses, reflecting sustained investment in brand equity and new product launches.

Portfolio Performance

  • Parachute Rigids: Reported 10% volume growth, marking the strongest performance in 20 quarters, with over 400 basis points gain in volume share.
  • VAHO (Value Added Hair Oils): Delivered 22% value growth, led by the mid and premium segments.
  • New Growth Engines:
    • Foods: Reached an annualized revenue run rate (ARR) of ₹1,300 crore.
    • Digital-first Portfolio: Achieved an ARR of ₹1,100 crore.
    • Premium Personal Care: Reached an ARR of ₹450 crore.

Strategic Developments

Management emphasized an "And" theory for channel strategy, investing in both traditional General Trade (GT) and alternate channels like quick commerce. The company has officially entered the shampoo category with a national launch under the Parachute Advanced brand, aiming to build critical mass. The focus remains on profitable growth, reducing the share of commodity-linked businesses and pivoting toward premium categories.

Outlook and Guidance

  • Full Year Revenue: Targeting double-digit growth to cross ₹15,000 crore.
  • EBITDA: Confident in high-teens EBITDA growth, with an aspiration to touch 20%.
  • Volume Growth: Expecting high single-digit volume growth for India and mid-teens constant currency growth for the international business.

Risks and Watch Points

  • Input Costs: Management noted divergent trends; while copra has corrected, crude-led derivatives (LP, polymers) and edible oils are experiencing significant cost pressures.
  • Channel Trends: A slight relative slowing down was noted in growth within modern trade and marketplace e-commerce.

Investor Takeaway

Marico has demonstrated strong execution capability in Q1 FY27, balancing robust volume growth in core segments with profitable scaling of new ventures like Foods and Digital-first brands. The company's focus on maintaining profitability thresholds while capturing share in large addressable markets provides a clear strategic direction. Investors should track the progress of new categories like shampoos and monitor input cost dynamics, particularly for crude-linked derivatives, which may influence gross margins in subsequent quarters.

4
General (11 Aug 2026, 11:28 pm)

Marico Limited Receives Unsolicited 'Leadership' ESG Rating of 71 from CRISIL

Marico Limited has disclosed that CRISIL ESG Ratings & Analytics Limited has assigned it an ESG score of 71, placing the company in the 'Leadership' category. The company clarified that this assessment was unsolicited and conducted independently by the rating agency. As per SEBI regulations, this intimation serves as a formal update on the company's external ESG benchmarking. For investors, this ESG score provides a snapshot of the company's external sustainability standing, though the unsolicited nature of the report should be considered in the overall evaluation of this information.

ESG Rating Update

Marico Limited has informed the stock exchanges regarding an external ESG assessment. The company received an ESG score of 71 from CRISIL ESG Ratings & Analytics Limited, which classifies the company under the 'Leadership' category according to the agency's methodology.

Understanding the Assessment

It is important for investors to note the following context provided by the company:

  • Unsolicited Rating: The company has clarified that it did not engage the agency to perform this assessment.
  • Independent Determination: The rating was calculated and determined independently by the agency without company involvement.
  • Regulatory Disclosure: This information was shared by the company to comply with transparency requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Investor Takeaway

The receipt of an ESG score of 71, categorized as 'Leadership', highlights a positive external perspective on the company's ESG practices. However, because the rating was unsolicited and not commissioned by the company, it serves as an independent external view rather than a company-sponsored certification. Investors should view this as an additional data point regarding the company's non-financial and sustainability-related standing rather than a direct operational or financial update.

3
Allotment of ESOP / ESPS (10 Aug 2026, 6:52 pm)

Marico Limited Allots 1,451 Equity Shares Under ESOP 2016

Marico Limited has announced the allotment of 1,451 equity shares of face value Re. 1 each under its Employee Stock Option Plan (ESOP) 2016. This allotment, approved by the Securities Committee of the Board on August 10, 2026, follows the exercise of vested stock options by eligible grantees. The company has explicitly clarified that this allotment is not material in nature. Following the issuance, the paid-up share capital increased from 1,29,83,86,399 to 1,29,83,87,850 shares. The newly issued shares rank pari passu with existing equity. This is a routine regulatory compliance event.

Key Highlights

ItemDetails
Allotment DateAugust 10, 2026
Total Shares Allotted1,451 shares
PurposeExercise of options under ESOP 2016
MaterialityNot material

Important Figures Used

Metric / ItemPeriod / ContextValue for ReportOriginal Figure
Total equity shares allottedAugust 10, 20261,451 shares1,451
Paid-up capital (Before)August 10, 20261,29,83,86,399 shares1,29,83,86,399
Paid-up capital (After)August 10, 20261,29,83,87,850 shares1,29,83,87,850

Corporate Action Details

The company allotted 1,451 equity shares under the Marico Employee Stock Option Plan, 2016. This allotment was executed by the Securities Committee of the Board of Directors on August 10, 2026. The newly issued shares rank pari passu with the existing equity shares, ensuring equal rights for the recipients.

The allotment was split into two segments:

  • Annexure I: 704 shares at an exercise price of Rs. 498.25 per share.
  • Annexure II: 747 shares at an exercise price of Rs. 520.96 per share.

What This Means for Investors

This update is a routine regulatory filing regarding employee compensation. Investors should note that the scale of this allotment (1,451 shares) is negligible compared to the company's total equity base of over 1.29 billion shares. Consequently, this event does not have any material impact on the company’s financials or share price.

Investor Takeaway

This announcement is purely administrative and relates to the standard exercise of employee stock options. There is no strategic change or material financial implication resulting from this capital increase. Existing shareholders can view this as a routine operational disclosure.

5
AGM (7 Aug 2026, 12:46 am)

Marico Limited Announces Results of 38th Annual General Meeting

Marico Limited conducted its 38th Annual General Meeting on August 6, 2026, via video conferencing, where shareholders approved all proposed resolutions. Key developments include the approval of a final dividend of ₹4 per equity share for the financial year ended March 31, 2026, and the ratification of the cost auditor for the upcoming financial year. Shareholders also re-appointed Mr. Rishabh Mariwala as a Director. The meeting, which saw attendance from both promoter and public shareholders via virtual means, was conducted with required regulatory compliance and passed with the requisite majority.

Key Highlights

Marico Limited successfully concluded its 38th Annual General Meeting (AGM) on August 6, 2026. The meeting was held via video conferencing and other audio-visual means, with all resolutions placed before the shareholders receiving the requisite majority approval.

EventDetails
AGM DateAugust 6, 2026
Record DateJuly 30, 2026
Total Shareholders (on Record Date)3,00,666

Corporate Action Details

Shareholders have formally approved the declaration of a final dividend of ₹4 per equity share for the financial year ended March 31, 2026. This provides a direct cash return to shareholders for the reported fiscal period.

Board Decision or Meeting Update

The company successfully passed several key resolutions:

  • Financial Statements: Adoption of the Audited Financial Statements (Standalone & Consolidated) for the financial year ended March 31, 2026, along with the reports of the Board of Directors and Statutory Auditors.
  • Director Appointment: Re-appointment of Mr. Rishabh Mariwala (DIN: 03072284) as a Director, who retired by rotation and offered himself for re-appointment.
  • Cost Auditor Ratification: Ratification of the remuneration payable to M/s. Ashwin Solanki & Associates, Cost Accountants (FRN: 100392), as Cost Auditors for the financial year ending March 31, 2027.

Investor Takeaway

The AGM outcome represents a standard completion of annual governance and compliance requirements for Marico Limited. Investors should note the approval of the ₹4 per share dividend, which confirms the company's commitment to shareholder returns for FY2025-26. All resolutions were passed smoothly, indicating shareholder alignment with management proposals presented during the meeting. There are no significant governance or procedural risks highlighted in the voting results.

6
AGM (7 Aug 2026, 12:53 am)

Marico Limited Concludes 38th Annual General Meeting, Confirms Final Dividend

Marico Limited successfully held its 38th Annual General Meeting on August 6, 2026, where shareholders approved all key resolutions, including a final dividend of ₹4 per equity share for FY 2025-26. Management highlighted a period of double-digit consolidated revenue and profit after tax growth for the fiscal year. Discussions focused on the company's "Vision 2030" and "Project SETU," emphasizing digital transformation, AI adoption, and ESG commitments. The audit reports were confirmed to be free of adverse observations, providing a stable governance outlook for the company.

Key Highlights

ItemDetails
Event38th Annual General Meeting
Final Dividend₹4 per equity share
Meeting Attendance76 members (27 Promoter, 49 Public)
Auditor StatusNo adverse observations reported

Corporate Action Details

Shareholders approved the declaration of a final dividend of ₹4 per equity share (face value ₹1) for the financial year ended March 31, 2026. This confirms the distribution of profits to shareholders for the reported fiscal year.

Financial Performance

Management reported that the company achieved double-digit growth in both consolidated revenue and profit after tax (PAT) for the financial year 2025-26. This performance reflects a strong operational year for the company despite prevailing demand trends in the FMCG sector.

Management Commentary

During the meeting, management outlined the company's strategic focus areas:

  • Strategic Vision: The Chairman discussed the theme of the eighth Integrated Annual Report, "Advancing towards Vision 2030," which outlines the company's long-term strategic imperatives.
  • Key Projects: Management highlighted "Project SETU" and provided updates on the foods and premium personal care business segments.
  • Operational Focus: The leadership team emphasized continued investment in innovation, digital transformation, AI, and smart analytics to drive efficiency. Progress on sustainability and ESG initiatives was also noted as a priority.
  • Governance: The Chairman confirmed that the reports from both the Statutory Auditors and the Secretarial Auditor contained no qualifications, observations, or remarks having any adverse effect on the company's functioning.

Investor Takeaway

The 38th AGM of Marico Limited proceeded with the formal approval of all listed resolutions, including the final dividend. The company's reaffirmation of double-digit consolidated growth in FY26, coupled with a clean audit report, signals operational stability and adherence to governance standards. Investors should continue to monitor the execution of "Vision 2030" and "Project SETU," as these remain core to the company's long-term strategy for premiumization and digital transformation.

2
Newspaper Publication (5 Aug 2026, 10:58 pm)

Marico Limited Announces Newspaper Publication of Quarterly Financial Results

Marico Limited has published its unaudited consolidated financial results for the quarter ended June 30, 2026, in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The financial results were previously approved by the Board of Directors at their meeting held on August 4, 2026. This announcement follows the standard publication process in designated newspapers, including Financial Express, Free Press Journal, and Navshakti. Investors can review the full financial statements and detailed disclosures on the company's official investor relations website.

Compliance Notice

Marico Limited has completed the mandatory newspaper publication of its unaudited consolidated financial results for the quarter ended June 30, 2026. This action is in accordance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Publication Details

The financial results, which were approved by the Board of Directors on August 4, 2026, have been published in the following newspapers:

  • Financial Express
  • Free Press Journal (English Daily)
  • Navshakti (Marathi Daily)

Investor Information

The company has made the detailed financial statements available to the public and shareholders via its official investor relations website. Investors are encouraged to refer to the full filing on the stock exchange platforms for the complete quarterly results.

Investor Takeaway

This filing confirms that the company has fulfilled its regulatory obligation to publish the quarterly results in widely circulated newspapers. There is no new financial or operational information contained in this specific notice.

3
Audio Recording (5 Aug 2026, 2:12 am)

Marico Limited: Audio Recording of Earnings Conference Call Available

Marico Limited has made the audio recording of its earnings conference call for the quarter ended June 30, 2026, available on its official investor relations website. This filing provides shareholders with access to management's detailed commentary on the financial results and operational performance discussed during the call held on August 4, 2026. Additionally, the company indicated that a written transcript of the conference call will be released on its website at a later date. Investors looking to review the management's insights and explanations regarding the recent quarterly performance may access the recording via the company's portal.

Earnings Conference Call Recording

Marico Limited has officially released the audio recording of its earnings conference call held on August 4, 2026. The call covered the company's unaudited financial results and operational performance for the quarter ended June 30, 2026.

Investor Access

Existing shareholders and interested investors can access the audio recording directly through the company's investor relations website. The company has also confirmed that a written transcript of the call will be prepared and published on the same platform in due course.

What This Means for Investors

This update ensures that all stakeholders have equitable access to the management's commentary provided during the earnings call. For investors, reviewing this recording is useful for gaining a deeper understanding of the management's perspective on the quarterly numbers, market conditions, and operational performance metrics discussed during the session.

Investor Takeaway

This is a standard administrative filing following the release of quarterly results. Investors are encouraged to visit the company's investor relations portal to listen to the call recording for context on the recent quarter's performance. No new material financial information was disclosed in this specific filing.

8
General (4 Aug 2026, 9:19 pm)

Marico Reports 23% Revenue Growth and 25% Profit Increase in Q1 FY27

Marico Limited reported a strong performance for the quarter ended June 30, 2026, with consolidated revenue from operations rising 23% year-on-year to ₹3,957 crore. Profit after tax also grew by 25% to ₹630 crore. The domestic business achieved 11% volume growth, the highest in 20 quarters, supported by broad-based market share gains. International business delivered 15% constant currency growth. EBITDA margins improved to 20.7%, reflecting strong operational execution. The management reaffirmed its outlook for double-digit revenue growth and high-teen EBITDA growth for FY27, as it continues to focus on portfolio premiumization and digital-first brands.

Key Highlights

ItemDetails
Revenue from Operations₹3,957 crore
EBITDA₹819 crore
Reported PAT₹630 crore
Domestic Volume Growth11%
International CCG15%

Financial Snapshot

MetricQ1 FY27Q1 FY26ChangeMeaning
Revenue₹3,957 Cr₹3,221 Cr23%Strong top-line growth
EBITDA₹819 Cr₹655 Cr25%Operating profit expansion
Reported PAT₹630 Cr₹504 Cr25%Significant profit growth

Revenue and Income Analysis

Consolidated revenue from operations grew by 23% year-on-year, reaching ₹3,957 crore. This growth was propelled by strong performance across key business segments, with the India business contributing a 21% year-on-year revenue increase to ₹3,003 crore, alongside 15% constant currency growth in international markets.

Profitability and Margin Analysis

EBITDA grew 25% to ₹819 crore compared to ₹655 crore in the same quarter last year. The EBITDA margin expanded to 20.7% from 20.3% in the prior-year period, representing a 40 basis points improvement. Reported profit after tax grew by 25% to ₹630 crore, driven by robust top-line growth and effective margin realization.

Domestic and International Business

The domestic India business recorded 11% volume growth, which marks its highest level in 20 quarters. Business fundamentals remained robust, with the company gaining or sustaining market share in over 96% of its business. The international business delivered 15% constant currency growth, with outperformance in Vietnam and MENA markets.

Concerns and Watch Points

TypePointWhat Shows ItWhy It Matters
Watch PointInflationary HeadwindsManagement commentaryPotential pressure on margins if input costs remain volatile.
ConcernBangladesh MarketManagement commentaryTransient demand softness due to inflation impacting growth in this key region.

What This Means for Investors

Marico has demonstrated strong operational leverage with its Q1 FY27 results. The company is actively pursuing its 'Vision 2030' strategy, focusing on scaling its premium and digital-first portfolios while maintaining strength in its core franchises. The high volume growth in the domestic market is a positive indicator of consumer demand and the effectiveness of current go-to-market strategies. Investors should track the company's ability to maintain these margins amidst commodity price volatility and the progress of its expansion into premium categories.

Investor Takeaway

The quarter reflects a solid start for FY27, with the company hitting multi-quarter highs in volume and profit growth. Management remains confident in achieving double-digit revenue growth and high-teen EBITDA growth for the year. Key factors to monitor include the stabilization of input costs and the recovery of consumer demand in international markets like Bangladesh.

7
Outcome of Board Meeting (4 Aug 2026, 9:14 pm)

Marico Limited Reports Consolidated Revenue of ₹3,957 Crore for Q1 June 30, 2026

Marico Limited announced its financial results for the quarter ended June 30, 2026, reporting a consolidated revenue of ₹3,957 crore and a net profit of ₹652 crore. The company also highlighted the acquisition of a 75% stake in Vietnam’s Skinetiq Joint Stock Company, expanding its international skincare portfolio. The figures reflect an accounting reclassification where certain customer-related advertisement expenses were netted off from revenue, impacting historical comparisons. The India segment contributed ₹3,003 crore to the revenue, while the international segment added ₹954 crore. Investors should note these strategic acquisitions and reporting changes.

Key Highlights

ItemDetails
Consolidated Revenue₹3,957 crore
Consolidated Net Profit₹652 crore
EPS (Basic)₹4.86
International Portfolio Contribution~24% of Group Revenue

Financial Snapshot

MetricQuarter Ended June 30, 2026Quarter Ended June 30, 2025
Consolidated Revenue₹3,957 crore₹3,221 crore
Net Profit₹652 crore₹513 crore
EPS (Basic)₹4.86₹3.90

Segment Performance

SegmentRevenue (Q1 June 30, 2026)
India₹3,003 crore
International₹954 crore

Corporate Action and Restructuring

  • Acquisition of Skinetiq: Effective April 2, 2026, Marico South East Asia Corporation acquired a 75% stake in the Vietnam-based digital-first skincare company, Skinetiq. This acquisition provides Marico with the 'Candid' skincare brand and exclusive distribution rights for 'Murad' in Vietnam.
  • Intra-group Restructuring: The company integrated the business of Just Herbs (effective October 1, 2025) and Beardo (effective June 29, 2026) through voluntary liquidations. These assets have been distributed to the parent company on a going concern basis. These transactions are accounted for as common control combinations and do not impact the consolidated financials.

Accounting Note

During the quarter, the company reclassified certain customer-related advertisement and promotional expenses. Previously included under 'Advertisement and Sales Promotion' expenses, these amounts are now netted off directly from 'Revenue from Operations'. This policy change has been applied retrospectively to previous periods for comparability. The company confirmed that this reclassification has no impact on net profit, total equity, cash flows, or EPS.

What This Means for Investors

Marico has demonstrated top-line and bottom-line growth on a year-over-year basis. The acquisition of Skinetiq indicates a continued focus on expanding the international skincare portfolio, which currently contributes approximately 24% to the group's revenue. Investors should account for the accounting reclassification of promotional expenses when comparing the current revenue figures with previous periods to ensure an accurate understanding of the performance trends. The consolidation of Just Herbs and Beardo reflects efforts to streamline operations under the parent entity.

Investor Takeaway

Investors should view this as a stable quarter with a focus on growth via both organic operations and inorganic acquisitions. The integration of domestic brands like Beardo and Just Herbs, alongside the new Vietnam acquisition, suggests an active strategy to diversify the brand portfolio. Monitor how the newly acquired entities contribute to the overall margin profile in subsequent quarters. Track the management's commentary on demand trends in the domestic and international markets.

7
Financial Results (4 Aug 2026, 9:10 pm)

Marico Limited Posts Consolidated Revenue of ₹3,957 Crore for Q1 FY27

Marico Limited announced its un-audited consolidated financial results for the quarter ended June 30, 2026, reporting a consolidated revenue from operations of ₹3,957 crore, up from ₹3,221 crore in the corresponding period last year. Consolidated net profit for the quarter rose to ₹652 crore, compared to ₹513 crore in the quarter ended June 30, 2025. Key developments include the integration of business entities Just Herbs and Beardo, and the acquisition of a 75% stake in Skinetiq Joint Stock Company. The company also implemented an accounting reclassification for customer-related advertisement expenses, affecting reported revenue figures retrospectively.

Key Highlights

Marico Limited has released its financial results for the quarter ended June 30, 2026. The company reported consolidated revenue growth and a rise in net profit compared to the corresponding quarter of the previous year. Key corporate actions include business integrations and an international acquisition.

Financial Snapshot

MetricQuarter ended June 30, 2026Quarter ended June 30, 2025
Revenue from operations (Consolidated)₹3,957 crore₹3,221 crore
Net profit for the period (Consolidated)₹652 crore₹513 crore

Segment Performance

SegmentRevenue (Q1 FY27)Segment Result (Q1 FY27)
India₹3,003 crore₹580 crore
International₹954 crore₹257 crore

Corporate Action Details

  • Business Restructuring: The company completed the integration of Just Herbs (effective October 1, 2025) and Beardo (effective June 29, 2026) through voluntary liquidation of the respective entities and distribution of their undertakings to the company.
  • International Acquisition: Marico South East Asia Corporation acquired a 75% stake in Skinetiq Joint Stock Company on April 2, 2026. Skinetiq operates in the skincare space in Vietnam.

Accounting Note

Marico has reclassified certain customer-related advertisement and promotional expenses. These amounts, previously included in 'Advertisement and Sales Promotion expenses', are now netted off from 'Revenue from Operations'. This change has been applied retrospectively to comparative periods to improve financial presentation. The company noted this reclassification has no impact on profit before tax, total equity, or EPS.

Investor Takeaway

For investors, the key takeaways from this quarter are the reported year-over-year growth in consolidated financial metrics and the company's continued strategic focus on inorganic growth through the acquisition of digital-first and skincare brands. The integration of entities like Beardo and Just Herbs reflects a simplified business structure. Investors should note the retrospective impact of the accounting reclassification on revenue figures when comparing current performance with past data. The company's expansion into Vietnam via the Skinetiq acquisition remains a focus area for international market development.

5
Audio Recording (28 Jul 2026, 3:59 am)

Marico to hold Q1 FY27 earnings conference call on August 4, 2026

Marico Limited has scheduled an investor and analyst conference call for Tuesday, August 4, 2026, at 6:00 p.m. IST, following the approval of its financial results for the quarter ended June 30, 2026. The management team, including Managing Director Mr. Saugata Gupta and Group CFO Mr. Pawan Agrawal, will discuss the company's operational and financial performance. Marico, which reported a turnover of ₹136.1 billion in FY 2025-26 and derives approximately 24% of its revenue from overseas markets, will provide insights into its business drivers during this session.

Event Details

Marico Limited has announced its investor and analyst conference call to discuss the financial results for the quarter ended June 30, 2026 (Q1 FY27).

  • Date: Tuesday, August 4, 2026
  • Time: 6:00 p.m. IST

The financial results will be available on the company website following board approval on the same day.

Management Participation

The conference call will be addressed by the following members of senior leadership:

NameDesignation
Mr. Saugata GuptaManaging Director & CEO
Mr. Pawan AgrawalGroup CFO & CEO - International Business

Company Context

Marico operates in the global beauty and wellness categories. Key financial and operational metrics include:

MetricValue / Detail
FY 2025-26 Turnover₹136.1 billion
Overseas Revenue ContributionApproximately 24%

The company manages a diverse brand portfolio including Parachute, Saffola, Hair & Care, Parachute Advansed, Nihar Naturals, Mediker, Pure Sense, Coco Soul, Revive, Set Wet, Livon, Beardo, Just Herbs, True Elements, Plix, Cosmix, and 4700BC.

What This Means for Investors

The upcoming earnings call serves as a primary touchpoint for investors to understand the company's performance for the first quarter of fiscal year 2027. Participants should monitor management commentary for updates on demand trends in domestic and overseas markets, input cost management, and strategic initiatives across the diverse brand portfolio.

4
Newspaper Publication (10 Jul 2026, 6:55 pm)

Marico Limited Announces 38th Annual General Meeting and Dividend Approval

Marico Limited has published notice of its 38th Annual General Meeting (AGM), scheduled for August 6, 2026, to be held via video conferencing. The company is dispatching its Integrated Annual Report for FY26. Shareholders are requested to note the remote e-voting period, which runs from August 3, 2026, to August 5, 2026. The cut-off date for voting eligibility is July 30, 2026. The meeting will also seek approval for the final equity dividend recommended by the Board on May 5, 2026. Investors should track the record date and e-voting timelines to participate in the corporate governance process.

AGM and Corporate Meeting Details

Marico Limited has scheduled its 38th Annual General Meeting (AGM) to be held on August 6, 2026, at 9:00 a.m. The meeting will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM), in compliance with applicable regulatory requirements under the Companies Act, 2013, and SEBI regulations.

Dividend Approval Process

The Board of Directors has recommended a final equity dividend for the financial year 2025-26. This dividend is subject to approval by shareholders at the upcoming 38th AGM. If approved, the dividend is expected to be paid on or before September 5, 2026.

Voting Schedule

Shareholders are eligible to vote based on their holdings as of the cut-off date of July 30, 2026. The company has provided a remote e-voting facility for members to cast their votes electronically.

EventDateTime
Cut-off Date for VotingJuly 30, 2026N/A
Remote E-voting StartAugust 3, 20269:00 a.m.
Remote E-voting EndAugust 5, 20265:00 p.m.
Date of AGMAugust 6, 20269:00 a.m.

Investor Takeaway

This announcement marks the start of the formal governance process for Marico Limited's fiscal year. Shareholders should note the upcoming cut-off date for voting eligibility and the remote e-voting window. The primary focus for investors at the AGM will be the formal approval of the final equity dividend. Existing shareholders are encouraged to review the Integrated Annual Report for FY26, which has been dispatched, to prepare for the meeting.

2
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 (10 Jul 2026, 6:23 pm)

Marico Limited Submits Quarterly Compliance Certificate for June 2026

Marico Limited has filed its compliance certificate for the quarter ended June 30, 2026, as mandated by Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by the company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited, confirms that all securities received for dematerialization during the quarter were processed within the prescribed timelines. This update is a routine regulatory disclosure regarding shareholder record maintenance and dematerialization procedures. It has no impact on the company's financial performance or business operations.

Compliance Certificate Details

Marico Limited has filed its compliance certificate for the quarter ended June 30, 2026, as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

The certificate was provided by MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent (RTA).

Key Confirmations

The RTA has confirmed the following for the quarter ended June 30, 2026:

  • Timely Processing: Securities received for dematerialization were processed (confirmed or rejected) within the timelines prescribed by regulations.
  • Verification: Security certificates received for dematerialization were mutilated and cancelled after due verification by the depository participant.
  • Record Maintenance: The register of members has been updated to reflect the depositories as the registered owners of the securities.

Investor Takeaway

This filing is a routine regulatory procedure intended to ensure the integrity of share transfer and dematerialization processes. It serves as a standard compliance check for shareholder record-keeping and does not contain any financial or operational updates. Investors should view this as a matter of standard corporate governance maintenance.

5
General (10 Jul 2026, 12:00 am)

Marico Limited Announces 38th AGM Date and Final Dividend of ₹4 Per Share for FY 2025-26

Marico Limited has scheduled its 38th Annual General Meeting (AGM) for August 6, 2026, to be conducted via video conference. The company has declared a final dividend of ₹4 per equity share for the financial year 2025-26. The record date for both dividend entitlement and remote e-voting eligibility is July 30, 2026. Shareholders may participate in remote e-voting between August 3 and August 5, 2026. The dividend payout is scheduled for on or before September 5, 2026. Investors are advised to keep their KYC and bank account details updated with their depositories for timely credit.

Key Highlights

Marico Limited has announced the schedule for its 38th Annual General Meeting (AGM) and confirmed the payout details for its final dividend for the financial year 2025-26.

Important Figures Used

Metric / ItemPeriod / ContextValue for Report
Final Dividend per equity shareFY 2025-26₹4
Record DateFY 2025-26July 30, 2026
AGM DateFY 2025-26August 6, 2026
E-voting Start DateFY 2025-26August 3, 2026
E-voting End DateFY 2025-26August 5, 2026
Dividend Payment DateFY 2025-26On or before September 5, 2026

Corporate Action Details

The company has declared a final dividend of ₹4 per equity share for FY 2025-26. To be eligible for this dividend, shareholders must hold the shares as of the record date, which is July 30, 2026. The company expects to process the dividend payment on or before September 5, 2026.

Investor Takeaway

Investors should note the key dates to ensure their dividend eligibility and participation in the AGM voting process. The record date of July 30, 2026, is critical for both dividend receipt and e-voting entitlement. Shareholders are encouraged to verify that their KYC details, PAN, and bank account information are correctly updated with their Depository Participant or Registrar to avoid any delays in the dividend credit process. The AGM will be held on August 6, 2026, via video conference, with remote e-voting available from August 3 to August 5, 2026.

5
Business Responsibility and Sustainability Reporting (BRSR) (9 Jul 2026, 6:28 pm)

Marico Limited Files Business Responsibility and Sustainability Report for FY 2025-26

Marico Limited has published its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, detailing progress on its ESG 2030 Roadmap. Key metrics include a 77.33% renewable energy share and 100% Extended Producer Responsibility (EPR) compliance. The company reported a 96% customer satisfaction index, reflecting brand health across its distribution network, which spans over 5.8 million retail outlets. Additionally, Marico announced intra-group restructuring via the voluntary liquidation of two subsidiaries to streamline digital operations. The report, independently assured by Bureau Veritas, outlines Marico’s commitment to sustainable sourcing, climate goals, and long-term value creation.

Key Highlights

Marico Limited's Business Responsibility and Sustainability Report (BRSR) for FY 2025-26 highlights the company's shift toward outcome-oriented ESG delivery. The company maintains its ESG 2030 Roadmap, focusing on carbon neutrality, water stewardship, and circularity.

ItemDetails
Renewable Energy Share77.33%
Customer Satisfaction Index96%
EPR Compliance100%
Distribution Network10,200+ distributors; 5.8 million+ retail outlets

Important Figures Used

Metric / ItemPeriod / ContextValue for Report
Paid-up CapitalFY 2025-26₹129.81 crore (₹12,981.49 lakh)
CSR TurnoverFY 2025-26₹7,485.38 crore (₹748,537.97 lakh)
CSR Net WorthFY 2025-26₹5,269.58 crore (₹526,958.05 lakh)
Total Scope 1 EmissionsFY 2025-261653.3 MtCO2e
Total Scope 2 EmissionsFY 2025-266229.5 MtCO2e
Total Water WithdrawalFY 2025-26124,872.5 KL
Total Energy ConsumedFY 2025-26190,741.9 GJ
Total Waste GeneratedFY 2025-263,716.70 MT
Permanent EmployeesFY 2025-261,932

Corporate Action Details

In line with its digital-first strategy, Marico has undertaken an intra-group restructuring initiative. This involved the voluntary liquidation of its wholly owned subsidiaries, Apcos Naturals Private Limited and Zed Lifestyle Private Limited. The entire business undertakings of these entities were distributed to Marico on a going-concern basis to augment the company's digital transformation journey.

Operational Performance

Marico operates a deep distribution network across India, supporting its market presence in beauty and wellness products. The company’s operations include:

  • Manufacturing Reach: 6 manufacturing facilities in India, supplemented by 25 warehouses and 4 re-distribution centres.
  • Market Penetration: The network supports 60,000 villages and almost every Indian town with a population exceeding 5,000.
  • Export Contribution: Exports accounted for 4.5% of the total turnover for the year.

Climate and Sustainability Initiatives

Marico’s ESG strategy is underpinned by independent reasonable assurance provided by Bureau Veritas (India) Private Limited for core indicators.

  • Energy: The company consumed 190,741.9 GJ of energy, with renewable sources accounting for 77.33% of the total.
  • Water: The company reported a total water withdrawal of 124,872.5 KL, with a focus on replenishment through watershed development and rainwater harvesting initiatives.
  • Waste: Total waste generation was 3,716.70 MT, with the company achieving 100% EPR compliance for plastic waste.

Risks and Watch Points

The report identifies material risks related to climate change, including erratic rainfall and droughts, which pose potential threats to agricultural-based raw material quality and supply chain stability. Several manufacturing units are located in high water-risk zones, such as Puducherry, Perundurai, Sanand, and Jalgaon, necessitating ongoing water stewardship efforts to mitigate operational risks.

Investor Takeaway

Marico’s latest sustainability report underscores a consistent commitment to ESG targets, including net-zero ambitions for Indian manufacturing by 2030. The detailed disclosures regarding supply chain audits, employee wellbeing, and risk management provide clarity on the company's governance and operational sustainability. Investors should continue to monitor the company’s progress on its ESG 2030 Roadmap, particularly how the integration of the recently liquidated digital-focused subsidiaries contributes to operational efficiency and revenue growth in coming quarters.

8
Reg. 34 (1) Annual Report (9 Jul 2026, 6:19 pm)

Marico Limited Reports Consolidated Revenue Growth of 26% to ₹13,611 Crore in FY26

Marico Limited has reported strong financial performance for FY26, with consolidated revenue growing 26% year-on-year to ₹13,611 crore. Recurring consolidated net profit after tax rose 11% to ₹1,762 crore. Key operational highlights include an 8% growth in domestic volumes and 20% constant currency growth in international markets. The company's digital-first portfolio achieved an annualised revenue run-rate exceeding ₹1,100 crore, with brands like Beardo and Plix turning profitable. Management has set long-term growth aspirations to reach ₹20,000 crore in revenue by FY30, supported by the 'Fewer, Bigger, Bolder, Faster' strategy.

Key Highlights

Marico Limited delivered a strong financial performance in FY26, driven by top-line growth and resilience in its core franchises.

ItemDetails
Consolidated Turnover₹13,611 crore
Recurring Consolidated Net Profit₹1,762 crore
Consolidated EBITDA₹2,328 crore
Consolidated EPS₹13.6/share
ROCE49.1%

Financial Snapshot

MetricFY26 (₹ crore)FY25 (₹ crore)
Revenue from operations13,61110,831
Total income13,81511,039
Total expenses11,5388,923
Profit before tax2,2772,116
Profit for the year1,8131,658

Revenue and Income Analysis

Consolidated revenue grew by 26% YoY to ₹13,611 crore. The performance was supported by strong volume growth of 8% in the domestic business and 20% constant currency growth in the international business.

Profitability Analysis

Recurring consolidated net profit after tax rose 11% to ₹1,762 crore. The company emphasized its focus on profitable growth amidst an inflationary input cost environment.

Corporate Action Details

The company recommended a final dividend of ₹4 per equity share of ₹1 each for FY26.

Management, Auditor, and Compliance Changes

  • Cost Auditors: The Board appointed M/s. Ashwin Solanki & Associates, Cost Accountants, as Cost Auditors for FY27 at a remuneration of ₹0.11 crore (₹11 lakh).
  • Auditor Remarks: Financial statements (standalone and consolidated) have received unmodified opinions.

What Looks Positive

  • Top-line Growth: Multi-year high revenue growth.
  • Digital Transformation: Digital-first portfolio achieved an annualized run-rate exceeding ₹1,100 crore.
  • Turnaround Success: Brands like Beardo and Plix turned profitable.
  • Capital Efficiency: ROCE increased to 49.1% and Return on Net Worth improved to 43.0%.

Concerns and Watch Points

  • Operating Environment: Challenges include elevated input costs and geopolitical developments impacting supply chains.

What This Means for Investors

Marico Limited’s FY26 results show a business model effectively balancing core franchise stability with new, high-growth digital categories. The transition of digital brands to profitability and the continued growth in international markets provide a clear direction for long-term investors.

Investor Takeaway

Investors should track the company's progress on its Vision 2030 roadmap, which aims for ₹20,000 crore revenue by FY30. While core performance remains resilient, monitoring the impact of input cost volatility and management's success in scaling its digital-first and foods portfolios will be crucial for sustained future growth.

8
AGM (9 Jul 2026, 6:11 pm)

Marico Reports Consolidated Turnover of ₹13,611 Crore for FY26

Marico Limited released its Integrated Annual Report for FY26, delivering a consolidated turnover of ₹13,611 crore, marking a 26% year-on-year increase. Recurring consolidated net profit after tax and minority interest rose 11% to ₹1,762 crore. The company showcased resilient performance with double-digit growth in its digital-first portfolio and core franchises. Marico declared a final dividend of ₹4 per equity share and remains focused on its 'Vision 2030' target of ₹20,000 crore revenue. Management maintains a positive outlook despite volatility in input costs, focusing on premiumization and digital acceleration.

Key Highlights

ItemDetails
Consolidated Turnover (FY26)₹13,611 crore
Recurring Consolidated Net Profit (FY26)₹1,762 crore
Consolidated EBITDA (FY26)₹2,328 crore
Earnings Per Share (FY26)₹13.6
Return on Net Worth (FY26)43.0%
Return on Capital Employed (FY26)49.1%
Dividend Declared400% of Face Value

Financial Snapshot

MetricFY26FY25
Revenue from Operations₹13,611 crore₹10,831 crore
Consolidated EBITDA₹2,328 crore₹2,139 crore
Recurring Net Profit (MI)₹1,762 crore₹1,593 crore

Operational and Strategic Performance

Marico delivered strong execution in FY26, achieving multi-year high consolidated revenue growth. The performance was supported by 8% volume growth in the India business and strong performance across core franchises. The digital-first portfolio reached an annualized revenue run-rate exceeding ₹1,100 crore.

Strategic Developments

  • Acquisitions: The company completed the acquisitions of 4700BC (premium snacking) and Cosmix (functional nutrition) during the year to address portfolio white spaces.
  • Digital Expansion: Successful scale-up of digital-first brands like Beardo and Plix has been instrumental, with these brands now turning profitable.
  • Distribution: Project SETU, a distribution expansion initiative, continues to strengthen direct reach in General Trade.

Corporate Action

The Board has recommended a final dividend of ₹4 per equity share of ₹1 each for the financial year ended March 31, 2026, subject to shareholder approval at the upcoming 38th AGM.

What Looks Positive

  • Growth Execution: Strong 26% year-on-year growth in consolidated turnover.
  • Capital Efficiency: Return on Capital Employed (ROCE) improved to 49.1%, showing disciplined capital deployment.
  • Strategic Roadmap: Clear 'Vision 2030' plan with a target of ₹20,000 crore in revenue, focused on core franchises and new high-growth adjacencies.

Concerns and Watch Points

  • Input Cost Volatility: The operating environment was marked by hyperinflation in raw materials like copra prices, impacting gross margins.
  • Geopolitical Risk: The Middle East conflict caused temporary supply chain disruptions, impacting international business segments.

Investor Takeaway

Marico's performance in FY26 demonstrates its ability to navigate a challenging and volatile macroeconomic environment while maintaining volume-led growth. Investors should monitor the integration of recent acquisitions and the impact of input cost fluctuations on operating margins in the coming quarters. The focus remains on the long-term 'Vision 2030' roadmap, balancing core business stability with high-growth digital-first expansion.

5
Board Meeting (9 Jul 2026, 1:34 am)

Marico Limited to Approve Q1 Financial Results on August 4, 2026

Marico Limited has scheduled a meeting of its Board of Directors for Tuesday, August 4, 2026. The board will consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, along with the Limited Review Report from the auditors. Additionally, the company has announced that the trading window for dealing in its shares has been closed from June 26, 2026, through August 6, 2026. This filing is a standard corporate compliance update regarding the timeline for the company's upcoming first-quarter financial performance disclosure.

Board Meeting Schedule

Marico Limited has informed the exchanges that a meeting of its Board of Directors is scheduled for Tuesday, August 4, 2026. The primary purpose of this meeting is to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, along with the Limited Review Report of the auditors.

Trading Window Closure

The company has mandated a closure of the trading window for dealing in its shares. This period of closure is effective from June 26, 2026, through August 6, 2026 (both days inclusive). This is a standard compliance procedure to prevent trading during the period when unpublished price-sensitive information is being finalized.

Investor Takeaway

Investors should note that the results for the quarter ended June 30, 2026, are expected to be released following the board meeting on August 4, 2026. This announcement serves as a routine regulatory update and does not contain any financial performance details at this stage.

4
Newspaper Publication (8 Jul 2026, 12:26 am)

Marico Limited to Hold 38th Annual General Meeting on August 6, 2026

Marico Limited has announced its 38th Annual General Meeting (AGM) scheduled for Thursday, August 6, 2026, at 9:00 a.m. IST. The meeting will be conducted through Video Conferencing or Other Audio-Visual Means, and physical attendance is not permitted. The company has published notice of this meeting in English and Marathi newspapers. Members are advised to update their KYC, bank mandates, and contact details with their respective depository participants or the Registrar and Transfer Agent to ensure they receive all necessary documentation and AGM information.

Meeting Details

Marico Limited will conduct its 38th Annual General Meeting (AGM) on August 6, 2026, at 9:00 a.m. IST. The company will hold the meeting exclusively through Video Conferencing (VC) or Other Audio-Visual Means (OAVM). Physical attendance for shareholders has been dispensed with.

Shareholder Actions

The company has requested its members to take the following actions:

  • Update KYC, bank mandate, and contact details with their respective Depository Participant or the Registrar and Transfer Agent.
  • Ensure registered email addresses are updated to receive the AGM Notice and Integrated Annual Report 2025-26 electronically.

Publication Information

The notice regarding the AGM was published on July 7, 2026, in the following newspapers:

  • Business Standard (English)
  • Navshakti (Marathi)

Regulatory Compliance

This filing is in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and complies with the Companies Act, 2013, along with relevant circulars from the Ministry of Corporate Affairs and SEBI.

Investor Takeaway

The announcement is a procedural update regarding the upcoming 38th AGM. Shareholders should ensure their contact and financial details are updated with their depository participants to receive necessary documents and participate in the meeting voting process.

5
Postal Ballot (8 Jul 2026, 12:08 am)

Marico Limited Shareholders Approve Appointment of Independent Director via Postal Ballot

Marico Limited has announced the successful passing of a special resolution via postal ballot, confirming the appointment of Mr. Girish Paranjpe as an Independent Director. The appointment is for a term of five years, effective from June 1, 2026, to May 31, 2031. The resolution received strong shareholder support, with 98.8645% of the votes cast in favour. This appointment strengthens the company's independent board oversight. Investors should note this as a standard corporate governance development aimed at ensuring board composition compliance and continued professional leadership.

Key Highlights

ItemDetails
AppointmentMr. Girish Paranjpe (Independent Director)
Term5 years (June 1, 2026 – May 31, 2031)
Approval StatusPassed with 98.8645% majority

Voting Results

The resolution for the appointment of the Independent Director saw robust participation and approval.

MetricFigure
Total Votes Polled1,17,34,45,643
% of Outstanding Shares Polled90.3830%
Votes in Favour1,16,01,20,805
% Votes in Favour98.8645%
Votes Against1,33,24,838
% Votes Against1.1355%

Board Appointment Details

Shareholders have formally approved the appointment of Mr. Girish Paranjpe as an Independent Director of the company. The appointment follows the recommendation of the Nomination and Remuneration Committee and the Board. This appointment is in accordance with the provisions of the Companies Act, 2013, and SEBI Listing Regulations, ensuring the company maintains the required standards of independent board oversight.

Investor Takeaway

This update is procedural in nature and reflects the company's commitment to good corporate governance. The strong majority support for the resolution indicates alignment between the board and shareholders regarding the new director's appointment. Investors should view this as a routine board composition update with no immediate financial impact.

6
Analyst / Investor Meet (3 May 2026, 9:55 pm)

Marico Updates Investor Call Details for Q4FY26 Earnings

Marico Limited announces update for its Q4FY26 earnings investor call.

Summary

  • Marico Limited has updated the logistics for its Q4FY26 earnings conference call.
  • The call is scheduled for Tuesday, May 5, 2026, at 5:30 p.m. IST, following the announcement of financial results.
  • An updated link for the live webcast has been shared.
  • Key executives, including MD & CEO Saugata Gupta and Group CFO Pawan Agrawal, will represent the company.

Key Numbers & Dates

  • Conference Call: May 5, 2026, at 5:30 p.m. IST
  • Financial Year End: March 31, 2026
  • Board Meeting for Results Approval: May 5, 2026
  • FY24-25 Turnover: ₹108.3 billion (USD 1.3 billion equivalent)
  • Overseas Revenue Contribution: Approximately 25% of Group's revenue
  • Initial Conference Call Invite: April 17, 2026
  • Update Notice Date: May 3, 2026

What to Track Next

  • Announcement of Marico's financial results for Q4FY26 on May 5, 2026.
  • Participation in the investor/analyst conference call on May 5, 2026.
9
Audio Recording (17 Apr 2026, 7:56 pm)

Marico Announces Q4FY26 Earnings Call on May 5, 2026

Marico hosts FY26 earnings call on May 5, 2026. FY24-25 turnover reported at ₹108.3 billion.

Summary

  • Marico Limited will host an investor and analyst conference call on Tuesday, May 5, 2026, at 5:30 p.m. IST.
  • The call will focus on the financial results and operations for the quarter and financial year ended March 31, 2026.
  • The company reported a turnover of ₹108.3 billion (USD 1.3 billion) during FY24-25.
  • Audio recordings and transcripts of the call will be published on the company's website.

Key Numbers & Dates

  • Conference Call Date: May 5, 2026
  • Financial Year End: March 31, 2026
  • FY24-25 Turnover: ₹108.3 billion
  • FY24-25 Turnover (USD): USD 1.3 billion
  • Call Start Time: 5:30 p.m. IST

What to Track Next

  • Marico's financial results for Q4 FY26 and the full FY26 will be announced on May 5, 2026.
  • Management commentary on the company's performance and operations during the conference call.
1
Board Meeting (17 Apr 2026, 7:22 pm)

Marico Limited Board Meeting Scheduled for May 5, 2026, to Approve FY2026 Results

Marico Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2026 ,inter alia, to consider and approve i. the Audited Standalone & Consolidated financial results of the Company for the quarter and financial year ended March 31, 2026; ii. take on record the Auditor's Report on Standalone & Consolidated financial results; and iii. consider a proposal for recommendation of Final Equity Dividend, if any, for the Financial Year 2025-26, for approval of the shareholders at the ensuing 38th Annual General Meeting of the Company.

📊 Performance Summary

  • Reporting Period(s): Quarter and Financial Year ended March 31, 2026 (Consideration scheduled).
  • Notice Date: April 17, 2026.

✅ What Looks Positive

  • The Board is scheduled to consider a proposal for a final equity dividend for the financial year 2025-26.

⚠️ Risk Alerts & Concerns

  • No financial data or performance results were provided in this document as it is a notice of a scheduled meeting.

🧠 Investor Takeaway

  • Investors should await the official release of audited financial results on or after the scheduled board meeting on May 5, 2026. The trading window remains closed from March 26, 2026, till May 7, 2026, as per the company's regulatory compliance notice.
Company Update (4 Apr 2026, 5:16 pm)

Adani Group Overhauls Structure, FMCG Firms Foresee Growth Amidst Global Headwinds, Himatsingka Announces Special Securities Window

Himatsingka Seide Limited published a notice regarding the special window for transfer and dematerialisation of physical securities. This notification was published in Business Standard and Vartha Bharathi newspapers on April 4, 2026, following SEBI guidelines.

Himatsingka Seide Limited has announced a special window for the transfer and dematerialisation of physical securities. This initiative, in line with SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, is open from February 05, 2026, to February 04, 2027. It applies to physical securities purchased or sold before April 1, 2019, that were previously rejected or remain unprocessed. The company published this notice in the Business Standard and Vartha Bharathi newspapers on April 4, 2026.

8
Company Update (2 Apr 2026, 6:48 pm)

Marico Completes Acquisition of Vietnam's Skinetiq

Marico Limited announced the completion of its subsidiary's acquisition of 75% of Vietnam's Skinetiq, owner of the Candid skincare brand.

Summary

  • Marico Limited has announced the completion of its subsidiary's acquisition of a 75% stake in Skinetiq Joint Stock Company.
  • Skinetiq, a company based in Vietnam, owns the digital-first skincare brand 'Candid' and holds exclusive distribution rights for the 'Murad' brand in Vietnam.

Key Numbers & Dates

  • Acquisition Stake: 75% of Skinetiq's total share capital.
  • Completion Date: April 2, 2026.
  • Proposal Intimation Date: February 9, 2026.

What Changes for the Business

  • Skinetiq Joint Stock Company has now become a subsidiary of Marico's wholly owned subsidiary, Marico South East Asia Corporation.
  • Consequently, Skinetiq is now a subsidiary of Marico Limited.
  • The acquisition brings the digital-first skincare brand 'Candid' and exclusive distribution rights for 'Murad' in Vietnam under Marico's operational umbrella.
9
Company Update (2 Apr 2026, 1:57 pm)

Marico Q4 FY26 Update: Revenue Grows Low Twenties, India Volume Up High Single Digits

Marico Q4 FY26 update shows revenue growth in low twenties, India volume up high single digits.

Summary

  • Marico's Q4 FY2025-26 update indicates stable sector demand and strong performance across its key business segments.
  • The India business achieved high single-digit underlying volume growth, supported by brands like Parachute and Saffola Oils.
  • International operations delivered robust growth in high teens (constant currency), while consolidated revenue grew by low twenties year-on-year.
  • The company expects double-digit operating profit growth for the quarter and is confident in achieving healthy volume-led revenue growth for FY2027.

Key Numbers & Dates

  • Q4 FY2025-26 Consolidated Revenue Growth: low twenties (YoY).
  • FY2025-26 Full-Year Revenue Growth: Achieved mid-twenties aspiration.
  • India Business Volume Growth: high single-digit (underlying) for Q4 FY2025-26.
  • Value Added Hair Oils Growth: in the twenties for Q4 FY2025-26.
  • International Business Growth: high teens in constant currency for Q4 FY2025-26.
  • Copra Price Correction: approximately 35% from its peak.
  • Operating Profit Growth: Expected double-digit for Q4 FY2025-26.
  • Quarter Ended: March 31, 2026.
  • Report Date: April 2, 2026.

What Changes for the Business

  • Easing copra prices, down ~35% from their peak, are expected to improve gross margins sequentially.
  • The company is strategically focusing on mid and premium segments, enhanced direct reach, innovation, and affordability to drive sustainable, volume-led growth.
  • Investments in brand building are sustained to strengthen long-term equity and accelerate portfolio diversification.

⚠️ What Could Go Wrong (source-based)

  • [Other] Geopolitical headwinds in the Middle East impacted the Gulf region in March and remain a monitorable for overall consumption trends.
  • [Financial] Vegetable oils and crude-sensitive materials exhibit a pronounced upward bias in input prices, although the company plans to use pricing power to mitigate impacts.

What to Track Next

  • A detailed Information Update will follow once the Board of Directors approves the Audited consolidated and standalone financial results for the quarter and financial year ended March 31, 2026.
7
Company Update (1 Apr 2026, 2:20 pm)

Marico Appoints Pawan Agrawal to Lead Overall International Business, Announces SMP Changes

Marico announces senior management changes effective April 1, 2026, with Pawan Agrawal expanding his international business leadership role.

Summary

  • Marico has announced changes to its Senior Management Personnel (SMP) effective April 1, 2026.
  • Pawan Agrawal will take on an expanded role as Group CFO and Chief Executive Officer International Business, leading the overall international operations.
  • Mr. Binjit Kadakapcedlikayal and Mr. Ryan Bartram will be re-categorized as they move under a new reporting structure, ceasing to be SMPs.

Key Numbers & Dates

  • Effective Date: April 1, 2026

What Changes for the Business

  • Pawan Agrawal's responsibilities will broaden to encompass the entire international business of Marico, including Rest of South Asia and SE Asia.
  • The reporting structure for Binjit Kadakapcedlikayal (EVP - Middle East & North Africa) and Ryan Bartram (MD – Marico South Africa) will change under the CEO - International Business, and they will no longer be classified as SMPs.
4
Allotment of ESOP / ESPS (23 Mar 2026, 8:28 pm)

Marico Allots 3,856 Shares Under ESOP, States It's Not Material

Marico allotted 3,856 equity shares under ESOP 2016, stating it is not material.

Summary

  • Marico Limited allotted 3,856 equity shares under its Employee Stock Option Plan (ESOP) 2016.
  • This allotment was made pursuant to the exercise of stock options by eligible employees.
  • The company explicitly stated that this share allotment is not material in nature.

Key Numbers & Dates

  • Shares Allotted: 3,856 equity shares
  • Face Value per Share: Rs. 1
  • Exercise Price per Share: Rs. 483.50
  • Premium per Share: Rs. 482.50
  • Total Issued Share Capital (Post Allotment): Rs. 1,29,81,48,935
  • Previous Total Issued Share Capital: Rs. 1,29,81,45,079
  • Allotment Date: March 23, 2026

What Changes for the Business

  • The paid-up share capital has seen a marginal increase due to the allotment of 3,856 new equity shares.
  • Marico Limited has confirmed that this change is not material to the company.
7
Allotment of ESOP / ESPS (11 Mar 2026, 5:01 pm)

Marico Allots 9,348 Shares Under ESOP 2016, States Non-Material Impact

Marico allotted 9,348 shares under its ESOP 2016 plan, increasing paid-up capital but stating the event is not material.

Summary

  • Marico Limited has allotted 9,348 equity shares on March 11, 2026, under its ESOP 2016 plan.
  • This allotment increases the total paid-up share capital to Rs. 1,29,81,45,079.
  • The company has clarified that this event is not material in nature.

Key Numbers & Dates

  • Allotment Date: March 11, 2026
  • Shares Allotted: 9,348
  • Previous Total Issued Shares: 1,29,81,35,731
  • Previous Total Issued Share Capital: ₹1,29,81,35,731 (₹129.81 cr)
  • New Total Issued Shares: 1,29,81,45,079
  • New Total Issued Share Capital: ₹1,29,81,45,079 (₹129.81 cr)

What Changes for the Business

  • The company's total paid-up share capital has increased due to the allotment of 9,348 equity shares.
  • The total number of outstanding equity shares has risen to 1,29,81,45,079.
  • The newly allotted shares rank pari-passu with the existing equity shares.
5
Analyst / Investor Meet (9 Mar 2026, 4:29 pm)

Marico Limited Announces Investor Meetings in Singapore on March 24-25, 2026

Marico Limited to hold investor meetings in Singapore on March 24-25, 2026.

Summary

  • Marico Limited announced that its management will hold meetings with investors in Singapore.
  • These meetings will take place on March 24 and March 25, 2026, as part of a Non-Deal Roadshow.
  • The roadshow is organized by J.P. Morgan India Private Limited.

Key Numbers & Dates

  • Investor Meetings: March 24, 2026
  • Investor Meetings: March 25, 2026

⚠️ What Could Go Wrong (source-based)

  • [Other] The schedule of investor meetings is subject to changes and may be impacted by exigencies from the Company, Analysts, or Investors.
6
Company Update (25 Feb 2026, 2:21 pm)

Marico's CSR Program Strengthens Early Childhood Education for Over 1,700 Children in Bahraich

Marico's Nihar Shanti Pathshala Funwala CSR initiative has enhanced early childhood education for over 1,700 children across 100 Anganwadi centres in Bahraich.

Summary

  • Marico Limited's CSR initiative, Nihar Shanti Pathshala Funwala (NSPF), has successfully enhanced early childhood education for over 1,700 children across 100 Anganwadi centres in Bahraich, Uttar Pradesh.
  • The program, a partnership with Sesame Workshop India, focuses on foundational literacy and numeracy (FLN) through play-based pedagogy and digital tools.
  • It trains Anganwadi workers, helpers, and parents, aligning with the National Education Policy 2020.
  • Marico reported a FY 2024-25 turnover of USD 1.3 billion.

Key Numbers & Dates

  • Over 1,700 children educated in Bahraich through NSPF.
  • 100 Anganwadi centres covered in Bahraich.
  • 100 Anganwadi workers and 100 helpers trained in Bahraich.
  • 1,500 parents/caregivers enrolled in the Bahraich initiative.
  • Previously, NSPF impacted over 12 lakh students and 62,500 teachers across Madhya Pradesh, Jharkhand, and Rajasthan.
  • Marico's turnover for FY 2024-25 was USD 1.3 billion.
  • International consumer products contribute approximately 25% of the Group's revenue.
  • Press Release Date: February 25, 2026.

What Changes for the Business

  • This CSR initiative strengthens Marico's commitment to social impact and community development in early childhood education, enhancing its brand reputation and ESG profile.
  • The program's scalable, community-centric approach and alignment with national education policies could serve as a model for future social initiatives.

What to Track Next

  • The scalability of the NSPF program beyond Bahraich and its long-term impact on educational outcomes.
  • Marico's continued investment and reporting on its CSR initiatives and their societal impact.
5
Allotment of ESOP / ESPS (24 Feb 2026, 10:24 am)

Marico Allots 17,077 ESOP Shares; Issue Deemed Non-Material

Marico allotted 17,077 ESOP shares (face value Re. 1) on Feb 24, 2026, increasing share capital, but stated it's not material.

Summary

  • Marico Limited's Securities Committee approved the allotment of 17,077 equity shares of face value Re. 1 each under its ESOP 2016 plan.
  • This allotment increases the company's paid-up share capital to 1,29,81,35,731 shares.
  • The company explicitly stated that the allotment of these shares is not material in nature to Marico.

Key Numbers & Dates

  • Shares Allotted: 17,077 (Unit: Shares)
  • Face Value per Share: ₹1 (Unit: INR)
  • Total Value of Allotted Shares: ₹17,077 (Unit: INR)
  • Previous Paid-up Share Capital: 1,29,81,18,654 Shares
  • New Paid-up Share Capital: 1,29,81,35,731 Shares
  • Allotment Date: February 24, 2026

What Changes for the Business

  • The issuance of 17,077 equity shares results in a minor dilution of existing shareholders' stakes.
  • These shares were issued as part of the Marico Employee Stock Option Plan 2016 to eligible employees.

⚠️ What Could Go Wrong

  • The document explicitly states that the allotment is not material in nature, indicating no significant risks or negative impacts are highlighted by the company regarding this event.
8
Company Update (18 Feb 2026, 12:09 pm)

Marico Limited Investor Call Transcript (Feb 13, 2026): Outlines Digital Transformation, Aggressive Acquisition Strategy, and FY30 Growth Targets

Marico's conference call detailed its transformation into a digital-first powerhouse via strategic acquisitions.

Marico Limited's conference call on February 13, 2026, unveiled its strategic vision to evolve into a digital-first consumer powerhouse. Management detailed a playbook centered on strategic acquisitions, focusing on scalable, profitable digital brands in foods and personal care. The company shared ambitious revenue growth targets, including for its foods segment (15x FY20 by FY30) and digital personal care (5x FY24 levels), aiming for double-digit EBITDA margins and INR 4,000 crores for global digital brands by FY30.

News Crux

Marico Limited held a conference call on February 13, 2026, to discuss its recent strategic investments and its transformation into a digital-first consumer powerhouse. Management outlined a strategy focused on evidence-based acquisitions, profitable scale-up, synergy acceleration, prudent capital allocation, and a repeatable playbook for growth.

Guidance & Strategy

Marico's vision rests on five strategic pillars: evidence-based acquisitions, profitable scale-up via operational discipline, synergy acceleration, prudent capital allocation, and a repeatable playbook. The company is building a 'digital chessboard' spanning three strategic domains: digital foods, digital personal care (PPC), and global digital brands.

Key Targets & Projections:

  • Acquisitions Growth: Targeting 3x to 3.5x revenue growth in digital acquisitions by FY30.
  • Foods Segment: Expected to reach 9x of FY20 levels next year (likely FY27) and 15x by FY30. Key brands include Saffola, True Elements, 4700BC, Cosmix, and Plix (in nutraceuticals).
  • Digital Personal Care (PPC): Digital-first PPC annual run rate is expected to be 5x of FY24 levels. Brands include Beardo, Plix (beauty/personal care), Kaya, and Just Herbs.
  • International Expansion: Strategy includes replicating the playbook in high-growth markets such as Vietnam and the Middle East. Candid in Vietnam is scaling, and organic digital brands (Astroman, Lashe) are being developed.
  • Profitability: EBITDA margin of the digital portfolio is targeted to be in the teens by FY30.
  • Global Digital Brands: Collectively aim for a top-line of INR 4,000 crores in FY30.

The strategy emphasizes disciplined execution, leveraging Marico's distribution and supply chain strengths, and driving growth through digital-first engagement.

Financial Deep Dive

While specific quarterly results were not presented, the call provided insights into the financial trajectory of acquired businesses:

  • 4700BC Profitability: The brand is currently experiencing an "EBITDA bleed" but targets becoming EBITDA positive within the next 12 to 18 months. A medium-term goal is to achieve mid-to-high single-digit EBITDA margins within three years.
  • Digital-First PPC Margins: The digital-first PPC business is projected to achieve double-digit operating margins by FY27 and move into teens EBITDA margins over the next three to four years.
  • Foods Segment Margins: The blended margins for the foods segment, including core offerings like Saffola, are expected to be higher and potentially reach company operating margin levels once scaled appropriately (around INR 200-250 crores).

Key Events

  • Recent strategic investments and acquisitions in digital-first brands across India and international markets (Vietnam).
  • A conference call held on February 13, 2026, to discuss these strategic moves and future outlook.

Outlook

Marico is actively transforming into a digital-first consumer powerhouse, shaping the digital consumer revolution. The company is confident in delivering sustainable profitable growth by building new growth engines that are digital-first, premium, and globally scalable, all while maintaining its DNA of disciplined value creation.

6
Company Update (17 Feb 2026, 7:17 pm)

Marico Limited: Announces Availability of Conference Call Transcript on Strategic Investments

Marico Limited has released the transcript of its conference call held on February 13, 2026.

Marico Limited has made public the transcript of a conference call conducted on February 13, 2026. This call centered on the company's recent strategic investments, offering shareholders and analysts deeper insights into these decisions, their rationale, and potential future impact on the business. The full transcript is accessible on the company's official website for investors.

News Crux

Marico Limited has officially announced the availability of a conference call transcript. The call, which took place on February 13, 2026, focused on the company's recent strategic investments.

Key Events

The company has provided access to the transcript of its conference call held on February 13, 2026. This call served as a platform to discuss recent strategic investments made by Marico Limited. The transcript is now available on the company's website for public access.

6
Audio Recording (13 Feb 2026, 6:46 pm)

Marico Limited: Conference Call Recording on Strategic Investments Now Available Online

Marico Limited has made the audio recording of its recent conference call available on its website.

Marico Limited has released the audio recording of its conference call held on February 13, 2026, which centered on discussions regarding recent strategic investments. The company has made this recording accessible on its official website for investors. The transcript of this call is expected to be provided subsequently.

News Crux

Marico Limited has announced that the audio recording of its conference call, held on February 13, 2026, is now available on the company's website. This call was conducted to discuss recent strategic investments made by the company.

Guidance & Strategy

The conference call discussed recent strategic investments made by Marico Limited. Further details on strategy and guidance would be available in the upcoming transcript.

Key Events

  • Availability of the audio recording of the conference call held on February 13, 2026.
  • The conference call's subject matter was recent strategic investments.
3
Allotment of ESOP / ESPS (13 Feb 2026, 4:47 pm)

Marico Allots 10,356 Shares Under ESOP 2016, Paid-up Capital Marginally Increases

Marico Limited announced the allotment of 10,356 equity shares under its ESOP 2016 plan on February 13, 2026.

Marico Limited announced on February 13, 2026, the allotment of 10,356 equity shares under its Employee Stock Option Plan (ESOP) 2016. The allotment, approved by the Securities Committee of the Board, increases the company's paid-up share capital from approximately 1.298 billion shares to 1.298 billion shares. The company stated this issuance is not material in nature, complying with SEBI regulations.

News Crux

Marico Limited announced on February 13, 2026, the allotment of 10,356 equity shares of face value Re. 1 each under its Marico Employee Stock Option Plan, 2016, to eligible employees upon exercise of stock options. The company clarified that this allotment is not material in nature.

Financial Deep Dive

The allotment resulted in an increase in the company's paid-up share capital. The total number of equity shares increased from 1,29,81,08,298 to 1,29,81,18,654, with each share having a face value of Re. 1. Consequently, the total issued share capital rose to Rs. 1,29,81,18,654. The annexures detail specific allotments totaling 10,356 shares across different exercise prices.

Key Events

  • Allotment of 10,356 equity shares under the Marico Employee Stock Option Plan, 2016, to eligible employees.
8
Analytical Updates (13 Feb 2026, 2:52 pm)

Marico Unveils Ambitious Digital-First Strategy Targeting 15x Foods Growth, 3x in Nutraceuticals & Personal Care by FY30

Marico outlines aggressive digital-first strategy for Foods, Personal Care, and Nutraceuticals, aiming for substantial growth by FY30 through acquisitions and organic expansion.

Marico Limited presented its vision to become a digital-first powerhouse, detailing a strategic framework built on evidence-backed acquisitions and operational discipline. The company forecasts aggressive growth, with Foods revenue targeting a ~15x increase by FY30, while its digital-first nutraceutical (Cosmix) and personal care (Candid) businesses are projected for 3x expansion. The strategy also includes scaling brands like 4700BC, leveraging synergies, and enhancing profitability through premiumization and operational efficiencies across its expanding digital portfolio.

News Crux

Marico Limited presented its "Digital-First Powerhouse" vision, outlining a strategic blueprint for ambitious growth by FY30. The strategy emphasizes scaling acquired digital brands in Foods, Personal Care, and Nutraceuticals, targeting significant revenue multipliers and profitability improvements through operational synergies and market penetration.

Guidance & Strategy

  • Vision: To transform Marico into a digital-first powerhouse by integrating and scaling acquired brands.
  • Strategic Framework: Five pillars - Evidence-Backed Acquisitions, Operational Discipline, Synergy Acceleration, Prudent Capital Allocation, and a Repeatable Playbook, supported by Enablers like Tech & Data Backbone and Talent.
  • Portfolio Growth Targets:
    • Foods: Aiming for ~15x revenue growth by FY30, driven by brands like 4700BC (targeting 3.5x growth from ₹140 Cr ARR by FY30) and other acquisitions.
    • Digital-First Nutraceuticals (Cosmix): Targeting 3x growth by FY30 from ₹100 Cr ARR, with a projected 100%+ revenue CAGR for FY24-26E.
    • Digital-First Personal Care (Candid, Beardo, Just Herbs, Kaya): Candid in Vietnam targeting 3x growth by FY30 from ~₹100 Cr CY25 revenue, with a projected 200%+ revenue CAGR for CY23-25.
  • Profitability Outlook: Digital-first Personal Care (PPC) EBITDA margin projected to increase from ~11% (FY24) to ~33% (FY30).
  • Business Mix Shift: Expected increase in the share of Foods & PPC (including Digital-first) in India revenues to ~22% by FY30.

Key Events

  • Strategic integration and scaling of acquired brands including 4700BC (Gourmet Snacking), Plix (Plant-based Nutraceuticals), Cosmix (Functional Wellness), and Just Herbs (Natural Personal Care).
  • Focus on leveraging Marico's platform for procurement, supply chain, market penetration, and operational efficiencies across these digital brands.

Outlook

Marico anticipates a significant transformation into a digital-first company by FY30, driven by its diversified portfolio of acquired brands in high-growth segments like Foods, Nutraceuticals, and Personal Care. The company expects substantial revenue growth, margin expansion, and a diversified revenue mix as a result of its strategic focus.

9
Earnings Call Transcript (12 Feb 2026, 6:00 pm)

PVR INOX Limited Discusses Strong Q3 FY2026 Results, Industry Growth, and Optimistic Outlook in Analyst Call

PVR INOX Q3 FY2026 results show strong industry growth, company revenue increase, and debt reduction.

PVR INOX reported Q3 FY2026 results with ₹1,908 Cr revenue and ₹115 Cr PAT, driven by a record Indian theatrical market in CY2025. Management discussed 18% EBITDA margins at 28.5% occupancy, debt reduction to ₹365 Cr, and plans to add ~100 screens in FY2026. Outlook for CY2026 is optimistic with a strong content slate.

This document is a transcript of the PVR INOX Limited Q3 and nine-month FY 2026 Earnings Conference Call held on February 05, 2026. The call discussed the company's financial performance, the broader industry context, and future outlook.


Industry Performance

Calendar Year 2025 emerged as the strongest year ever for the Indian theatrical business, achieving an all-India gross box office collection of ₹13,400 crores, a 13% year-on-year increase. This performance was significantly above pre-pandemic levels and saw a record 37 films crossing the ₹100 crores mark. Hindi films contributed strongly, with collections over ₹5,500 crores (18% YoY growth), bolstered by tentpole releases like 'Dhurandhar'. Hollywood also saw a robust recovery, with box office collections of ₹1,400 crores (49% YoY growth). Regional cinema continued its growth, with Gujarati cinema up 188% YoY and Kannada cinema up 74% YoY.

Financial Results (Q3 FY 2026)

PVR INOX welcomed 40.5 million guests during the quarter, a 9% year-on-year increase, with occupancy improving to 28.5% from 25.7% in the prior year's quarter. Average ticket price (ATP) and food & beverage spend per head both saw a 4% year-on-year increase to ₹293 and ₹146, respectively.

  • Total Revenue: ₹1,908 crores (vs. ₹1,739 crores in Q3 FY 2025) - a 9.7% YoY increase.
  • EBITDA: ₹345 crores (vs. ₹258 crores in Q3 FY 2025) - a 33.7% YoY increase.
  • PAT: ₹115 crores (vs. ₹68 crores in Q3 FY 2025) - a 69.1% YoY increase.

A one-time provision of ₹44.6 crores related to the adoption of new labor codes was recognized as an exceptional item below EBITDA, impacting reported PAT.

The company achieved 18% EBITDA margins at around 28% occupancy for two consecutive quarters, highlighting sustained benefits from merger synergies and structural cost optimization.

Operational Updates & Screen Expansion

During Q3 FY2026, PVR INOX added 20 new screens and exited three underperforming screens. Year-to-date, 62 new screens have been added and 11 loss-making screens exited. The company is on track to add nearly 100 new screens in FY 2026. The current screen portfolio stands at 1,791 screens across 358 cinemas in 112 cities.

Financial Health & Debt Reduction

As of December 31, 2025, net debt reduced to ₹365 crores, marking over a ₹1,000 crores reduction since the merger. This deleveraging was driven by strong free cash flows and disciplined capital allocation. The company concluded the divestment of its stake in the '4700BC' premium snacking brand to Marico for ₹226.8 crores in cash.

Outlook & Guidance

Management expressed optimism for Calendar Year 2026, citing a stronger and more evenly distributed content visibility across Hindi, Regional, and Hollywood films. Key upcoming releases mentioned include 'Dhurandhar 2', 'King', 'Ramayana Part 1', 'Avengers Doomsday', and 'Dune 3'. The company expects CY2026 and CY2027 to surpass the performance of CY2025 and CY2026.

For FY2027, the company plans a Capex outlay between ₹350 crores and ₹400 crores, including new screens, renovations, and maintenance. There is an increased focus on renovating existing cinemas and upgrading technology. While there are no immediate plans for dividends or buybacks, the Board will consider this at the appropriate time.

Key Discussions

Discussions covered advertising revenue, which was lower in Q3 FY2026 due to fewer marketable films but is expected to recover. The company also highlighted its strategy for expanding its F&B business, including a joint venture with Devyani for scaling up food courts and launching new in-house brands. The sustainability of current occupancy levels was affirmed, with management indicating that the best years are ahead.

  • Screen Addition Targets: ~100 screens in FY2026, ~150 screens in FY2027.
  • FY2027 Capex: ₹350-400 crores.
  • Net Debt: Reduced to ₹365 crores; targeting negligible levels by end FY2026.
  • Divestment: 4700BC stake sold for ₹226.8 crores.
  • Occupancy & Margins: 18% EBITDA margin achieved at ~28.5% occupancy.
  • Outlook: Strong content pipeline and optimistic for CY2026-27.
3
Company Update (12 Feb 2026, 1:00 pm)

Marico Limited Announces Resignation of EVP Akash Banerji from Digital Transformation Role

Marico Limited announces resignation of EVP Akash Banerji from Digital Transformation role.

Marico Limited has formally announced a significant change in its senior management team. Mr. Akash Banerji, who served as the Executive Vice President (EVP) and Head of Digital Transformation and Beauty & Styling for its Digital Business, has tendered his resignation. The company's filing under SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, states that Mr. Banerji's decision stems from his desire to pursue entrepreneurial opportunities outside the organization. His last working day with Marico is scheduled for May 31, 2026, in accordance with company service rules. The disclosure includes supplementary details and a copy of his resignation letter, adhering to SEBI's master circular. This development marks a leadership transition within Marico's digital initiatives. No financial results, performance metrics, or future outlook guidance were provided in this specific announcement, focusing solely on the personnel change.

Marico Limited has announced a change in its Senior Management Personnel (SMP) through a regulatory filing. Mr. Akash Banerji, who held the position of EVP & Head of Digital Transformation and Beauty & Styling for the Digital Business, has tendered his resignation from the company. Mr. Banerji has decided to pursue entrepreneurial opportunities outside of Marico. His last day of employment is scheduled to be May 31, 2026, subject to the company's service rules. The company has provided the requisite disclosure details as per SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, and made the information available on its website. This announcement pertains solely to a personnel change and does not include any financial results, performance updates, or future outlook.

6
Analyst / Investor Meet (10 Feb 2026, 10:06 pm)

Marico Limited Invites Investors for Conference Call on February 13, 2026, to Discuss Strategic Investments

Marico Limited announces an investor conference call on Feb 13, 2026, following strategic investment announcements.

Marico Limited is holding a conference call on February 13, 2026, to discuss recent strategic investments in Zea Maize Pvt. Ltd., Cosmix Wellness Pvt. Ltd. (India), and Skinetiq Joint Stock Company (Vietnam). Management will provide insights and engage in Q&A. The presentation will be available before the call. Marico, a leading consumer products company, had a turnover of ₹108.3 billion in FY24-25.

Marico Limited has announced an investor and analyst conference call scheduled for Friday, February 13, 2026, from 3:30 p.m. to 4:30 p.m. IST. The primary purpose of this call is to discuss recent strategic investments made by the company.

These investments include stakes in Zea Maize Pvt. Ltd. and Cosmix Wellness Pvt. Ltd. in India, and Skinetiq Joint Stock Company in Vietnam. The management, including the Managing Director & CEO, Mr. Saugata Gupta, and Group CFO & CEO - International Business, Mr. Pawan Agrawal, will represent the company. They are expected to provide perspectives on these investments and engage in a question-and-answer session with participants.

A presentation pertaining to the call will be made available on the company's website and filed with the stock exchanges before the event. Marico has stated that no unpublished price-sensitive information will be shared during the call.

Marico Limited is described as one of India's leading consumer products companies operating in beauty and wellness categories. For FY24-25, the company recorded a turnover of ₹108.3 billion (USD 1.3 billion) from products sold in India, Asia, and Africa. Its brand portfolio includes well-known names such as Parachute, Saffola, Livon, Beardo, and True Elements, among others. Overseas products constitute approximately 25% of the group's revenue.

No specific financial results, quarterly or annual performance metrics, forward-looking financial guidance, or detailed financial deep dives are provided in this announcement. The focus is solely on the upcoming conference call and its agenda.

7
Company Update (5 Feb 2026, 7:17 pm)

Marico Limited Completes Acquisition of 60% Stake in Cosmix Wellness Private Limited, Making it a Subsidiary

Marico Limited finalized its acquisition of 60% in Cosmix Wellness, completing the transaction on February 5, 2026.

Marico Limited announced the completion of its acquisition of 60% of Cosmix Wellness Private Limited, the owner of the 'Cosmix' brand. The transaction, effective February 5, 2026, makes Cosmix Wellness a subsidiary of Marico. This strategic move aims to expand Marico's portfolio in the wellness sector.

Marico Limited has officially announced the completion of its acquisition of a 60% stake in Cosmix Wellness Private Limited, the company that owns the brand 'Cosmix'. The transaction, which was initially entered into via definitive agreements, was successfully concluded on February 5, 2026. Consequently, Cosmix Wellness has now become a subsidiary of Marico Limited. This corporate action is an update pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and has been formally communicated to the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) for record. The information is also accessible on Marico's investor relations website.

8
Company Update (5 Feb 2026, 4:21 pm)

Indian Market Buzz: Mixed Corporate Results, Strategic Deals, Regulatory Scrutiny, and Sectoral Outlooks

Indian companies report Q3 FY26 results with Emcure Pharma, Apollo Tyres, and Emcore Pharma showing strong profit growth. Marico acquires a wellness stake, M&M secures a large vehicle order. IndiGo faces CCI probe. Sectoral trends in AI and EVs discussed.

Indian market news featured Q3 FY26 results with Emcure Pharma (+50% PAT), Apollo Tyres (+40% Net Profit), and Emcore Pharma (+48% PAT) reporting significant profit jumps. Marico acquired a 60% stake in Coffeess Wellness for ₹225.67 crore, and M&M received a large LCV order for 35,000 units from Indonesia. Regulatory action saw the CCI launching an investigation into IndiGo for alleged market abuse. Sectoral insights included positive outlooks for AI and EV supply chains, and Larry Fink's optimistic views on India's digital infrastructure and economic potential. Fractal Analytics announced its IPO with an estimated ₹15,840 crore valuation.

The financial news landscape is diverse, featuring corporate earnings, strategic moves, regulatory scrutiny, and macroeconomic outlooks. Kanpur Plastipack Ltd. has informed its shareholders about SEBI's one-time Special Window for the transfer and dematerialisation of physical securities, operational from February 5, 2026, to February 4, 2027, a procedural compliance announcement.

Several Indian companies have reported their Q3 FY26 financial results. Emcure Pharmaceuticals showcased a notable 50% year-on-year (YoY) surge in net profit, while Apollo Tyres achieved a 40% YoY increase in net profit, attributed to strong performance in both domestic and export markets. Emcore Pharma also posted a robust 48% YoY rise in profit after tax, with revenue from operations up 20% YoY, though its PAT was partially impacted by a new tax rule. Emami recorded a 14.5% YoY increase in net profit and a 9.8% rise in revenue. Kalpataru Projects International's consolidated profit grew by approximately 7% YoY, and Trent's net profit saw a 3.1% YoY increase with revenue up 14.8% YoY. Tata Power's consolidated profit marginally increased to ₹1,194 crore, and Bajaj Finserv's profit remained stable at ₹2,229 crore. Tamilnad Mercantile Bank's net profit rose 14% to ₹342 crore.

In strategic corporate actions, Marico announced its expansion into the wellness sector with the acquisition of a 60% stake in Coffeess Wellness for ₹225.67 crore. Mahindra & Mahindra (M&M) secured a substantial order to supply 35,000 units of its light commercial vehicle 'Supro' to an Indonesian entity, Agnas Pangan Nusantara, for delivery in 2026. Zydus Lifesciences received a tentative USFDA approval for its Dapagliflozin tablets, a move that could enhance its product offerings.

On the regulatory front, the Competition Commission of India (CCI) has initiated an investigation into IndiGo concerning allegations of abusing its dominant market position. This action follows a series of flight cancellations by the airline and broader concerns about market consolidation within the domestic aviation sector. IndiGo has reportedly contested the CCI's jurisdiction in the matter.

Sectoral insights indicate that the government is poised to approve five to seven additional applications under the Electronics Manufacturing Scheme (EMS), projecting an investment of around ₹11,150 crore and an output of ₹29,000 crore. The outlook for the EV battery supply chain appears promising, with Crisil Ratings forecasting growth between 16-18% in the upcoming fiscal year, recovering from current supply chain challenges.

Market sentiment was also shaped by positive commentary from Larry Fink, Chairman and CEO of BlackRock, who highlighted India's emergence as a leader in digital public infrastructure and expressed optimism about its economic trajectory, emphasizing Artificial Intelligence (AI) as a transformative technology. This optimism is mirrored by the upcoming Initial Public Offering (IPO) of Fractal Analytics, an enterprise AI company, which has set a price band of ₹857-₹900 per share, indicating an estimated valuation of ₹15,840 crore. The company's CEO conveyed strong conviction in AI's disruptive capabilities.

Cognizant, a Nasdaq-listed firm with significant Indian operations, reported a 19% increase in net profit and a 4.9% rise in revenue for its fourth quarter, while also providing a guidance of 4-6.5% growth for 2025.

7
Company Update (4 Feb 2026, 5:54 pm)

Marico Acquires 60% Stake in Digital-First Wellness Brand Cosmix for ₹225.67 Cr

Marico Limited announces strategic investment, acquiring 60% stake in functional wellness brand Cosmix for ₹225.67 crore.

Marico Limited announced a strategic investment to acquire a 60% stake in Cosmix Wellness Private Limited for ₹225.67 crore, valuing the company at approximately ₹375 crore. Cosmix Wellness owns the 'Cosmix' brand, a leading digital-first functional wellness brand in India, specializing in plant-based protein powders and functional food blends. This move aligns with Marico's strategy to expand its footprint in premium food and nutrition categories. Cosmix, incorporated in January 2022, is bootstrapped, profitable, and reported an ARR of ₹100 crore (L6M) with high teen EBITDA margins. The acquisition is expected to complete within 30 days. Marico also holds an option to acquire the remaining stake after FY29, subject to milestones and approvals.

Marico Limited has announced a significant strategic move by entering into definitive agreements to acquire a 60% stake in Cosmix Wellness Private Limited, the company behind India's leading digital-first functional wellness brand, "Cosmix". The transaction involves a cash consideration of ₹225.67 crore for the majority stake, implying an equity valuation of approximately ₹375 crore for Cosmix Wellness. This acquisition is aligned with Marico's strategic objective to expand its presence in premium food and nutrition categories by integrating a digital-first brand with a strong consumer proposition.

Cosmix Wellness, incorporated on January 31, 2022, and headquartered in Bengaluru, has demonstrated robust growth, with its turnover increasing from ₹5.39 crore in FY2022-23 to ₹24.32 crore in FY2023-24 and ₹50.93 crore in FY2024-25. Notably, the brand has achieved a last 6 months Annual Recurring Revenue (ARR) of approximately ₹100 crore (as of January 2026) and operates with a sustainable high teen EBITDA margin profile. The brand is known for its vegan, gut-friendly, plant-based protein powders, functional superfood blends, and plant-protein food items, with strong traction on its D2C website and leading positions in online plant protein categories.

The acquisition is expected to be completed within approximately 30 days, subject to customary closing conditions. Beyond the initial stake, Marico has secured an option to acquire the remaining stake in Cosmix Wellness after the completion of FY29, contingent upon the achievement of certain milestones and requisite approvals. This strategic investment is poised to enhance Marico's digital-first portfolio and accelerate Cosmix's growth trajectory by expanding into adjacent wellness and nutraceutical categories, strengthening distribution, and continuing to build a premium brand based on innovation and differentiation.

1
Allotment of ESOP / ESPS (3 Feb 2026, 6:02 pm)

Marico Limited: Allots 20,639 Equity Shares Under ESOP 2016; Not Material

Marico Limited has allotted 20,639 equity shares under its ESOP 2016 plan.

Marico Limited announced the allotment of 20,639 equity shares under its ESOP 2016 plan. The total paid-up capital increased to Rs. 1,29,81,08,298. This routine issuance, compliant with SEBI regulations, was deemed non-material by the company, indicating no significant impact on its financial standing or market position.

Marico Limited has announced the allotment of 20,639 equity shares under its Employee Stock Option Plan, 2016, effective February 3, 2026. These shares, each with a face value of Re. 1, were issued pursuant to the exercise of stock options by eligible employees. This issuance has led to an increase in the company's total paid-up share capital from 1,29,80,87,659 equity shares (aggregating Rs. 1,29,80,87,659) to 1,29,81,08,298 equity shares (aggregating Rs. 1,29,81,08,298). The company explicitly clarified that this allotment is not material in nature. The disclosure is made in compliance with Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The detailed particulars of the allotment are provided in Annexures I and II.

1
Analyst / Investor Meet (2 Feb 2026, 3:18 pm)

Marico Limited Announces Management Attendance at Nuvama India Conference 2026; No UPSI to be Shared

Marico management to attend Nuvama India Conference on Feb 11, 2026, in Mumbai; no UPSI to be shared.

Marico Limited will have its management participating in the Nuvama India Conference - 2026 on February 11, 2026, in Mumbai. The company has informed exchanges about this scheduled investor meeting which includes one-on-one interactions. As is standard practice, Marico clarified that no unpublished price-sensitive information (UPSI) will be shared. A presentation typically used by the company for such interactions is available on its investor website. The schedule is subject to change.

Marico Limited has officially announced its management's upcoming participation in the Nuvama India Conference - 2026. The event is scheduled to take place on Wednesday, February 11, 2026, in Mumbai, and will involve one-on-one meetings between the company's management, analysts, and investors. This engagement is part of Marico's ongoing investor relations activities. Pursuant to SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the company clarified that no unpublished price-sensitive information (UPSI) pertaining to Marico will be shared during any of these meetings. Furthermore, the presentation materials that company officials typically use for such investor conferences are made available on the company’s official website, accessible through a provided link. The announced schedule is noted as being subject to change due to potential exigencies on the part of analysts, investors, or the company itself. This announcement serves to inform stakeholders of planned corporate interactions.

8
Company Update (30 Jan 2026, 5:23 pm)

Marico Q3 FY26 Earnings Call: Strategic 4700BC Investment, Positive Outlook for VAHO & Foods, Parachute Pricing Strategy Detailed

Marico's Q3 FY26 earnings call highlighted sequential India volume growth, robust international performance, and a strategic investment in gourmet snacking brand 4700BC.

Marico's Q3 FY26 earnings call revealed sequential India volume growth and strong international performance. A key strategic investment was made in 4700BC (gourmet snacking), targeting significant ARR expansion. The company is confident in accelerating growth for its Value-Added Hair Oils (VAHO) and Foods segments. Management detailed a strategic approach to Parachute pricing to navigate copra price deflation, expecting progressive operating profit improvements and margin expansion.

Marico's Q3 FY26 earnings call detailed a performance characterized by sequential volume growth in its India business, despite an elevated pricing environment that began tapering towards the end of the quarter. The company noted strong offtakes across core portfolios and continued gains in market share and penetration. The international business demonstrated robust and broad-based growth across key markets including Bangladesh, Vietnam, and South Africa.

Key category highlights include Value-Added Hair Oils (VAHO) delivering strong performance with accelerated market share gains, reaching an all-time high value share of nearly 30% and demonstrating a positive two-year CAGR. Saffola Edible Oil experienced a soft quarter, with volumes sacrificed in certain packs to protect margins, though future growth is anticipated to improve with premiumization efforts. The Foods portfolio, after a strategic pause for profitability correction, is expected to resume accelerated growth over the next two quarters. A significant strategic development was the announcement of an investment in premium gourmet snacking brand 4700BC, with projections to scale its Annual Recurring Revenue (ARR) by 3x in three years. The Digital-First portfolio is on track to exit FY26 with over INR 1,000 crore ARR, aiming for double-digit EBITDA margins by FY27.

Management provided a positive outlook, expecting progressive improvement in operating profit growth rates driven by moderating input costs and easing margin pressures. The company is transitioning towards 'purposeful acceleration' with sharp portfolio choices and agile execution. Regarding Parachute pricing, with copra prices down significantly from peaks, Marico plans to pass on benefits strategically through a single price cut after assessing the trajectory, likely post-March-April, to optimize trade rhythm and potentially support margin expansion. The company expressed confidence in managing potential volume challenges arising from price adjustments, leveraging improved supply chain efficiencies.

Guidance includes resuming accelerated growth in the organic food business within two quarters, with the overall Foods segment (organic and inorganic) targeted for 20-25% growth. An operating margin expansion of 150-200 basis points is targeted for the next fiscal year.

7
Company Update (29 Jan 2026, 5:57 pm)

Marico Limited Completes Acquisition of Zea Maize (4700BC Brand), Making It a Subsidiary

Marico Limited has completed the acquisition of 93.27% of Zea Maize, owner of the '4700BC' brand.

Marico Limited has completed the acquisition of 93.27% of Zea Maize Private Limited, the company owning the '4700BC' brand. This transaction, finalized on January 29, 2026, makes Zea Maize a subsidiary of Marico. The move is strategic for Marico's expansion into the premium food segment, leveraging the established '4700BC' brand. While this announcement confirms the deal closure, it does not include specific financial details, performance metrics of Zea Maize, or Marico's updated financial guidance. The primary impact is Marico's portfolio diversification and increased market presence in premium consumer goods.

Marico Limited has officially announced the successful completion of its acquisition of a 93.27% stake in Zea Maize Private Limited. Zea Maize is recognized as the entity behind the premium '4700BC' brand. The definitive agreements, initially entered into on January 26, 2026, were finalized on January 29, 2026. Consequently, Zea Maize Private Limited has now officially become a subsidiary of Marico Limited. This strategic integration signifies Marico's intention to bolster its presence and offerings within the premium food products market. The current announcement focuses solely on the completion of this corporate action and does not provide any details regarding recent financial results, management guidance, concall commentary, or a deep dive into specific financial statements like income statements, balance sheets, or cash flows. Information concerning the specific deal value or the expected financial impact on Marico's performance is not included in this disclosure. The primary event highlighted is the successful culmination of the acquisition, which represents a key step in Marico's strategy for portfolio diversification and expanding its market reach, particularly within the premium consumer goods segment.

5
Company Update (29 Jan 2026, 5:53 pm)

PVR INOX Limited Completes Divestment of Subsidiary Zea Maize Private Limited to Marico Limited

PVR INOX Ltd. finalized the sale of its subsidiary, Zea Maize Private Limited, owner of the '4700BC' brand, to Marico Limited.

PVR INOX Limited announced the completion of its divestment of its entire shareholding in its subsidiary, Zea Maize Private Limited (ZMPL), owner of the '4700BC' brand, to Marico Limited. The transaction was finalized on January 29, 2026, with ZMPL ceasing to be a subsidiary. This follows the company's prior intimation on January 26, 2026, regarding the approval and entry into definitive agreements for the sale.

PVR INOX Limited has officially completed the divestment of its entire shareholding in its subsidiary, Zea Maize Private Limited (ZMPL). ZMPL is known for owning the brand "4700BC". The buyer of this subsidiary is Marico Limited. PVR INOX Limited had previously informed the stock exchanges about the approval of this sale and the entering into definitive agreements with Marico Limited on January 26, 2026. The transaction has now been finalized on January 29, 2026, with ZMPL ceasing to be a subsidiary of PVR INOX Limited from that date.

Company Update (28 Jan 2026, 5:00 pm)

Marico Limited Discloses Un-audited Financial Results for Q3 FY2026

Marico Limited has published its un-audited consolidated financial results for the quarter and nine months ended December 31, 2025. These results were approved by the Board on January 27, 2026, and are available on the company's website and stock exchanges.

Marico Limited announced its un-audited consolidated financial results for the quarter and nine months ending December 31, 2025, as approved by its Board of Directors on January 27, 2026. The company has published these results in leading newspapers including The Financial Express, Free Press Journal, and Navshakti, and made them available on its corporate website and stock exchange platforms.

Company Update (28 Jan 2026, 4:46 pm)

Kaiser Corp Leads With Financial Results Publication Amidst Broader Market Filings

Kaiser Corporation Ltd. has published its financial results for the quarter and nine months ended December 31, 2025. The company submitted these results to the BSE as per SEBI regulations.

Kaiser Corporation Ltd. has officially announced its financial results for the quarter and nine months ending December 31, 2025, via newspaper publications on January 28, 2026. The report also includes financial results from Colinz Laboratories Limited. Notably, Marico Limited and Asian Paints have also published their consolidated and standalone financial results for the same period, indicating a busy period for corporate financial disclosures.

2
Audio Recording (27 Jan 2026, 9:03 pm)

Marico Limited Announces Availability of Q3 FY26 Earnings Conference Call Recording

Marico Limited has made its Q3 FY26 earnings call recording available on its investor website.

Marico Limited has informed the stock exchanges that the audio recording of its earnings conference call, held on January 27, 2026, to discuss the un-audited financial results and operations for the quarter and nine months ended December 31, 2025, is now available on the company’s investor website. The transcript will be published subsequently.

Marico Limited has officially informed the stock exchanges, including BSE Limited and the National Stock Exchange of India Limited, regarding the availability of the audio recording of its recent earnings conference call. This communication, made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirms that the audio recording is now accessible to investors and stakeholders. The conference call took place on Tuesday, January 27, 2026, and focused on the company's un-audited financial results and operational performance for the quarter and the nine-month period ended December 31, 2025. Investors can access this recording through Marico’s official website, specifically on the investor relations page under the quarterly results section (https://marico.com/india/investors#quarterly). Furthermore, the company has indicated that the transcript of this earnings call will be provided to the stock exchanges and subsequently published on the company's website at a later date. This announcement serves as a procedural step, informing stakeholders about the availability of management's commentary on the company's financial standing and operational activities for the period.

5
Company Update (27 Jan 2026, 4:01 pm)

Marico Limited Announces Intra-Group Restructuring to Integrate 'Beardo' Business via Voluntary Liquidation

Marico Limited to integrate its subsidiary Zed Lifestyle ('Beardo') via voluntary liquidation.

Marico Limited announced the integration of its wholly-owned subsidiary Zed Lifestyle ('Beardo') through voluntary liquidation. This strategic move aligns with its digital-first strategy, aiming for operational synergies and a simplified structure. Zed's contribution to turnover and net worth is minimal, with no material impact anticipated on consolidated financials. The process is subject to necessary approvals.

Marico Limited has announced its intention to undertake an intra-group restructuring, integrating its wholly-owned subsidiary, Zed Lifestyle Private Limited, which operates the 'Beardo' brand, into the main company. This strategic move, planned as part of Marico's digital-first strategy and digital transformation journey, aims to achieve operational synergies, more efficient resource allocation, and a simplified corporate group structure.

The restructuring will be implemented through the voluntary liquidation of Zed Lifestyle, with its entire business undertaking to be distributed to Marico Limited on a going concern basis. This proposed voluntary liquidation has received in-principle approval from Zed's board and approval from Marico's board of directors on January 27, 2026. However, it remains subject to further approvals from Zed's board, shareholders, creditors, and necessary statutory and regulatory bodies.

Zed Lifestyle is not classified as a material subsidiary, and the company has stated that this restructuring will not have any material impact on Marico's consolidated financials. In the last financial year, Zed contributed ₹214.17 crore in turnover (1.98% of consolidated turnover) and ₹18.61 crore in net worth (0.39% of consolidated net worth). The completion of the liquidation and distribution is expected upon receipt of necessary approvals, after which Zed will be dissolved by order of the National Company Law Tribunal (NCLT). There will be no change in Marico's shareholding pattern as a result of this transaction, and the shares held by Marico in Zed will be cancelled upon dissolution.

9
Company Update (27 Jan 2026, 3:53 pm)

Marico Q3 FY26: Revenue Surges 27% Driven by India & International Growth; Acquires Premium Snacking Brand '4700BC'

Marico reported Q3 FY26 results with 27% YoY revenue growth to ₹3,537 Cr. India volume grew 8%, International CCG 21%. Acquired 4700BC.

Marico reported Q3 FY26 revenue growth of 27% YoY to ₹3,537 Cr, with 8% volume growth in India and 21% constant currency growth internationally. EBITDA rose 11% YoY to ₹592 Cr, though margins declined 234 bps YoY to 16.7%. PAT increased 12% to ₹447 Cr. The company announced a strategic investment in premium gourmet snacking brand '4700BC', acquiring a majority stake. Outlook is positive with expected double-digit revenue growth.

Marico Limited announced its unaudited consolidated financial results for the quarter and nine months ended December 31, 2025 (Q3 FY26). The company reported a strong top-line performance, with consolidated revenue from operations growing 27% year-on-year (YoY) to ₹3,537 crore in Q3 FY26. This growth was propelled by an 8% volume growth in the India business and a robust 21% constant currency growth in the international business. For the nine months ended December 31, 2025 (9MFY26), consolidated revenue also grew by 27% YoY to ₹10,278 crore.

Profitability saw EBITDA increase by 11% YoY to ₹592 crore. However, EBITDA margins contracted by 234 basis points YoY to 16.7% in Q3 FY26, primarily due to higher material costs and sustained investments in Advertising & Sales Promotion (A&P) spends, which rose 15% YoY. Sequentially, margins improved by approximately 90 bps due to easing copra prices. Profit After Tax (PAT) grew 12% YoY to ₹447 crore.

The India business revenues stood at ₹2,681 crore, up 28% YoY, driven by sequential improvement in volume growth and pricing interventions over the past 12 months. Traditional trade channels showed improved traction alongside continued leadership from e-commerce and quick commerce. Key brands demonstrated resilience and growth: Parachute Rigids reported 50% revenue growth with underlying volumes up 2% (after ml-age adjustments), while Value-Added Hair Oils (VAHO) delivered 29% value growth and gained 170 bps in market share. Saffola Edible Oils saw flattish revenue growth amidst an elevated pricing environment, with a pivot towards premium offerings. The Foods portfolio grew 5% YoY.

The international business maintained its strong growth trajectory with 21% CCG in Q3 FY26, with notable contributions from Bangladesh (29% CCG), Vietnam (22% CCG), MENA (17% CCG), and South Africa (16% CCG).

In a significant strategic move, Marico announced a definitive agreement to make a strategic investment in Zea Maize Private Limited, the company behind the premium gourmet snacking brand '4700BC', acquiring a 93.27% stake. This acquisition aims to expand Marico's presence in the premium gourmet snacking market.

Looking ahead, Marico expects a gradual uptick in consumption trends, supported by favourable macroeconomic indicators. The company projects over 25% consolidated revenue growth for FY26 and targets double-digit revenue growth in the medium term. The Foods portfolio is expected to grow at 25%+ CAGR to approximately 8 times its FY20 revenues by FY27, and the Digital-first portfolio aims to scale to 2.5 times its FY24 ARR by FY27, with a focus on achieving double-digit EBITDA margins in this segment by FY27. Marico anticipates progressive improvement in operating profit growth as input cost pressures moderate.

9
Board Meeting (27 Jan 2026, 3:49 pm)

Marico Limited Announces Strong Q3 FY26 Revenue Growth, Consolidated Net Profit Up 13.3% YoY

Marico reports consolidated Q3 FY26 revenue up 26.6% YoY to ₹3,537 Cr and net profit up 13.3% to ₹460 Cr.

Marico Limited posted robust Q3 FY26 results, reporting a 26.6% YoY increase in consolidated revenue to ₹3,537 Cr and a 13.3% rise in net profit to ₹460 Cr. For the nine months ended December 31, 2025, consolidated revenue grew 26.9% to ₹10,278 Cr, while net profit was ₹1,405 Cr (up 7%). The company also noted acquisitions of stakes in Satiya Nutraceuticals and HW Wellness, and completion of True Elements. Standalone net profit for 9 months surged 33.5% YoY.

Marico Limited announced its un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025.

Consolidated Performance:
For the third quarter of FY26, Marico reported a consolidated revenue from operations of ₹3,537 crore, marking a significant Year-over-Year (YoY) growth of 26.6% compared to ₹2,794 crore in Q3 FY25. Profit Before Tax (PBT) increased by 9.5% YoY to ₹567 crore, from ₹518 crore in the previous year. The Net Profit for the quarter stood at ₹460 crore, a 13.3% increase YoY from ₹406 crore in Q3 FY25. Basic Earnings Per Share (EPS) grew by 12.0% YoY to ₹3.45 from ₹3.08.

For the nine months ended December 31, 2025, consolidated revenue from operations grew by 26.9% YoY to ₹10,278 crore (₹8,101 crore in 9M FY25). Net Profit for the nine-month period was ₹1,405 crore, an increase of 7.0% YoY from ₹1,313 crore in the corresponding period of FY25. Basic EPS for the nine months was ₹10.60, up 6.6% from ₹9.94 YoY.

Standalone Performance:
On a standalone basis, revenue from operations for Q3 FY26 increased by 23.8% YoY to ₹2,461 crore (₹1,988 crore in Q3 FY25). Net Profit for the quarter rose by 19.5% YoY to ₹441 crore (₹369 crore in Q3 FY25). For the nine months ended December 31, 2025, standalone revenue grew 24.3% YoY to ₹7,197 crore (₹5,791 crore in 9M FY25). Standalone Net Profit surged by 33.5% YoY to ₹1,605 crore (₹1,202 crore in 9M FY25). Basic EPS for the nine months was ₹12.40, a 33.5% increase from ₹9.29 YoY.

Corporate Actions & Developments:
The company noted several key developments. During the quarter ended June 30, 2025, Marico acquired an 8.8% stake in Satiya Nutraceuticals on a fully diluted basis. In the quarter ended September 30, 2025, the company entered into a definitive agreement to acquire the remaining 46.02% equity in HW Wellness, aiming for 100% ownership. The acquisition of aggregate 99.96% equity in True Elements was completed, with the remaining 0.04% acquired on October 17, 2025, making it a wholly owned subsidiary. An intra-group restructuring involving the integration of the business of Just Herbs was also undertaken.

9
Board Meeting (27 Jan 2026, 3:49 pm)

Marico Limited Announces Strong Q3 FY26 Revenue Growth, Consolidated Net Profit Up 13.3% YoY

Marico reports consolidated Q3 FY26 revenue up 26.6% YoY to ₹3,537 Cr and net profit up 13.3% to ₹460 Cr.

Marico Limited posted robust Q3 FY26 results, reporting a 26.6% YoY increase in consolidated revenue to ₹3,537 Cr and a 13.3% rise in net profit to ₹460 Cr. For the nine months ended December 31, 2025, consolidated revenue grew 26.9% to ₹10,278 Cr, while net profit was ₹1,405 Cr (up 7%). The company also noted acquisitions of stakes in Satiya Nutraceuticals and HW Wellness, and completion of True Elements. Standalone net profit for 9 months surged 33.5% YoY.

Marico Limited announced its un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025.

Consolidated Performance:
For the third quarter of FY26, Marico reported a consolidated revenue from operations of ₹3,537 crore, marking a significant Year-over-Year (YoY) growth of 26.6% compared to ₹2,794 crore in Q3 FY25. Profit Before Tax (PBT) increased by 9.5% YoY to ₹567 crore, from ₹518 crore in the previous year. The Net Profit for the quarter stood at ₹460 crore, a 13.3% increase YoY from ₹406 crore in Q3 FY25. Basic Earnings Per Share (EPS) grew by 12.0% YoY to ₹3.45 from ₹3.08.

For the nine months ended December 31, 2025, consolidated revenue from operations grew by 26.9% YoY to ₹10,278 crore (₹8,101 crore in 9M FY25). Net Profit for the nine-month period was ₹1,405 crore, an increase of 7.0% YoY from ₹1,313 crore in the corresponding period of FY25. Basic EPS for the nine months was ₹10.60, up 6.6% from ₹9.94 YoY.

Standalone Performance:
On a standalone basis, revenue from operations for Q3 FY26 increased by 23.8% YoY to ₹2,461 crore (₹1,988 crore in Q3 FY25). Net Profit for the quarter rose by 19.5% YoY to ₹441 crore (₹369 crore in Q3 FY25). For the nine months ended December 31, 2025, standalone revenue grew 24.3% YoY to ₹7,197 crore (₹5,791 crore in 9M FY25). Standalone Net Profit surged by 33.5% YoY to ₹1,605 crore (₹1,202 crore in 9M FY25). Basic EPS for the nine months was ₹12.40, a 33.5% increase from ₹9.29 YoY.

Corporate Actions & Developments:
The company noted several key developments. During the quarter ended June 30, 2025, Marico acquired an 8.8% stake in Satiya Nutraceuticals on a fully diluted basis. In the quarter ended September 30, 2025, the company entered into a definitive agreement to acquire the remaining 46.02% equity in HW Wellness, aiming for 100% ownership. The acquisition of aggregate 99.96% equity in True Elements was completed, with the remaining 0.04% acquired on October 17, 2025, making it a wholly owned subsidiary. An intra-group restructuring involving the integration of the business of Just Herbs was also undertaken.

9
Result (27 Jan 2026, 3:47 pm)

Marico Limited Announces Q3 FY26 Un-audited Results: Consolidated Revenue Up 26.6% YoY, Standalone PAT Up 19.5% YoY

Marico reports Q3 FY26 results with strong consolidated revenue growth of 26.6% YoY. Standalone PAT also shows robust growth.

Marico Limited announced its un-audited financial results for Q3 FY2025-26 and YTD. Consolidated revenue reached ₹3,537 Cr (up 26.6% YoY), with consolidated PAT at ₹460 Cr (up 13.3% YoY). Standalone revenue grew 23.8% YoY to ₹2,461 Cr, and standalone PAT was ₹441 Cr (up 19.5% YoY). For the nine months, consolidated revenue was ₹10,278 Cr (up 26.9% YoY), while standalone PAT saw a significant 33.5% YoY increase. The company also noted acquisitions and business restructuring.

Marico Limited announced its un-audited consolidated and standalone financial results for the quarter and nine months ended December 31, 2025.

Consolidated Performance: For the third quarter of FY2025-26, consolidated revenue from operations increased by 26.59% year-on-year to ₹3,537 crore, compared to ₹2,794 crore in Q3 FY2024-25. Profit Before Tax (PBT) grew by 9.46% to ₹567 crore from ₹518 crore, while Net Profit After Tax (PAT) rose by 13.30% to ₹460 crore from ₹406 crore. The consolidated PAT margin for the quarter was 13.00%, a decrease from 14.53% in the prior year. For the nine months ended December 31, 2025, consolidated revenue stood at ₹10,278 crore, marking a 26.87% YoY increase from ₹8,101 crore. Consolidated PAT for the nine months was ₹1,405 crore, up 6.99% YoY from ₹1,313 crore.

Standalone Performance: On a standalone basis, revenue from operations for Q3 FY2025-26 grew by 23.79% YoY to ₹2,461 crore from ₹1,988 crore. Standalone PAT increased significantly by 19.51% YoY to ₹441 crore from ₹369 crore. For the nine months ended December 31, 2025, standalone revenue was ₹7,197 crore, a 24.28% YoY increase from ₹5,791 crore. Standalone PAT demonstrated strong growth, rising 33.53% YoY to ₹1,605 crore from ₹1,202 crore.

Key Developments: The company reported several strategic actions. During Q2 FY2025-26, Marico completed the acquisition of aggregate 99.96% equity capital in True Elements and entered an agreement to acquire the balance 46.02% for HW Wellness, aiming for 100% ownership. It also acquired an 8.8% stake in Satiya Nutraceuticals, increasing its holding to 60%. An intra-group restructuring involving Just Herbs was completed as a common control transaction with no impact on consolidated results.

Regulatory Impact: The new Labour Codes, effective November 21, 2025, were assessed, and their incremental impact was deemed not material to the financial results.

Outlook: No specific forward-looking guidance or outlook was provided in this announcement.

8
Company Update (26 Jan 2026, 2:09 pm)

PVR INOX Sells Entire Stake in Zea Maize (4700BC) to Marico for ₹226.8 Cr

PVR INOX divests its entire stake in snacking firm Zea Maize (4700BC) to Marico Limited for ₹226.8 crore in an all-cash deal.

PVR INOX will sell its entire stake in subsidiary Zea Maize Private Limited (4700BC brand) to Marico Limited for ₹226.8 crore cash. The divestment is part of a strategic review to unlock shareholder value, strengthen PVR INOX's balance sheet, and reallocate resources to its core cinema business, with the transaction expected to be accretive to profit and cash flow.

PVR INOX Limited has announced the signing of definitive agreements to divest its entire stake in Zea Maize Private Limited, the company behind the premium snacking brand 4700BC, to Marico Limited. This strategic transaction, valued at INR 226.8 crore, will be conducted as an all-cash deal. The divestment stems from PVR INOX's strategic review, which aims to unlock shareholder value, strengthen its balance sheet, and reallocate capital towards its core cinema exhibition business. PVR INOX anticipates that this move will be accretive to its profits, free cash flow, and overall return ratios, while noting that it will not materially impact its in-cinema food and beverage revenues or its growth trajectory.

Marico Limited, a leading consumer products company, views this acquisition as a significant step in its ambition to participate in fast-growing food categories. The company plans to leverage its established FMCG scale and distribution network to further expand the 4700BC brand's presence across various channels, building on its strong consumer connect and innovation capabilities.

Axis Capital served as the exclusive financial advisor, and Shardul Amarchand Mangaldas & Co provided legal counsel to PVR INOX for this transaction.

8
Company Update (26 Jan 2026, 1:59 pm)

Marico Limited Acquires 93.27% Stake in Gourmet Snacking Brand '4700BC' for Rs. 226.83 Cr

Marico to acquire 93.27% stake in Zea Maize, owner of premium snacking brand '4700BC', for Rs. 226.83 Cr.

Marico Limited is acquiring a 93.27% stake in Zea Maize Private Limited, which owns the premium gourmet snacking brand '4700BC', for up to Rs. 226.83 Cr. This move is aimed at expanding Marico's total addressable market in value-added foods by adding a differentiated gourmet snacking brand. The transaction is expected to be completed within 30 days and will make Zea Maize a subsidiary of Marico.

Marico Limited has announced definitive agreements to acquire a 93.27% stake in Zea Maize Private Limited, the company operating the premium gourmet snacking brand '4700BC'. The transaction, valued at up to Rs. 226.83 Crores and payable in cash, is slated for completion within 30 days, subject to customary closing conditions, which will make Zea Maize a subsidiary of Marico. The company also holds an option to acquire the remaining stake after three years, contingent on achieving certain milestones and securing necessary approvals.

This strategic investment is in line with Marico's objective to expand its presence in value-added food categories. '4700BC' is identified as a leading premium gourmet snacking brand with a differentiated positioning, offering products like popcorn and innovative snacks such as popped chips, makhana, crunchy corn, and nachos, catering to the urban, premium consumer segment. Zea Maize Private Limited, incorporated in 2013, reported a turnover of Rs. 98.66 Crores in FY25 and Rs. 75.29 Crores in FY24. A significant indicator of its recent growth momentum is its last three months' Annualised Run Rate (ARR) from October to December 2025, which stood at approximately Rs. 140 Crores.

Management commentary from Marico's MD and CEO indicates that the investment in '4700BC' aligns with the company's ambition to participate in fast-growing food segments with distinctive brands, leveraging Marico's existing scale for broader distribution and enhanced innovation. Chirag Gupta, the founder of '4700BC', expressed enthusiasm for partnering with Marico's FMCG expertise to drive the brand's next growth phase. PVR INOX, the seller, views this transaction as a strategic move to monetize a non-core asset, having supported the brand in its formative years.
The announcement does not include Marico's latest financial results or future guidance but focuses on the acquisition details and strategic rationale. The acquisition is expected to facilitate accelerated growth for '4700BC' through new product launches and distribution network expansion.

6
Analyst / Investor Meet (15 Jan 2026, 1:50 pm)

Marico Limited Invites Investors to Q3 FY26 Earnings Conference Call on January 27, 2026

Marico announces investor call for Q3 FY26 results on January 27, 2026, with revised timing.

Marico Limited announced its Q3 FY26 earnings conference call is scheduled for January 27, 2026, at 6:30 PM IST. Management, including MD & CEO and CFO, will present the financial results and discuss operational performance for the quarter ended December 31, 2025. Results will be available on the company website post-Board approval.

Marico Limited has announced an investor and analyst conference call to discuss its financial results for the quarter ended December 31, 2025 (Q3 FY26). The call is scheduled for Tuesday, January 27, 2026, with the timing revised to 6:30 PM IST. The company's management, including Mr. Saugata Gupta, Managing Director & CEO, and Mr. Pawan Agrawal, Group CFO & CEO - International Business, will represent the company and provide commentary on its operational performance and financial outcomes. The financial results will be approved by the Board of Directors on the same day and will be made available on Marico's corporate website, www.marico.com.

Additionally, Marico had previously issued a Q3 FY26 update indicating expectations of consolidated revenue growth in the thirties year-on-year, driven by pricing and mix, with India volume growth in high single digits and international business achieving strong constant currency growth in the twenties. The company anticipated sequential gross margin improvement in the latter half of FY26, leading to double-digit operating profit growth, due to expected easing input cost pressures. This call will likely delve deeper into these aspects and provide further strategic insights.

7
Audio Recording (9 Jan 2026, 5:54 pm)

Marico Announces Q3 FY26 Earnings Conference Call for January 27, 2026

Marico Limited will host an investor and analyst conference call on January 27, 2026, to discuss its Q3 FY26 financial results.

Marico Limited has scheduled an investor/analyst conference call for Tuesday, January 27, 2026, at 6:00 PM IST to discuss its financial results and operations for the quarter ended December 31, 2025. The company's MD & CEO and Group CFO will represent management. An audio recording and transcript will be made available on the company's website post-call.

Marico Limited has announced that it will hold an investor and analyst conference call on Tuesday, January 27, 2026, at 6:00 PM IST. The purpose of the call is to discuss the company's financial results and operations for the third quarter of the fiscal year 2026, which ended on December 31, 2025. Senior management, including Mr. Saugata Gupta, Managing Director & CEO, and Mr. Pawan Agrawal, Group CFO & CEO - International Business, will be present to provide commentary. Following the Board of Directors' approval of the financial results on the same day, an audio recording and transcript of the conference call will be published on Marico's official website.

1
Company Update (8 Jan 2026, 6:30 pm)

Marico Limited Files Routine Compliance Certificate for Quarter Ended December 31, 2025

Marico Limited submitted its quarterly compliance certificate as per SEBI regulations for the period ending December 31, 2025.

Marico Limited has filed its compliance certificate concerning Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. The company received this from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, confirming proper handling of dematerialisation during the period.

Marico Limited has officially submitted a compliance certificate to the stock exchanges (BSE and NSE) as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter ended December 31, 2025. The company received this confirmation from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited. The filing confirms that securities received from depository participants for dematerialisation during the quarter were processed according to regulations, and the relevant certificates have been listed on the stock exchanges. This is a routine procedural update and does not contain any specific financial performance data or strategic updates.

6
Board Meeting (6 Jan 2026, 4:55 pm)

Marico Announces Board Meeting on January 27, 2026, to Approve Q3 FY26 Financial Results

Marico Limited has scheduled a Board meeting for January 27, 2026, to approve its Q3 FY26 financial results and has closed its trading window.

Marico Limited announced a Board meeting on January 27, 2026, to approve its un-audited standalone and consolidated financial results for Q3 FY26 (quarter ended December 31, 2025), along with the auditors' limited review report. The company also informed that the trading window for dealing in its shares will be closed from December 26, 2025, to January 29, 2026, in compliance with SEBI regulations.

Marico Limited has announced that its Board of Directors will convene a meeting on January 27, 2026. The primary agenda for this meeting is to consider and approve the un-audited standalone and consolidated financial results for the quarter ended December 31, 2025 (Q3 FY26), along with the Limited Review Report from the auditors. In line with regulatory practices for financial result announcements, the company has also declared a closure of the trading window for dealing in its shares. This closure will be effective from December 26, 2025, and will remain in place until January 29, 2026, inclusive of both dates.

9
Company Update (2 Jan 2026, 3:35 pm)

Marico Reports Steady Q3 FY26 Performance: High Single-Digit India Volume Growth, Margin Improvement Expected

Marico's Q3 FY26 update shows steady demand, high single-digit India volume growth, and nearly 20% international CC growth. Copra prices corrected, expecting margin improvement.

Marico's Q3 FY26 update reveals steady sector demand and a positive outlook for consumption. India business achieved high single-digit volume growth, with Parachute showing resilience and VAHO growing in the twenties. International business grew nearly 20% in constant currency. Copra price correction is expected to drive sequential gross margin improvement, and operating profit growth is anticipated in double digits. The company aims for sustainable, profitable volume-led growth.

Marico Limited has released a quarterly update for Q3 FY2025-26, highlighting steady demand trends in the sector and an optimistic outlook for consumption growth, supported by easing inflation, GST rate rationalization, and MSP hikes.

The India business witnessed high single-digit underlying volume growth, showing a slight sequential improvement. Key brand performances included stellar resilience from Parachute, which saw marginal volume decline but positive growth after normalizing for ml-age reductions. Saffola Oils experienced a muted quarter due to the anniversarying of prior pricing actions. Value Added Hair Oils (VAHO) demonstrated strong traction, growing in the twenties, with expectations of sustained double-digit growth momentum driven by strategic focus on mid and premium segments, Project SETU, and GST rationalization. The Foods segment had a benign quarter but is expected to reaccelerate growth in the coming two quarters, while Premium Personal Care (PPC), including digital-first brands, continued to scale ahead of aspirations.

The international business maintained robust momentum, posting constant currency growth in the high twenties, with Bangladesh leading the performance, and Vietnam and South Africa returning to double-digit growth.

Consolidated revenue growth for the quarter is projected in the high twenties on a year-on-year basis, aiming to meet the full-year aspiration. Regarding input costs, copra prices have corrected approximately 30% from their peaks and are expected to trend downwards. Vegetable oil prices remained elevated, while crude oil derivatives were benign. Consequently, Marico anticipates an uptick in gross margin sequentially, following a low in the preceding quarter, with further improvements expected due to the lagged pass-through of lower copra costs. Brand-building investments were sustained to strengthen long-term equity and drive portfolio diversification. In light of these factors, the company expects operating profit growth to reach double digits on a year-on-year basis.

Marico reiterated its medium-term aspiration to deliver sustainable and profitable volume-led growth, supported by the strengthening brand equity of its core franchises and the scaling of new growth engines across markets.

6
Company Update (17 Dec 2025, 6:20 pm)

Marico Limited Extends PLIX Acquisition Timeline by 12 Months Amidst Strong FY26 Performance

Marico Limited has extended its acquisition timeline for the remaining 40% stake in PLIX by 12 months, following robust Q1 and Q2 FY26 results and strategic expansion efforts.

Marico Limited has extended the deadline for acquiring the remaining 40% stake in Satiya Nutraceuticals (PLIX) by 12 months, subject to milestones. This follows robust Q1 FY26 consolidated revenue growth of 23.31% YoY to ₹3,259 Cr and Q2 FY26 revenue growth of 30.7% YoY to ₹3,482 Cr. The company also finalized the acquisition of True Elements, reflecting a strategic focus on growth and expansion.

Marico Limited has announced an amendment to its definitive agreement concerning the acquisition of Satiya Nutraceuticals Private Limited (PLIX), extending the period for acquiring the remaining 40% stake by an additional 12 months, subject to mutually agreed milestones and conditions. This strategic update follows previously reported strong financial performance.

In Q1 FY26, Marico posted robust consolidated revenue growth of 23.31% YoY to ₹3,259 crore and consolidated Profit After Tax (PAT) of ₹513 crore, an 8.23% YoY increase, though PAT margins contracted. Standalone PAT saw a significant surge of 149.84% YoY to ₹777 crore, primarily due to substantial 'other income'. The India segment revenue grew 27.17% YoY, while international segment revenue increased by 12.19% YoY.

For Q2 FY26, the company reported consolidated revenue growth of 30.7% YoY to ₹3,482 Cr, with PAT remaining flat at ₹432 Cr. EBITDA margins saw a contraction of 350 bps to 16.1% due to input cost inflation. For the half-year ended September 30, 2025, consolidated revenue grew 27.0% YoY to ₹6,741 Cr, with PAT up 4.2% to ₹945 Cr.

Marico also completed the acquisition of the remaining 46.02% stake in HW Wellness Solutions (True Elements), strengthening its presence in the healthy foods sector. The company has guided for approximately 25% revenue growth for FY26 and double-digit profit CAGR over the next two years. Marico also received strong ESG ratings, underscoring its commitment to sustainability. Other corporate activities included an intra-group restructuring for Apcos Naturals and investor engagements.

7
Company Update (17 Dec 2025, 12:54 pm)

Marico Limited Earns Dual A- CDP Scores and Leads FMCG Sector in NSE ESG Ratings

Marico Limited recognized for strong sustainability performance with dual A- CDP scores and leading NSE ESG ratings.

Marico Limited announced dual A- CDP scores for Climate Change and Water Security, and a leading ESG rating of 78 from NSE, recognizing its robust sustainability strategy. The company aims for net-zero emissions by 2040 and has made progress in renewable energy and responsible sourcing.

Marico Limited has announced two major sustainability achievements: securing dual A- ratings from CDP for Climate Change and Water Security, marking a return to the leadership band for Climate Change after five years and achieving its first high ranking in Water Security. Additionally, the company was rated 78 ('Leader') by NSE Sustainability Ratings and Analytics, positioning it as the top performer in the FMCG sector for ESG. These accolades reflect Marico's disciplined approach to sustainability, including its climate ambitions, water stewardship, and progress in deforestation-free sourcing. The company has set ambitious targets, aiming for net-zero emissions globally by 2040 and in India by 2030, with 72% of its operational energy already sourced from renewables. Marico is also committed to 100% recyclable packaging by 2030 and enhancing responsible sourcing through its 'Samyut' framework.

8
(12 Dec 2025, 7:12 pm)

Sharekhan Equity ValueGuide (Dec 2025): Market Recap, Sector Outlook & Q2FY26 Stock Performance Analysis

Sharekhan's Dec 2025 report reviews Indian market, sectors, and Q2FY26 stock performance with recommendations.

Sharekhan's December 2025 Equity ValueGuide presents a detailed analysis of the Indian equity market in 2025, highlighting single-digit returns, FII outflows, and a weak rupee, but also a positive outlook for H2FY26 earnings. It provides sector-specific insights, with financials expected to perform well, IT at an inflection point due to AI, and positive trends in FMCG, real estate, and metals. The report extensively covers Q2FY26 results for numerous large, mid, and small-cap companies, including revenue growth, margin performance, PAT, management guidance, and analyst recommendations (BUY/HOLD).

The Sharekhan Equity ValueGuide for December 2025 offers a comprehensive analysis of the Indian equity market and specific company performances.

Market Overview:
2025 was a challenging year for Indian equities, with single-digit returns and lagging global peers, influenced by FII outflows and a weak rupee. However, domestic factors like strong GDP data and RBI rate cuts provided support. The report notes a divergence in performance, with the Nifty gaining modestly while the small-cap index saw a decline, attributing this to stretched valuations in smaller segments. The outlook for H2FY26 is positive, anticipating an earnings acceleration cycle and potential market consolidation providing a better risk-reward ratio. Large-cap stocks are expected to remain in favor.

Sector Performance & Outlook:

  • Financials: Expected to show healthy performance in H2FY26, driven by credit momentum, with RBI rate cuts being a tailwind for NBFCs.
  • IT: At an inflection point with increasing AI-led project wins and stable margins; the structural outlook is brightening.
  • FMCG: Sequential volume growth is projected to be strong due to festive demand and post-GST rate cut normalization.
  • Real Estate: Positive outlook with a launch-heavy second half and demand boosted by rate cuts.
  • Metals: Bullish outlook driven by new-age technologies and government focus on critical minerals.

Q2FY26 Stock Performance Highlights:
The report provides detailed Q2FY26 results and recommendations for numerous companies.

  • Strong Performers: Bharat Electronics reported robust Q2FY26 with strong revenue growth and a significant order book (Rs 74,453 crore). Titan Company and Cummins India also posted strong results with revenue and profit growth. Asian Paints saw double-digit volume growth and improved margins.
  • Subdued Performance: Hindustan Unilever and Bata India reported weak revenue and margin performance. Emami faced headwinds from GST 2.0 and monsoons, leading to revenue and PAT decline.
  • Guidance: Companies like TCPL, Astral, Samhi Hotels, and Asian Paints provided positive guidance on future growth drivers and margin expectations.
  • Key Events: Bharat Electronics, HAL (order book of Rs 2.7 lakh crore), and KEC International (order book of Rs 44,000 crore) highlighted strong order visibility. Cipla launched its first biosimilar in the US, while Sun Pharma is on track for key US launches. Acquisitions were noted for Zydus Wellness, Torrent Pharma, and Godrej Consumer.

Overall Outlook: The report suggests a constructive outlook for the Indian market, driven by improving earnings and domestic inflows, while cautioning on speculative froth in the small-cap segment.

2
Allotment of ESOP / ESPS (12 Dec 2025, 5:28 pm)

Marico Limited Allots 34,423 Equity Shares Under ESOP 2016 on December 12, 2025

Marico Limited announced the allotment of 34,423 equity shares under its ESOP 2016 plan on December 12, 2025.

Marico Limited announced the allotment of 34,423 equity shares on December 12, 2025, under its Employee Stock Option Plan, 2016. This allotment increases the company's paid-up share capital from Rs. 1,29,80,53,236 to Rs. 1,29,80,87,659. The company explicitly stated that this allotment is not material in nature and complies with SEBI regulations. The shares rank pari-passu with existing equity shares.

Marico Limited announced on December 12, 2025, the allotment of 34,423 equity shares of Re. 1 each under its Employee Stock Option Plan, 2016 (ESOP 2016). This action, approved by the Securities Committee of the Board, increases the company's paid-up share capital from Rs. 1,29,80,53,236 to Rs. 1,29,80,87,659, bringing the total number of equity shares to 1,29,80,87,659. The company specified that the exercise prices for these shares varied, as detailed in the annexures of its filing. Marico confirmed that the allotment is not material in nature and that the newly issued shares rank pari-passu with the existing equity shares. This disclosure adheres to regulations mandated by SEBI.

7
Company Update (10 Dec 2025, 1:15 pm)

Marico Limited Receives 'Leader' ESG Rating of 78 from NSE Sustainability

Marico Limited received an ESG rating of 78 ('Leader') from NSE Sustainability Ratings & Analytics.

Marico Limited announced its receipt of an ESG rating of 78 from NSE Sustainability Ratings & Analytics, placing it in the 'Leader' category. The rating was independently assigned by the SEBI-registered provider without prior engagement from Marico, highlighting the company's strong environmental, social, and governance performance.

Marico Limited has announced that it has received an Environmental, Social, and Governance (ESG) rating of '78', categorizing it as a 'Leader'. This rating was assigned by NSE Sustainability Ratings & Analytics Limited, a SEBI registered ESG Rating Provider. The company clarified that it had not engaged NSE Sustainability for this assessment and that the rating was independently determined. This disclosure, made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, is also available on Marico's investor relations website.

2
Allotment of ESOP / ESPS (2 Dec 2025, 6:08 pm)

Marico Limited Allots 63,494 Equity Shares Under ESOP 2016; Deemed Non-Material

Marico Limited allotted 63,494 shares under ESOP on Dec 2, 2025; deemed non-material.

Marico Limited executed the allotment of 63,494 equity shares on December 2, 2025, under its Employee Stock Option Plan, 2016, to eligible grantees. This action increases total paid-up share capital but is explicitly stated as non-material, complying with SEBI regulations.

Marico Limited announced on December 2, 2025, the allotment of 63,494 equity shares under its Marico Employee Stock Option Plan, 2016, to eligible grantees upon exercise of their stock options. This allotment increased the company's total paid-up share capital from 1,29,79,89,742 to 1,29,80,53,236 equity shares. Marico has explicitly stated that this issuance is "not material in nature" and adheres to SEBI disclosure requirements.

Company Update (1 Dec 2025, 3:43 pm)

Marico Limited Notifies Shareholders of Impending IEPF Share Transfer for Unclaimed Dividends

Marico Limited has published a public notice regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF) due to unclaimed dividends from FY2018-19. Shareholders with unclaimed amounts must claim them by the deadline to retain their shares.

Marico Limited has issued a public notice on December 1, 2025, in Business Standard and Navshakti, informing shareholders about the transfer of equity shares to the IEPF. This action is for shareholders whose 2nd Interim Dividend for FY2018-19 remains unclaimed for seven years. Shareholders must lodge their claims by a specified deadline to prevent their shares and underlying dividends from being transferred to the IEPF, in compliance with SEBI LODR and IEPF Authority Rules.

9
Company Update (21 Nov 2025, 3:44 pm)

Marico Limited Q2 FY26 Earnings Call Transcript: Revenue Surges 30.7%, Focus on Margin Recovery and Diversification

Marico's Q2 FY26 earnings call detailed 30.7% revenue growth to ₹3,482 Cr, with flat PAT amid margin pressure; H1 FY26 revenue up 26.6%.

Marico's Q2 FY26 call highlighted strong revenue growth (30.7% YoY to ₹3,482 Cr) despite GST disruptions and input cost inflation impacting margins. Management is optimistic for H2 FY26 profit growth, aiming for ~25% FY26 revenue. Diversification in Foods and digital segments, along with Project SETU, are key strategic drivers. The acquisition of remaining True Elements stake was completed.

Marico Limited's Q2 FY26 earnings conference call transcript reveals consolidated revenue growth of 30.7% YoY to ₹3,482 Cr, with EBITDA rising 7% to ₹560 Cr. However, EBITDA margins contracted by 350 bps to 16.1% due to input cost inflation, leading to flat PAT at ₹432 Cr. H1 FY26 consolidated revenue grew 26.6% YoY to ₹6,741 Cr, with PAT up 4.2% to ₹945 Cr. India volume growth stood at 7%, while the international business achieved 20% constant currency growth. Management discussed disruptions from GST rate implementation in September but expressed optimism for demand recovery driven by easing inflation and supportive policies. Key segments like Value-Added Hair Oils (VAHO) and digital brands (Beardo, Plix) showed strong growth, with VAHO margins being significantly higher than company average. The Foods portfolio's growth moderated temporarily due to integration and profitability focus, with expectations of returning to higher growth by Q4 FY26. The company completed the acquisition of the remaining 46.02% stake in HW Wellness Solutions (True Elements) on October 17, 2025. It also faced a ₹1,00,000 FSSAI penalty for alleged misbranding, for which it plans to appeal, stating no material financial impact. Outlook remains positive, targeting ~25% FY26 revenue growth and double-digit profit growth in H2 FY26.

1
Allotment of ESOP / ESPS (20 Nov 2025, 1:40 pm)

Marico Limited Allots Equity Shares Under ESOP 2016, Declared Non-Material

Marico Limited has allotted 54,074 equity shares under its ESOP 2016, increasing its paid-up capital. The company clarified this is not material.

Marico Limited's Securities Committee, on November 20, 2025, allotted 54,074 equity shares of Re. 1 each under the ESOP 2016. This raises the total number of equity shares to 1,29,79,89,742, with a paid-up capital of Rs. 1,29,79,89,742. The company explicitly stated that this allotment is not material in nature, as per SEBI regulations, and the new shares rank pari-passu with existing ones.

Marico Limited's Securities Committee, on November 20, 2025, approved the allotment of 54,074 equity shares under its Employee Stock Option Plan, 2016 (ESOP 2016). Each share has a face value of Re. 1. This issuance increases the company's total equity shares to 1,29,79,89,742, with the paid-up share capital now standing at Rs. 1,29,79,89,742. The company has clarified that this allotment is considered "not material in nature" and adheres to SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The newly allotted shares will rank pari-passu with the existing equity shares of Marico.

Company Update (15 Nov 2025, 3:09 pm)

Marico Limited Publishes Un-audited Q2 FY26 Financial Results

Marico Limited has published its un-audited consolidated financial results for the quarter and half-year ended September 30, 2025. The results, approved by the Board on November 14, 2025, are now available on the company's website and in select newspapers.

Marico Limited has officially disclosed its un-audited consolidated financial results for the second quarter and the first half-year ended September 30, 2025. The Board of Directors approved these results in a meeting held on November 14, 2025. The company has published this information in The Financial Express, Free Press Journal (English), and Navshakti (Marathi) newspapers on November 15, 2025. Investors can also access these results on Marico's official website, specifically under the investor documentation section for shareholder information.

8
Audio Recording (14 Nov 2025, 8:04 pm)

Marico Limited: Q2 FY26 Earnings Conference Call Recording Now Available

Marico Limited has made the audio recording of its Q2 FY26 earnings conference call, held on November 14, 2025, publicly accessible.

Marico Limited has released the audio recording of its Q2 FY26 earnings conference call, held on November 14, 2025, discussing financial results for the quarter and half-year ended September 30, 2025. Q2 saw revenue up 30.7% to ₹3,482 Cr, with flat PAT at ₹432 Cr, and EBITDA margins contracting to 16.1% due to input costs. H1 FY26 revenue grew 26.6% and PAT 4.2%. The transcript will also be provided.

Marico Limited has announced the public availability of the audio recording of its earnings conference call held on November 14, 2025. This call focused on the company's un-audited financial results and operational performance for the second quarter and the first half-year ended September 30, 2025 (Q2 FY26 and H1 FY26). The recording is accessible on the company's investor relations website, and the transcript will be furnished to stock exchanges and published online subsequently.

The financial results discussed included robust Q2 FY26 consolidated revenue growth of 30.7% year-on-year, reaching ₹3,482 crore. However, consolidated Profit After Tax (PAT) remained flat at ₹432 crore. EBITDA increased by 7% to ₹560 crore, but EBITDA margins contracted by 350 basis points to 16.1%, primarily due to input cost inflation. For the first half of FY26 (H1 FY26), consolidated revenue grew by 26.6% YoY to ₹6,741 crore, while PAT saw a modest increase of 4.2% to ₹945 crore. This follows the company's Q1 FY26 performance, which reported revenue of ₹3,259 Cr (+23.3% YoY) and PAT of ₹513 Cr (+8.2% YoY), with EBITDA margins declining to 20.1% amidst commodity inflation. The company continues to focus on growth drivers like its Foods and Premium Personal Care segments and strategic acquisitions, aiming for around 25% revenue growth for FY26.

9
Company Update (14 Nov 2025, 12:55 pm)

Marico Reports Strong Q2 FY26 Results: Revenue Surges 31% YoY to ₹3,482 Cr, India Volume Growth at 7%, International CCG at 20%

Marico's Q2 FY26 revenue jumped 31% YoY to ₹3,482 Cr. India volume grew 7%, international CCG 20%. EBITDA up 7%, PAT up 8% (like-for-like).

Marico Limited announced robust Q2 FY26 results with consolidated revenue up 31% YoY to ₹3,482 Cr. India volume growth was 7%, and international business achieved 20% constant currency growth. EBITDA increased 7% to ₹560 Cr, and like-for-like PAT rose 8% to ₹420 Cr. EBITDA margins contracted 350 bps to 16.1% due to input cost inflation. The company highlighted strong performance in core brands, Foods, Premium Personal Care, and positive outlook for demand improvement and diversification.

Marico Limited reported a strong Q2 FY26 with consolidated revenue growth of 31% YoY to ₹3,482 Cr, reaching a multi-quarter high. India business revenue surged 35% YoY to ₹2,667 Cr, supported by price increases and achieving 7% volume growth. The international business demonstrated robust momentum with 20% constant currency growth (CCG). Consolidated EBITDA grew 7% YoY to ₹560 Cr, and Profit After Tax (PAT), excluding one-offs, increased by 8% YoY to ₹420 Cr. However, EBITDA margins compressed by 350 bps YoY to 16.1%, impacted by a significant gross margin contraction (~810 bps YoY) due to commodity inflation and a 19% increase in A&P spends. For the half-year ended September 30, 2025, consolidated revenue grew 27% YoY to ₹6,741 Cr, and PAT (excl. one-offs) rose 8% to ₹924 Cr, with EBITDA margins at 18.0% (down 360 bps YoY).

Within India, Parachute Rigids saw 59% revenue growth, with normalized volumes remaining flattish despite a 3% volume decline due to copra price inflation. Value-Added Hair Oils grew 16% in value, and Saffola Edible Oils showed 19% revenue growth with flattish volumes. The Foods business expanded by 12% to an annualized run rate of ₹1100 Cr. The Premium Personal Care and Digital-first portfolio crossed ₹1000 Cr ARR. International business showed strength, with Bangladesh achieving 22% CCG and MENA posting 27% CCG.

Management anticipates gradual improvement in consumer sentiment driven by easing inflation and a positive crop outlook. The company expects steady growth in core categories, supported by Project SETU for expanded direct reach and the benefits of recent GST rationalization. Diversification into Foods and Premium Personal Care remains a strategic priority, targeting 25%+ CAGR for Foods and scaling the Digital-first portfolio. Double-digit CCG is projected for the International business.

Key events include the completion of the acquisition of the remaining 46.02% stake in HW Wellness Solutions (True Elements) on October 17, 2025. Marico also disclosed receiving a ₹1,00,000 penalty from FSSAI regarding alleged misbranding from a 2016 review, with plans to appeal the order dated July 30, 2025.

8
Board Meeting (14 Nov 2025, 12:54 pm)

Marico Limited Announces Q2 FY26 & H1 FY26 Un-audited Financial Results

Marico reported Q2 FY26 consolidated revenue up 30.7% YoY to ₹3,482 Cr, with PAT flat at ₹432 Cr. H1 FY26 revenue grew 27.0% YoY to ₹6,741 Cr.

Marico Limited's Board approved un-audited Q2 FY26 and H1 FY26 results on Nov 14, 2025. Consolidated revenue for Q2 FY26 grew 30.7% YoY to ₹3,482 Cr, with PAT flat at ₹432 Cr. For H1 FY26, consolidated revenue was ₹6,741 Cr (+27.0% YoY), and PAT increased 4.2% to ₹945 Cr. Standalone PAT for H1 FY26 surged 40.0% to ₹1,176 Cr. The company also finalized its acquisition of HW Wellness Solutions (True Elements).

Marico Limited announced its un-audited financial results for the quarter and half-year ended September 30, 2025, following a Board meeting on November 14, 2025.

Quarterly Performance (Q2 FY26 vs. Q2 FY25):
Consolidated revenue from operations grew by 30.7% YoY to ₹3,482 Cr. However, consolidated Profit After Tax (PAT) remained largely flat, decreasing marginally by 0.2% YoY to ₹432 Cr. Consolidated PAT margin contracted to 12.4% from 16.3% YoY. Standalone revenue increased by 30.3% YoY to ₹2,426 Cr, but standalone PAT declined by 24.6% YoY to ₹399 Cr, influenced by higher 'other income' in the prior year's comparable quarter.

Half-Yearly Performance (H1 FY26 vs. H1 FY25):
Consolidated revenue saw a robust increase of 27.0% YoY to ₹6,741 Cr. Consolidated PAT grew by 4.2% YoY to ₹945 Cr. Standalone revenue rose by 25.7% YoY to ₹4,707 Cr, with standalone PAT surging 40.0% YoY to ₹1,176 Cr, reflecting significant 'other income' reported in the first quarter.

Financial Deep Dive:
As of September 30, 2025, Marico's consolidated assets stood at ₹8,679 Cr with total liabilities at ₹4,473 Cr and total equity at ₹4,206 Cr. The company reported a net debt of approximately ₹1,274 Cr and a Debt/Equity ratio of 0.30x. Consolidated cash flow from operations for H1 FY26 was ₹701 Cr, with capital expenditure (payment for property, plant and equipment and intangible assets) amounting to ₹142 Cr.

Key Events:
Marico successfully completed the acquisition of the remaining 46.02% stake in HW Wellness Solutions Private Limited (True Elements) on October 17, 2025, making it a wholly-owned subsidiary and strengthening its position in the healthy foods sector.

9
Result (14 Nov 2025, 12:50 pm)

Marico Limited Reports Strong Q2 FY26 Consolidated Revenue Growth of 30.7%, Net Profit Flat YoY at ₹432 Cr

Marico's Q2 FY26 consolidated revenue rose 30.7% YoY to ₹3,482 Cr, with net profit remaining flat at ₹432 Cr. Standalone profit declined 24.6% YoY.

For the half-year ended September 30, 2025, Marico's consolidated revenue grew 26.6% YoY to ₹6,741 Cr with net profit up 4.2% to ₹945 Cr. Standalone revenue grew 25.7% to ₹4,707 Cr, and net profit surged 40.0% to ₹1,176 Cr. The company also completed its acquisition of HW Wellness Solutions (True Elements).

Marico Limited announced its un-audited financial results for the quarter and half-year ended September 30, 2025 (Q2 FY26).

Consolidated performance saw robust revenue growth, with Q2 FY26 revenue from operations increasing by 30.7% YoY to ₹3,482 Cr, and for H1 FY26 by 26.6% YoY to ₹6,741 Cr. However, consolidated net profit witnessed flat year-on-year growth in Q2 FY26 at ₹432 Cr (0.0% YoY change), impacting EPS to ₹3.24. For H1 FY26, consolidated net profit grew by 4.2% YoY to ₹945 Cr, with EPS at ₹7.14.

On a standalone basis, revenue from operations also showed strong growth, up 30.4% YoY in Q2 FY26 to ₹2,426 Cr and 25.7% YoY in H1 FY26 to ₹4,707 Cr. However, standalone net profit declined significantly by 24.6% YoY in Q2 FY26 to ₹399 Cr, primarily due to a sharp 63.5% YoY decrease in 'other income' to ₹173 Cr. This contrasts with H1 FY26 standalone net profit growth of 40.0% to ₹1,176 Cr, which was bolstered by a 102.2% YoY increase in 'other income' to ₹647 Cr.

The company's balance sheet shows consolidated total assets growing to ₹8,679 Cr as of September 30, 2025, from ₹8,338 Cr at the end of FY25. Consolidated liabilities increased to ₹4,473 Cr, while consolidated equity stood at ₹4,206 Cr.

Cash flow from operations remained strong, with consolidated CFO at ₹701 Cr for H1 FY26 (up 120% YoY) and standalone CFO at ₹497 Cr (up 67.3% YoY). Consolidated capital expenditure for H1 FY26 was ₹142 Cr.

A significant development noted is the completion of the acquisition of the remaining 46.02% stake in HW Wellness Solutions Private Limited (True Elements) on October 17, 2025, making it a wholly owned subsidiary.

8
Audio Recording (7 Nov 2025, 7:32 pm)

Marico Invites Investors to Q2FY26 Earnings Conference Call on November 14, 2025

Marico Limited announces an investor/analyst conference call scheduled for Friday, November 14, 2025.

Marico Limited has scheduled an investor/analyst conference call for Friday, November 14, 2025, at 6:00 PM IST. Management, including the MD & CEO and Group CFO, will discuss the financial results and operations for the quarter and half-year ended September 30, 2025. Results will be approved by the Board on the same day and published on the company's website.

Marico Limited has officially informed the BSE Limited and National Stock Exchange of India Limited about an upcoming investor and analyst conference call. The call is scheduled for Friday, November 14, 2025, at 6:00 PM IST. During this conference, the management, including Mr. Saugata Gupta (Managing Director & CEO) and Mr. Pawan Agrawal (Group CFO & CEO - International Business), will provide commentary on the company's financial results and operational performance for the quarter and half-year ended September 30, 2025. The financial results are expected to be approved by Marico's Board of Directors in a meeting held on November 14, 2025, and will be subsequently published on the company's corporate website. The announcement also details how to join the call, including universal dial-in numbers, international toll-free numbers, and a 'diamond pass' link for pre-registration to ensure a smooth joining process. A live webcast option will also be available. Marico is recognized as a leading Indian consumer products company in the beauty and wellness sectors, with a significant market presence and a diverse portfolio of brands both domestically and internationally.

7
Company Update (6 Nov 2025, 3:06 pm)

Marico Awards Integrated Media Mandate to Omnicom Media Group's PHD India, Signalling Strategic Shift in Brand Building

Marico Limited appoints Omnicom Media Group's PHD India for its integrated media mandate, aiming for future-ready brand growth.

Marico Limited has awarded its integrated media mandate to Omnicom Media Group’s PHD India following a multi-agency pitch. This strategic appointment is aimed at building a future-ready, insight-led media ecosystem to drive brand and business growth for its extensive portfolio, including legacy brands like Parachute and Saffola, and new-age brands like Beardo. The move signifies Marico's commitment to a digitally empowered strategy and deepens its focus on innovation and consumer-centricity. PHD India expressed excitement, viewing it as a privilege and commitment to unlock new growth possibilities, aligning with Marico’s legacy and ambition.

Marico Limited, a leading Indian FMCG company, has appointed Omnicom Media Group’s PHD India as its Agency of Record (AOR) for its integrated media mandate. This decision follows a rigorous multi-agency pitch process. PHD India will be responsible for end-to-end media strategy, planning, and buying across Marico's extensive brand portfolio, which includes well-known brands such as Parachute, Parachute Advansed, Saffola, Nihar, Livon, and Set Wet, alongside newer digital-first brands like Beardo, Just Herbs, and True Elements. Marico views this partnership as a strategic inflection point, aligning with its goal to become a future-ready, digitally empowered consumer company. The focus is on augmenting brand-building, enhancing consumer engagement, and diversifying across contemporary channels. Akash Banerji, EVP & Head, Digital Transformation at Marico, highlighted the importance of media strategy in forging meaningful connections and translating insights into cultural impact, emphasizing the need for sophisticated approaches in modern media planning. He expressed delight in partnering with PHD India, whose expertise matches Marico's vision for leveraging data, creativity, and technology. He also thanked Madison Media for their long-standing contributions. PHD India, recognized for its 'Intelligence.Connected' ethos, aims to leverage its strategic foresight and understanding of the Indian market to drive business impact and cultural relevance for Marico. This win is significant for PHD India, adding one of the largest FMCG mandates to its portfolio. Monaz Todywalla, CEO of PHD India, and Kartik Sharma, Group CEO of Omnicom Media Group India, both expressed enthusiasm for the partnership, underscoring the alignment between Marico's brand legacy and their agency's philosophy of driving transformative business outcomes through strategic innovation. The move reinforces Marico's historical commitment to investing in advertising and promotion to maintain brand momentum and category leadership.

2
Analyst / Investor Meet (31 Oct 2025, 11:09 am)

Marico Limited Notifies Schedule of Investor Conferences for November-December 2025

Marico management will attend investor conferences in November and December 2025, including Avendus Spark INDX and Goldman Sachs India Consumer Forum.

Marico Limited has formally notified the stock exchanges regarding the schedule of its management's participation in forthcoming investor engagements. The company's leadership team is slated to attend two significant events: the Avendus Spark INDX: Annual Investor Conference, scheduled to take place in Mumbai on Wednesday, November 19, 2025, where meetings will be conducted in a one-on-one or group format. Following this, the management will participate in the Goldman Sachs India Consumer Forum, a virtual event scheduled for Monday, December 1, 2025, involving group discussions. This announcement is part of Marico's ongoing investor relations strategy to maintain transparency and communication with the financial community. Crucially, the company has stipulated that no unpublished price-sensitive information will be disclosed during these interactions. Investors can refer to the standard presentation materials, readily available on Marico's official investor relations website, for general company information.

Marico Limited has filed a regulatory update with the stock exchanges, informing them about the schedule of investor meetings that its management team will attend. The company's leadership is confirmed to participate in the Avendus Spark INDX: Annual Investor Conference, which is set to be held in Mumbai on Wednesday, November 19, 2025. During this event, management will engage with investors through one-on-one or group meetings. Further, Marico's executives are also scheduled to attend the Goldman Sachs India Consumer Forum, a virtual conference taking place on Monday, December 1, 2025, where they will participate in group discussions. This announcement aligns with Marico's commitment to regular stakeholder engagement and providing access to its management. The company has explicitly stated that the schedule is subject to changes due to unforeseen circumstances. Furthermore, it has been emphasized that no unpublished price-sensitive information pertaining to the Company will be shared with any analysts or institutional investors during these meetings. The presentation materials that Marico's management typically uses for such investor meets are available on the company’s website, under the investor documentation section, for broader access. This disclosure pertains solely to the scheduling of investor interactions and does not include any updates on financial performance, future guidance, or other operational developments.

4
Company Update (22 Oct 2025, 4:45 pm)

Marico Limited Receives 'Very Good' ESG Rating of 77 from Unsolicited Assessment by CFC Finlease

Marico Limited was assigned an unsolicited ESG score of 77, indicating a 'Very Good' rating, by CFC Finlease Private Limited.

Marico Limited has been assigned an ESG score of '77', categorized as 'Very Good', by CFC Finlease Private Limited, a SEBI registered ESG Rating Provider. Notably, the company stated it had not engaged CFC Finlease for this assessment, with the rating being independently determined by the provider. This unsolicited rating offers an external perspective on Marico's environmental, social, and governance practices, potentially influencing investor perception.

Marico Limited has received an ESG rating of '77', which translates to a 'Very Good' score according to the methodology of CFC Finlease Private Limited, a SEBI registered ESG Rating Provider. The company was formally intimated about this rating on October 22, 2025. A crucial clarification provided by Marico is that it did not engage CFC Finlease for the purpose of this ESG assessment; the rating was independently determined by the provider. This disclosure falls under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information is also available on Marico's website under investor documentation. This unsolicited rating provides an external benchmark of Marico's sustainability performance, which is increasingly a factor in investment decisions, although the company did not solicit this particular evaluation.

4
Company Update (17 Oct 2025, 10:58 pm)

Marico fined ₹1 lakh by FSSAI for alleged product misbranding; plans appeal

Marico fined ₹1 lakh by FSSAI for alleged misbranding; company to appeal.

Marico Limited disclosed on October 17, 2025, receiving an order from the Food Safety and Standards Authority of India (FSSAI) imposing a penalty of ₹1,00,000 under Section 52 of the Food Safety and Standards Act, 2006. This regulatory action pertains to alleged misbranding of product samples identified during a 2016 review, with proceedings finalized by an adjudicating officer on July 30, 2025. Marico has explicitly stated its intention to file an appeal against this order at the appropriate forum, signalling a challenge to the ruling. Importantly, the company assured investors that there will be no material impact on its financials or operational activities, thereby mitigating potential investor concern over this penalty. The disclosure was made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Marico Limited made a disclosure on October 17, 2025, regarding a regulatory action from the Food Safety and Standards Authority of India (FSSAI). The FSSAI has levied a penalty of ₹1,00,000 on the company under Section 52 of the Food Safety and Standards Act, 2006. This penalty relates to alleged misbranding of a few product samples identified at a retail store, pertaining to a matter that originated in 2016. The adjudicating officer passed the order on July 30, 2025, and Marico received this notification on October 17, 2025. The company has indicated that it reserves the right to file an appeal against this order at the appropriate legal forum. Marico has also assured its stakeholders that this penalty will have no material impact on the company's financials or its day-to-day operations. The disclosure was made in adherence to SEBI Listing Regulations.

7
Company Update (17 Oct 2025, 5:35 pm)

Marico Limited Completes Acquisition of Remaining Stake in True Elements, Making it a Wholly Owned Subsidiary

Marico Limited completed its acquisition of its remaining stake in True Elements on October 17, 2025.

Marico Limited has officially confirmed the completion of its strategic acquisition of the remaining 46.02% equity stake in HW Wellness Solutions Private Limited, operating under the brand 'True Elements'. This landmark transaction, finalized on October 17, 2025, fulfills the definitive agreement Marico had entered into on September 11, 2025, thereby elevating its aggregate equity stake from 53.98% to a complete 100%. As a result, True Elements is now a wholly owned subsidiary of Marico. This move signifies Marico's commitment to consolidating its position in the fast-growing wellness and health foods sector. The full ownership is expected to enable enhanced strategic integration, operational efficiencies, and accelerated growth by leveraging True Elements' established market presence and product portfolio. The company will now be able to implement a unified strategy across its operations to maximize shareholder value. Investors will be keen to observe the synergy realization and contribution to Marico's overall financial performance in upcoming quarters.

News Crux: Marico Limited has successfully concluded its acquisition of the remaining 46.02% equity capital in HW Wellness Solutions Private Limited, commonly known as 'True Elements'. This development, effective from October 17, 2025, converts True Elements into a wholly owned subsidiary of Marico.

Quarterly/Annual Results & Financials: This specific announcement does not provide details on quarterly or annual financial results, nor does it detail the financial outlays for this acquisition tranche. The financial impact will be assessed through future reporting.

Guidance & Concall Commentary: No management guidance or concall commentary is provided in this disclosure.

Key Events & Expansion:

  • Event: Completion of Acquisition of Remaining Stake in True Elements.
  • Date: October 17, 2025.
  • Status: Completed / Latest Event.
  • Context: Marico Limited had previously informed the stock exchanges on September 11, 2025, about entering into a definitive agreement to acquire the balance 46.02% equity stake in True Elements. This completion brings Marico's total ownership to 100%, making it a wholly owned subsidiary.
  • Strategic Significance: The acquisition consolidates Marico's stake in the promising health foods segment, allowing for more integrated strategy, enhanced operational control, and potential for greater synergy realization.

Outlook: The complete integration of True Elements is poised to strengthen Marico's portfolio in the health and wellness space. Full ownership offers greater flexibility for strategic decision-making, product development, and market expansion initiatives, potentially driving higher revenue growth and profitability for Marico's consumer products business. Investors will monitor the synergy benefits and operational integration over the coming periods.

7
Board Meeting (14 Oct 2025, 5:07 pm)

Marico Limited Announces Board Meeting to Approve Q2 & H1 FY26 Un-audited Financial Results on Nov 14, 2025

Marico board meeting scheduled for Nov 14, 2025, to approve Q2 and H1 FY26 financial results.

Marico Limited has scheduled a Board of Directors meeting for November 14, 2025, to review and approve its un-audited standalone and consolidated financial results for the second quarter and the first half-year ended September 30, 2025. This notification under SEBI regulations also states the trading window closure period from September 26, 2025, to November 18, 2025.

Marico Limited has issued a formal notice to BSE and NSE regarding an upcoming Board of Directors meeting scheduled for Friday, November 14, 2025. The primary agenda of this meeting is to consider and approve the un-audited standalone and consolidated financial results for the second quarter and the first half-year ended September 30, 2025. The Board will also review the Limited Review Report from the auditors on these financial statements. In accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has also informed that the trading window for dealing in Marico's shares will remain closed from September 26, 2025, until November 18, 2025, inclusive. This is a standard procedure preceding the release of financial results.

4
Company Update (13 Oct 2025, 4:10 pm)

Marico Ltd. Announces Winding Up of Dormant Bangladesh Subsidiary MBLIL

Marico Limited received a winding-up certificate for its dormant Bangladesh subsidiary, MBL Industries Limited, effective September 18, 2025.

Marico Limited informed exchanges about the voluntary liquidation of its wholly-owned step-down subsidiary in Bangladesh, MBL Industries Limited (MBLIL), effective September 18, 2025. The company received the winding-up certificate on October 12, 2025. MBLIL had remained dormant since 2009, contributing nil turnover and a minor net worth and loss, indicating no significant financial impact.

Marico Limited has officially announced the winding up and voluntary liquidation of its wholly-owned step-down subsidiary in Bangladesh, MBL Industries Limited (MBLIL). The company received the official order for the winding-up certificate from the Office of the Registrar of Joint Stock Companies and Firms, Bangladesh (RJSC&F) on October 12, 2025. MBLIL has been voluntarily liquidated with effect from September 18, 2025. The subsidiary, MBLIL, has been dormant since 2009. As per the disclosure, MBLIL contributed nil turnover as of February 15, 2025. Its income/(loss) was BDT (1,658,191) and net worth was BDT 2,602,940, indicating a minimal financial impact on Marico's consolidated financials. This intimation is made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

5
Postal Ballot (9 Oct 2025, 3:55 pm)

Marico Limited: Minutes of Postal Ballot Resolution Approved for Independent Director Appointment

Marico Limited announces minutes of resolution passed via postal ballot for appointing Mr. Bhaskar Bhat as Independent Director.

Marico Limited has officially released the minutes of a special resolution passed via postal ballot and remote e-voting on September 22, 2025. The resolution concerned the appointment of Mr. Bhaskar Bhat as an Independent Director, effective October 1, 2025, for a five-year term. The voting results indicate strong member confidence, with over 99.87% of votes polled in favour. This marks a key corporate governance update for the company.

Marico Limited has submitted the minutes of a resolution passed by postal ballot and remote e-voting on September 22, 2025, with the results announced on September 23, 2025. The special resolution approved the appointment of Mr. Bhaskar Bhat (DIN: 00148778) as an Independent Director.

The appointment is effective from October 1, 2025, for a term of five consecutive years, concluding on September 30, 2030. The resolution also covers the continuation of his directorship after attaining the age of 75 in FY 2029-30, as per SEBI Listing Regulations. This process complied with Section 110 of the Companies Act, 2013, and relevant MCA Circulars.

The voting period ran from August 24, 2025, to September 22, 2025. The results showed overwhelming support, with 1,18,79,45,881 votes (99.8791% of votes polled) in favour and 14,37,660 votes (0.1209%) against. This is a significant corporate governance development for Marico Limited.

1
Company Update (7 Oct 2025, 12:19 pm)

Marico Limited Files Quarterly Compliance Certificate for Dematerialization of Securities

Marico Limited submitted its quarterly compliance certificate for dematerialization of securities for the quarter ending September 30, 2025.

Marico Limited has filed its quarterly compliance certificate with exchanges for the period ending September 30, 2025, as per SEBI (Depositories and Participants) Regulations. Obtained from its Registrar and Share Transfer Agent, MUFG Intime India, the certificate confirms that securities processed for dematerialization during the quarter were handled according to guidelines, ensuring proper listing and register updates. This is a routine procedural update without financial disclosures.

Marico Limited has submitted a quarterly compliance certificate for the period ended September 30, 2025, as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate, obtained from MUFG Intime India Private Limited (formerly Link Intime India Private Limited), the company's Registrar and Share Transfer Agent, confirms the proper processing of securities dematerialization. According to the certificate, all securities received from depository participants during the quarter were processed according to regulatory guidelines, including confirmation to depositories, listing on stock exchanges, and updating the register of members by substituting the depositories' names. The physical certificates were also duly mutilated and cancelled. This filing is a routine procedural requirement and does not involve any new financial disclosures, performance updates, or strategic announcements from Marico Limited.

7
Company Update (3 Oct 2025, 4:04 pm)

Marico Q2 FY26 Update: Revenue Growth in Thirties, India Volume High Single Digits Amidst Margin Pressure

Marico provides Q2 FY26 update: stable demand, revenue growth in the thirties, and modest operating profit growth.

Marico's Q2 FY26 quarterly update projects consolidated revenue growth in the thirties YoY, driven by pricing and mix, with India volume growth in high single digits, albeit sequentially moderating due to trade disruptions. Approximately 30% of the India business benefited from GST, with benefits passed on. Parachute volumes declined low single digits, Saffola Oils were flattish with high teens revenue growth, VAHO grew high teens, and international business achieved twenties constant currency growth. Gross margins face incremental pressure from input costs, expected to ease in H2 FY26, resulting in modest operating profit growth.

Marico Limited has issued a quarterly update for Q2 FY2025-26, focusing on operating performance and demand trends ahead of its official financial results. The company reported stable demand throughout most of the quarter and anticipates a gradual improvement in consumer sentiment during the upcoming festive season, bolstered by easing inflation, favourable monsoons, a positive crop outlook, and policy stimulus. A significant development is the GST rate rationalization, which benefits around 30% of Marico's India business; the company has passed these benefits to consumers.

The India business demonstrated steady momentum in July and August, though it absorbed temporary disruptions in trade channels and CSD purchases preceding September's GST rate changes. Despite these factors, underlying volume growth for the India business remained in the high single digits, exhibiting a sequential moderation. Specific brand performances include Parachute volumes seeing a low single-digit decline, and being flattish in volume terms after accounting for ml-age reductions in lieu of significant year-on-year price increases exceeding 60%. Saffola Oils delivered flattish volumes against a high base, complemented by revenue growth in the high teens. Value Added Hair Oils (VAHO) recorded high teens growth, indicating a sustained recovery, with expectations of healthy momentum driven by strategic focus on mid and premium segments, Project SETU, and GST benefits. Foods and Premium Personal Care (including digital-first brands) maintained accelerated growth and diversification pace.

Internationally, Marico's business maintained robust momentum, achieving constant currency growth in the twenties, with Bangladesh and MENA markets notably outperforming. Consolidated revenue growth on a year-on-year basis is projected to reach the thirties, attributed to pricing interventions and an improved product mix, placing the company on track to meet its full-year aspirations.

However, the company foresees incremental pressure on gross margins, stemming from high vegetable oil prices and a high base effect from previous periods. This pressure is compounded by a pricing-led denominator effect. While copra prices have stabilized, the overall input cost scenario is challenging. Marico has continued brand-building investments and extended discounts to channel partners ahead of GST changes. Consequently, the company expects modest operating profit growth year-on-year. Marico reiterates its medium-term aspiration for sustainable, profitable, volume-led growth, supported by its core brand strength and expansion of new growth engines. The detailed financial results will be released after Board approval.

6
Company Update (1 Oct 2025, 1:49 pm)

Marico Limited Completes Intra-Group Restructuring: Integrates Apcos Naturals Business Effective October 1, 2025

Marico Limited integrates wholly-owned subsidiary Apcos Naturals, effective October 1, 2025, via voluntary liquidation.

Marico Limited has officially completed a key intra-group restructuring initiative involving its wholly-owned subsidiary, Apcos Naturals Private Limited. The company announced that following Apcos Naturals' voluntary liquidation, the liquidator has issued a Letter of Distribution, transferring the entire business undertaking to Marico Limited on a going concern basis. This integration is effective as of October 1, 2025, marking a significant step towards consolidating operations and potentially unlocking synergies. The company also noted that the liquidator will pursue the necessary steps for the final dissolution of Apcos through the Hon'ble National Company Law Tribunal (NCLT). This move follows an earlier disclosure on August 4, 2025, detailing the proposed restructuring.

Marico Limited has announced the completion of an intra-group restructuring involving the integration of its wholly-owned subsidiary, Apcos Naturals Private Limited. This consolidation is effective from October 1, 2025. The process was carried out through the voluntary liquidation of Apcos Naturals. As per the update, the liquidator has distributed the entire business undertaking of Apcos Naturals to Marico Limited on a going concern basis, as evidenced by a Letter of Distribution dated October 1, 2025. Consequently, Apcos Naturals' business operations are now consolidated with Marico Limited. The liquidator is expected to initiate the required legal steps to obtain approval from the National Company Law Tribunal (NCLT), Chandigarh, for the dissolution of Apcos. This announcement follows up on a prior disclosure made on August 4, 2025, regarding the proposed restructuring. The primary impact of this event is the simplification of Marico's group structure and the potential for improved operational efficiencies and financial reporting through the unified business undertaking.

1
Allotment of ESOP / ESPS (26 Sept 2025, 11:46 am)

Marico Limited Allots 1,800 Equity Shares Under ESOP 2016, Noted as Non-Material

Marico Limited allotted 1,800 equity shares under its ESOP 2016, increasing its paid-up share capital slightly.

This announcement from Marico Limited details the allotment of 1,800 equity shares under the Marico Employee Stock Option Plan, 2016, effective September 26, 2025. The Securities Committee of the Board approved this issuance following the exercise of stock options. Consequently, the company's paid-up share capital has increased from Rs. 1,29,79,33,868 to Rs. 1,29,79,35,668, with the total equity shares now standing at 1,29,79,35,668. The company has provided detailed disclosures as per SEBI regulations, including the exercise price of Rs. 372.10 per share. Crucially, Marico has clarified that this specific allotment is 'not material in nature' to the company's overall financial standing or operations. The issuance is a routine aspect of employee compensation plans.

Marico Limited officially announced the allotment of 1,800 equity shares of face value Re. 1 each, under the Marico Employee Stock Option Plan, 2016 ('ESOP 2016'). This decision was made by the Securities Committee of the Board of Directors on September 26, 2025, following the exercise of stock options by an eligible grantee. As a result of this allotment, the company's total paid-up share capital has increased. The share capital has risen from 1,29,79,33,868 equity shares aggregating to Rs. 1,29,79,33,868 to 1,29,79,35,668 equity shares aggregating to Rs. 1,29,79,35,668. The distinctive numbers for these new shares range from 1,29,79,33,869 to 1,29,79,35,668. The exercise price per share was Rs. 372.10, with a premium of Rs. 371.10 per share. Marico has explicitly stated in its filing that this allotment is 'not material in nature' to the company. The disclosure has been made in compliance with Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No financial performance figures, outlook, or other deep financial metrics were part of this announcement.

5
Company Update (25 Sept 2025, 10:20 am)

Marico Limited: Income Tax Survey Action Completed at Offices and Manufacturing Units

Marico Limited's Income Tax survey action is complete; company cooperated fully with no further material update.

Marico Limited has announced the completion of a survey action initiated by the Income Tax Department under Section 133A of the Income Tax Act, 1961. The survey covered certain company offices and manufacturing units within India. Marico Limited has confirmed that it fully cooperated with the authorities during the survey process. The company has further stated that, at present, there is no additional material information that warrants disclosure under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This suggests that the survey concluded without uncovering issues requiring immediate regulatory reporting or having a significant detrimental impact on the company's operations or financials, at least based on current information. Investors will monitor for any subsequent developments or potential liabilities that might arise from this tax authority action.

Marico Limited has formally informed the stock exchanges, under Regulation 30 of the SEBI Listing Regulations, about the conclusion of a survey action conducted by the Income Tax Department. The survey, which was carried out under Section 133A of the Income Tax Act, 1961, targeted certain offices and manufacturing units of the company located in India. This latest intimation, dated September 25, 2025, follows an earlier notice on September 17, 2025, regarding the commencement of the survey. Marico Limited has reported that the survey action has now been successfully completed and confirmed that the company extended its full cooperation to the tax authorities throughout the process. Crucially, Marico has stated that there is currently no further material update that requires disclosure under the SEBI Listing Regulations. This assertion suggests that, from the company's perspective, the survey did not uncover any immediate, significant issues that necessitate public disclosure or that would materially affect its financials or operations. While the company's statement aims to provide clarity and reassurance, investors typically remain vigilant following such regulatory actions. The long-term implications, if any, will depend on any subsequent assessments or findings by the Income Tax Department. For now, the situation appears contained as per Marico's communication.

2
Postal Ballot (23 Sept 2025, 7:07 pm)

Marico Limited: Special Resolution for Independent Director Appointment Passes with Overwhelming Majority via Postal Ballot

Shareholders of Marico Limited overwhelmingly approved the appointment of Mr. Bhaskar Bhat as an Independent Director through postal ballot.

Marico Limited has successfully concluded its postal ballot process, with shareholders overwhelmingly approving the appointment of Mr. Bhaskar Bhat as an Independent Director, effective October 1, 2025. The special resolution garnered strong support across all shareholder categories, including 100% approval from promoters and high percentages from public institutions (99.67%) and non-institutions (94.60%), fulfilling corporate governance requirements.

Marico Limited has announced the results of its postal ballot and remote e-voting process, confirming the successful passage of a special resolution for the appointment of Mr. Bhaskar Bhat as an Independent Director. The voting period concluded on September 22, 2025, and the appointment is effective from October 1, 2025.

The resolution received overwhelming support from shareholders. Promoters and the Promoter Group cast their votes entirely in favour (100.0000%), holding 76,49,42,740 shares that were polled. Public Institutions also showed strong approval, with 99.6665% of their polled votes in favour, totalling 42,25,91,871 votes, out of 42,40,06,076 polled. Public Non-Institutions provided 94.6046% of their polled votes in favour, amounting to 4,11,270 votes out of 4,34,725 polled.

Overall, the total votes in favour across all categories amounted to 99.8791% of the votes polled (1,18,79,45,881 votes), which represented 91.6394% of the total outstanding shares (1,18,93,83,541 votes polled). There were no invalid votes or abstentions. The appointment was conducted in compliance with Sections 108 and 110 of the Companies Act, 2013, read with relevant rules and SEBI Listing Regulations. This procedural step ensures the company's board structure is aligned with corporate governance norms.

3
Postal Ballot (23 Sept 2025, 7:03 pm)

Marico Limited: Shareholders Approve Mr. Bhaskar Bhat's Appointment as Independent Director via Postal Ballot

Marico Limited shareholders approved Mr. Bhaskar Bhat's appointment as Independent Director through postal ballot e-voting.

Marico Limited has informed the stock exchanges about the successful outcome of its postal ballot and remote e-voting process. Shareholders have given their approval for the appointment of Mr. Bhaskar Bhat as an Independent Director, effective October 1, 2025. The resolution was passed with a significant majority, underscoring shareholder confidence in the board's decision and the chosen candidate for this crucial governance role.

Marico Limited announced the results of its postal ballot and remote e-voting process concerning the appointment of Mr. Bhaskar Bhat as an Independent Director. The special resolution for Mr. Bhat's appointment, effective October 1, 2025, was put to vote via remote e-voting from August 24, 2025, to September 22, 2025. The Scrutinizer’s Report, dated September 23, 2025, confirms that the resolution was passed by the members with the requisite majority. Promoter and Promoter Group shareholders voted 100% in favour. Public Institutions voted 99.6665% in favour, and Public Non-Institutions voted 94.6046% in favour. Overall, 99.8791% of the votes polled were in favour, with no invalid or abstained votes cast. The appointment process adhered to Section 110 of the Companies Act, 2013, read with relevant rules and SEBI Listing Regulations.

7
Company Update (17 Sept 2025, 9:13 pm)

Marico Limited Intimates Income Tax Department Visit; No Material Impact Currently Reported

Marico Limited informed about Income Tax Department officials visiting its offices and units, with proceedings ongoing.

Marico Limited has issued an intimation to the stock exchanges regarding a visit by certain officials from the Income Tax Department to some of its offices and manufacturing units across India. The company confirmed that the proceedings are currently underway and it is extending its full cooperation to the officials. Crucially, Marico Limited has emphasized that, at this juncture, there is no material impact on the company's business operations stemming from this development. The management has committed to making further disclosures as per SEBI Listing Regulations should any material updates arise from the ongoing proceedings. This announcement is also available on the company's investor relations website, underscoring transparency regarding regulatory interactions.

Marico Limited has issued a formal intimation to the BSE and NSE, detailing a visit by certain officials from the Income Tax Department to some of its offices and manufacturing units in India. The company confirmed that the proceedings are currently underway, and it is fully cooperating with the tax authorities.

In its communication, Marico Limited stated that there has been no material impact on its business operations as a result of this visit at the current stage. The company has assured stakeholders that it will make necessary disclosures as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, should any further material update arise from these proceedings. This information is also accessible on the company's official website.

This event is a regulatory update, and no financial results, guidance, or specific financial deep-dive metrics are provided in the announcement. The focus is on the immediate procedural aspect of the Income Tax Department's visit and the company's response. The long-term direction and potential risks will depend on the outcome of the ongoing proceedings.

2
Company Update (13 Sept 2025, 1:40 pm)

Marico Joins Investor Campaign, Real Estate Sees RTMI Demand Slip, Banks Conduct Property Auctions

Marico Limited announces participation in an investor education campaign; Indian real estate market sees shift towards under-construction homes; financial institutions auction properties for loan recovery.

Marico Limited has announced its involvement in the 'Saksham Niveshak' campaign, a 100-day initiative by the Investor Education and Protection Authority focused on investor awareness. Concurrently, the Indian real estate market is experiencing a decline in demand for Ready-to-Move-In (RTMI) homes, with a preference shifting towards under-construction projects, influenced by pricing, developer confidence, and market dynamics. In parallel, financial entities like Bank of India, PNB Housing Finance, and Edelweiss ARC are conducting auctions for distressed properties mortgaged by defaulting borrowers, indicating active measures for asset recovery.

Marico Limited has announced its participation in the 'Saksham Niveshak' campaign, a 100-day initiative by the Investor Education and Protection Authority (IEPA) and the Ministry of Corporate Affairs (MCA), aimed at enhancing investor awareness and education. This announcement was published in newspapers on September 13, 2025.

In the real estate sector, demand for Ready-to-Move-In (RTMI) homes in India has declined significantly in the first half of 2025 (H1 2025). The demand ratio for RTMI versus new launches fell to 16:29, a stark reversal from the pandemic years when RTMI homes dominated. Experts attribute this shift to increased buyer confidence in listed developers and the reduced risk of project delays due to RERA. While RTMI homes offer immediate possession and no rent outflow, under-construction (UC) homes provide lower entry costs, staggered payments, and better appreciation potential. Factors like infrastructure development, developer reputation, and personal cash flow influence buyer decisions, with investors generally favoring UC properties.

Separately, several financial institutions are actively pursuing loan recovery through the auction of mortgaged properties. Bank of India (BOI) has scheduled auctions from September 20 to October 14, 2025, for properties mortgaged by various defaulting borrowers. PNB Housing Finance and Edelweiss ARC are also conducting similar auctions in September 2025 for properties associated with loan defaults, detailing reserve prices and auction procedures.

2
Allotment of ESOP / ESPS (12 Sept 2025, 5:02 pm)

Marico Limited Allots 29,818 Shares Under ESOP 2016, Cites Non-Material Impact

Marico Limited allotted 29,818 equity shares under ESOP 2016, increasing its paid-up capital, but stated the event is not material.

Marico Limited, through its Securities Committee, approved the allotment of 29,818 equity shares under its Employee Stock Option Plan, 2016, on September 12, 2025. This issuance increases the company's paid-up share capital from Rs. 1,29,79,04,050 to Rs. 1,29,79,33,868, bringing the total number of equity shares to 1,29,79,33,868. The company explicitly stated that this allotment is not material in nature, adhering to SEBI regulations.

Marico Limited announced the allotment of 29,818 equity shares on September 12, 2025, under its Employee Stock Option Plan, 2016 (ESOP 2016). This issuance, approved by the Securities Committee of the Board of Directors, resulted in an increase of the company's paid-up share capital. The share capital moved from Rs. 1,29,79,04,050/- (representing 1,29,79,04,050 equity shares of Re. 1 each) to Rs. 1,29,79,33,868/- (representing 1,29,79,33,868 equity shares of Re. 1 each). The shares were allotted pursuant to the exercise of stock options by eligible grantees, with exercise prices ranging from Rs. 346.04 to Rs. 545.34 per share. Despite the increase in issued shares, Marico Limited explicitly clarified that this allotment is not material in nature to the company. The disclosure was made in compliance with SEBI regulations, specifically Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

8
Company Update (11 Sept 2025, 5:59 pm)

Marico Limited to Acquire Remaining 46.02% Stake in True Elements (HW Wellness) for ₹138 Cr, Making it Wholly-Owned Subsidiary

Marico Limited is acquiring the remaining 46.02% stake in HW Wellness Solutions (True Elements) for up to ₹138 Crores.

Marico Limited announced a definitive agreement to acquire the remaining 46.02% stake in HW Wellness Solutions Private Limited, the entity behind the 'True Elements' brand, for up to ₹138 Crores. Expected to complete by September 30, 2025, this makes HW Wellness a wholly-owned subsidiary, strengthening Marico's position in healthy breakfast and snacking categories and accelerating its digital strategy.

Marico Limited has entered into a definitive agreement to acquire the balance 46.02% equity stake in HW Wellness Solutions Private Limited, the owner of the 'True Elements' brand, for an aggregate consideration of up to ₹138 Crores. This transaction, expected to be completed on or before September 30, 2025, subject to terms and conditions, will result in HW Wellness becoming a wholly-owned subsidiary of Marico. Previously, Marico held a 53.98% stake, making it a subsidiary. The strategic objective is to scale Marico's presence in the healthy breakfast and snacking categories and accelerate its digital transformation by integrating a strong, digital-first brand. HW Wellness Solutions Private Limited, incorporated in 2013 and based in Pune, operates in the packaged foods industry, focusing on healthy breakfast and snacks. The company reported revenues of ₹164.38 Crores for FY24-25, ₹76.42 Crores for FY23-24, and ₹57.40 Crores for FY22-23. The acquisition involves a cash consideration. The transaction is considered a related party transaction concerning the stake held by the Founders of HW Wellness and is conducted on an arm's length basis. The disclosure was made under Regulation 30 of the SEBI Listing Regulations, with no specific governmental or regulatory approvals required.

4
Company Update (9 Sept 2025, 11:50 am)

Marico Limited Launches New Hair Oil Variant 'Parachute Advansed Olive Enriched'

Marico Limited launched Parachute Advansed Olive Enriched Coconut Hair Oil, adding a new premium product to its haircare portfolio.

Marico Limited unveiled Parachute Advansed Olive Enriched Coconut Hair Oil, a new addition to its premium haircare range. This product features a 'superblend' of olive and coconut oils, targeting hair fall reduction and promoting stronger, smoother hair. Aimed at contemporary, informed consumers, it is exclusively available on e-commerce platforms for Rs. 350/300 ml, reinforcing the brand's commitment to natural and effective hair solutions.

Marico Limited has announced the launch of a new variant in its premium hair nourishment range: Parachute Advansed Olive Enriched Coconut Hair Oil. This product is positioned to highlight the benefits of olive for hair, combining it with coconut-based hair oil to create a 'superblend' aimed at reducing hair fall and improving hair strength and smoothness. According to the company, this blend can lead to up to 10x less hair fall and up to 90% stronger hair compared to untreated hair, based on technical studies. The new launch expands the brand's existing 'superblend' portfolio, which includes variants focused on long hair, hairfall control, softness, and growth. The product is targeted towards contemporary, digitally-savvy consumers who are aware of emerging beauty trends and ingredients. Marico's Chief R&D Officer, Dr. Shilpa Vora, emphasized the natural and effective solution this blend offers for stronger hair. Parachute Advansed Olive Enriched Coconut Hair Oil is priced at Rs. 350 for a 300 ml pack and is exclusively available on e-commerce platforms, aligning with modern purchasing behaviors.

2
Company Update (5 Sept 2025, 5:58 pm)

Various Indian Companies Issue AGMs, IEPF Notices, and Auction Alerts; The Bombay Store Announces FY24-25 Results

Multiple companies issued public notices for AGMs, IEPF share transfers, and asset auctions; The Bombay Store announced upcoming FY24-25 financial results.

This compilation features public notices from several Indian companies. Marico Limited and Hindustan Unilever Limited are undertaking routine transfers of unclaimed dividends to the Investor Education and Protection Fund (IEPF), a compliance measure. Uniphos International Limited and Expogas Limited have announced dates for their Annual General Meetings (AGMs) with e-voting. The Bombay Store has provided a notice regarding its financial year 2024-25 results. Additionally, numerous notices pertain to asset auctions and liquidation proceedings from entities such as Encore Asset Reconstruction Company, Bank of Baroda, Edelweiss ARC, and Winsome Textiles, indicating financial distress or recovery efforts.

The provided news consists of a series of public notices from various Indian companies and financial institutions.

Corporate Governance & Shareholder Information: Standard notices for Annual General Meetings (AGMs) were issued by Uniphos International Limited (33rd AGM on Sep 29, 2025) and Expogas Limited (42nd AGM on Sep 29, 2025), detailing e-voting procedures. The Bombay Store has announced its financial year 2024-25 results, with its AGM scheduled for September 19, 2025.

Regulatory Compliance (IEPF Notices): Marico Limited and Hindustan Unilever Limited have published notices regarding the mandatory transfer of unclaimed dividends (e.g., Marico's 1st Interim Dividend for FY2018-19) to the Investor Education and Protection Fund (IEPF), a routine compliance action.

Asset Auctions & Liquidation Proceedings: A significant theme involves distress asset sales and debt recovery. Encore Asset Reconstruction Company Private Limited, Bank of Baroda, and Edelweiss ARC have published e-auction notices for mortgaged properties. Winsome Textiles has a notice concerning liquidation proceedings, and Piramal Enterprises (associated with Swastik Safe Deposit) also has a notice related to liquidation. Bank of Baroda has multiple such auction notices.

Operational & Other Notices: Siemens Limited has announced an e-tender for the sale of scrap from its Kalwa factory. Indian Gymkhana Club has published a notice for the sale of immovable property.

8
AGM/EGM (3 Sept 2025, 6:07 pm)

Marico Limited 37th AGM Transcript: FY25 Revenue Surpasses ₹10,000 Cr, Eyes ₹20,000 Cr Target by 2030

Marico's AGM transcript reveals FY25 revenue crossed ₹10,000 Cr; targets ₹20,000 Cr by 2030, focusing on diversification.

Marico's 37th AGM saw management present a strong FY25 performance, with consolidated revenue crossing ₹10,000 Crore to ₹10,831 Cr. The company targets doubling revenue to ₹20,000 Cr by 2030, driven by core brands, Foods, Premium Personal Care, and digital growth, emphasizing resilience and innovation. A dividend of ₹10.50 per share was declared for FY25.

The transcript of Marico Limited's 37th Annual General Meeting (AGM) on August 8, 2025, provides insights into the company's FY24-25 performance and future strategies.

Key Performance Highlights (FY24-25):
Marico crossed the ₹10,000 Crore revenue mark, reporting consolidated revenue of ₹10,831 Crores, indicating double-digit growth. Operating profit stood at ₹2,139 Crores, up 6% YoY, with an operating margin of 19.7%. Profit After Tax (PAT) was ₹1,629 Crores, up 10% YoY. The India business achieved double-digit revenue growth, while the Foods business surpassed ₹900 Crores. The Premium Personal Care portfolio (digital-first brands) achieved a ₹750 Crore annualized revenue run-rate. International businesses also showed strong double-digit constant currency growth.

Outlook and Strategy:
The company aims to double its revenue to ₹20,000 Crores by 2030, driven by a strategy focusing on strengthening core brands, diversifying into Foods, Premium Personal Care, and digital businesses, and enhancing digital capabilities. Marico plans to maintain agility and resilience in operations, navigate competitive landscapes, and explore inorganic growth opportunities.

Financials and Shareholder Information:
The company reported a net surplus of ₹1,830 Crores as of March 31, 2025, with a minimal debt-to-equity ratio of 0.1%. R&D expenditure for FY25 was approximately ₹49.87 Crores, and Capex was around ₹160 Crores. The dividend payout for FY25 was ₹10.50 per share. Marico highlighted its strong ESG ratings, including an 'AA' MSCI ESG rating and a high NSE-ESG Score of 72.

Shareholder Engagement:
The AGM included discussions on various shareholder queries regarding bonus shares, physical meetings, R&D, digital adoption, AI, green energy, ESG initiatives, market share, and competition. Management addressed these, noting the board will consider bonus shares at an appropriate time and that current regulations prohibit shareholder gifts.

2
Company Update (29 Aug 2025, 8:51 pm)

Corporate Updates: Marico Opens Share Transfer Window; Several Firms Announce E-Voting for FY25 Results

Marico opens share transfer window; JSW Steel, Windsormachines, Spenta Socks, Simmonds Marshall announce e-voting for FY25 results.

Marico Limited has initiated a special window until January 6, 2026, to re-lodge physical share transfer requests submitted before April 2019, ensuring demat conversion. In parallel, firms including JSW Steel, Windsormachines, Spenta Socks, and Simmonds Marshall are scheduling e-voting for their Annual General Meetings, where shareholders will vote on the approval of their respective financial year 2025 results and annual statements.

The provided text contains several corporate announcements. Marico Limited has opened a special window from July 7, 2025, to January 6, 2026, for shareholders to re-lodge physical share transfer requests that were previously rejected due to documentation deficiencies. This initiative, guided by a SEBI circular dated July 2, 2025, aims to facilitate the conversion of physical shares to demat form.

Concurrently, multiple companies have issued notices regarding upcoming e-voting processes for their Annual General Meetings (AGMs). These include JSW Steel Limited, Windsormachines Limited, Spenta Socks Limited, and Simmonds Marshall Limited. These notices inform shareholders about the procedures for e-voting to approve their financial statements and results for the financial year ending March 31, 2025.

Additionally, Indiabulls Asset Reconstruction Company Limited published a notice for the e-auction sale of an immovable property related to debt recovery, and Inox APL Limited announced measures for share dematerialization.

3
Analyst / Investor Meet (25 Aug 2025, 5:32 pm)

Marico Updates Schedule for Goldman Sachs Asia Leaders Conference Participation

Marico Limited announced an update to its investor meeting schedule, rescheduling a key conference.

Marico Limited updated its investor engagement calendar, rescheduling its participation in the Goldman Sachs Asia Leaders Conference 2025 from September 4-5 to September 3-4, 2025, in Hong Kong. The company confirmed that other previously disclosed investor meetings are unchanged and its standard presentation will be available on its website, ensuring no unpublished price-sensitive information is shared.

Marico Limited has issued an update regarding its investor engagement calendar. The company announced the rescheduling of its participation in the Goldman Sachs Asia Leaders Conference 2025. The event was originally scheduled for September 4-5, 2025, but has now been moved to Wednesday and Thursday, September 3-4, 2025. The conference will be held in Hong Kong. Marico confirmed that the details of other investor conferences, as previously disclosed on August 18, 2025, remain unchanged. Furthermore, the company stated that the standard presentation used by its officials during these meetings is accessible on the Marico website. The update also includes a disclaimer that the schedule is subject to changes and that no unpublished price-sensitive information will be shared during any of these meetings.

3
Company Update (23 Aug 2025, 12:35 pm)

Marico Limited Discloses Publication of Shareholder Notice on Dividend Distribution and Voting

Marico Limited published a regulatory notice regarding share transfer, voting rights, and dividend distribution procedures.

Marico Limited made a regulatory disclosure on August 23, 2025, announcing the publication of a notice in leading business newspapers, Business Standard and Navshakti, as per SEBI Listing Obligations and Disclosure Requirements. This official communication informs shareholders about critical procedures, including share transfer mechanisms, the exercise of voting rights, and dividend distribution. Furthermore, the notice pertains to the upcoming 145th Annual General Meeting (AGM), scheduled for September 17, 2025. Shareholders eligible to vote are determined by a record date of September 10, 2025. The company has also outlined procedures for electronic voting and informed that its register of members and share transfer books will be closed from September 11 to September 17, 2025, ensuring smooth transaction processing during this period and upholding corporate governance.

Marico Limited made a regulatory disclosure on August 23, 2025, announcing the publication of a notice in leading business newspapers, Business Standard and Navshakti, as per SEBI Listing Obligations and Disclosure Requirements. This official communication informs shareholders about critical procedures, including share transfer mechanisms, the exercise of voting rights, and dividend distribution. Furthermore, the notice pertains to the upcoming 145th Annual General Meeting (AGM), scheduled for September 17, 2025. Shareholders eligible to vote are determined by a record date of September 10, 2025. The company has also outlined procedures for electronic voting and informed that its register of members and share transfer books will be closed from September 11 to September 17, 2025, ensuring smooth transaction processing during this period and upholding corporate governance.

6
Postal Ballot (22 Aug 2025, 4:41 pm)

Marico Limited Seeks Shareholder Approval for Mr. Bhaskar Bhat's Independent Director Appointment via Postal Ballot

Marico Limited has issued a postal ballot notice seeking shareholder approval for the appointment of Mr. Bhaskar Bhat as an Independent Director.

Marico Limited is seeking shareholder consent through a postal ballot for the appointment of Mr. Bhaskar Bhat as an Independent Director, effective October 1, 2025. The notice details his extensive experience, including as former MD of Titan Company Limited, and requests approval for his continued directorship beyond age 75. The remote e-voting period runs from August 24 to September 22, 2025.

Marico Limited has issued a postal ballot notice to seek shareholder approval for the appointment of Mr. Bhaskar Bhat as an Independent Director, effective October 1, 2025. The resolution also seeks approval for his continuation as Director after attaining the age of 75.

Shareholders are requested to cast their votes through remote e-voting. The e-voting period commenced on Sunday, August 24, 2025, at 9:00 a.m. IST and will conclude on Monday, September 22, 2025, at 5:00 p.m. IST. The results are expected to be declared on or before Wednesday, September 24, 2025.

Mr. Bhaskar Bhat brings over four decades of corporate experience, having served as the Managing Director of Titan Company Limited from April 2002 to September 2019. He is a Mechanical Engineering graduate from IIT Madras and holds a PGDBM from IIM Ahmedabad. He currently serves as an Independent Chairman for Kansai Nerolac Paints Limited and holds directorships in Metro Brands Limited, Lucas TVS Limited, and Orange County Resorts & Hotels Limited. His expertise spans corporate strategy, leadership, brand building, and FMCG operations. The company highlighted that Mr. Bhat will be entitled to remuneration as approved by the Board, including sitting fees and potential commission, within statutory limits.

The notice also provides detailed instructions for members on how to register their email addresses and participate in the remote e-voting process, catering to both dematerialized and physical shareholding. This announcement does not contain any information related to financial performance, outlook, or other financial metrics.

2
Allotment of ESOP / ESPS (21 Aug 2025, 8:03 pm)

Marico Limited Allots 9,294 Equity Shares Under ESOP Plan, Increasing Paid-Up Capital

Marico allotted 9,294 equity shares under its ESOP plan, slightly increasing its paid-up capital.

Marico Limited has informed exchanges about the allotment of 9,294 equity shares of Re. 1 each under its Marico Employee Stock Option Plan, 2016. This action, approved by the Securities Committee of the Board on August 21, 2025, increases the company's paid-up share capital to Rs. 1,29,79,04,050 from Rs. 1,29,78,94,756. The disclosures comply with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Marico explicitly stated that this allotment is not material in nature, and the shares allotted rank pari-passu with existing equity shares.

Marico Limited has announced the allotment of 9,294 equity shares of face value Re. 1 each under its Marico Employee Stock Option Plan, 2016 (ESOP 2016). The allotment was approved by the Securities Committee of the Board of Directors on August 21, 2025, pursuant to the exercise of stock options by eligible grantees.

This allotment has led to an increase in Marico's paid-up share capital. The share capital has moved from Rs. 1,29,78,94,756 (comprising 1,29,78,94,756 equity shares of Re. 1 each) to Rs. 1,29,79,04,050 (comprising 1,29,79,04,050 equity shares of Re. 1 each).

The company has emphasized that this allotment is 'not material in nature'. The disclosure has been made in compliance with Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The issued shares are identical in all respects to the existing equity shares and will rank pari-passu.

3
Company Update (21 Aug 2025, 5:59 pm)

Marico Limited Initiates 'Saksham Niveshak' Campaign for Shareholder KYC and Unclaimed Dividend Claims

Marico launches 'Saksham Niveshak' campaign to boost investor awareness and KYC updates.

Marico Limited is undertaking a 100-day "Saksham Niveshak" campaign, prompted by the MCA and IEPFA. The objective is to enhance investor awareness, urging shareholders to update their Know Your Customer (KYC) details such as PAN, contact information, and bank accounts. It also facilitates the claiming of unpaid or unclaimed dividends and shares prior to their statutory transfer to the Investor Education and Protection Fund (IEPF), typically after seven years of being unclaimed.

Marico Limited has announced the launch of a 100-day campaign titled "Saksham Niveshak", in response to directives from the Investor Education and Protection Authority (IEPFA) and the Ministry of Corporate Affairs (MCA). The primary objectives of this campaign are to promote investor awareness, encourage shareholders to update their Know Your Customer (KYC) details, and facilitate the claiming of unpaid or unclaimed dividends and shares. This is crucial as unclaimed dividends and corresponding shares are liable to be transferred to the IEPF after seven consecutive years of being unclaimed. Shareholders are urged to update essential details such as PAN, contact information, bank account details, and nomination. They are also advised to claim any unpaid dividends. Marico has provided contact information for its Registrar and Transfer Agent, MUFG Intime India Private Limited, and the company itself to assist shareholders with these processes. This initiative is focused on compliance and shareholder servicing rather than on financial performance updates.

3
Analyst / Investor Meet (18 Aug 2025, 5:12 pm)

Marico Announces Schedule of Investor Conferences for September 2025

Marico management to attend multiple investor conferences in September 2025 across Hong Kong, Gurgaon, and Mumbai.

Marico Limited has formally notified the stock exchanges about its management's upcoming participation in three significant investor conferences scheduled for September 2025. The company's executives will engage with analysts and investors at the Goldman Sachs Asia Leaders Conference in Hong Kong on September 4th and 5th, 2025. Following this, they will attend the Jefferies 4th India Forum in Gurgaon on September 17th, 2025, and conclude with the J.P. Morgan 10th Annual India Conference in Mumbai on September 22nd, 2025. A crucial aspect of this disclosure is Marico's commitment to adhering strictly to SEBI regulations, ensuring that no unpublished price-sensitive information (UPSI) will be disclosed during any of these meetings. The company also mentioned that the schedule is subject to change and that their standard investor presentation is available on their website.

Marico Limited has announced the schedule for its management's participation in several key investor conferences during September 2025. The company will engage with analysts and institutional investors at the Goldman Sachs Asia Leaders Conference, held in Hong Kong on September 4th and 5th, 2025. Subsequently, the management will attend the Jefferies 4th India Forum in Gurgaon on September 17th, 2025. The series of meetings will conclude with the J.P. Morgan 10th Annual India Conference in Mumbai, scheduled for September 22nd, 2025. These events will involve one-on-one and group interactions aimed at providing updates and engaging with the investment community. Crucially, Marico has emphasized strict adherence to SEBI regulations, stating that no unpublished price-sensitive information (UPSI) will be shared with participants at any of these conferences. The company also noted that the announced schedule is provisional and subject to potential changes due to unforeseen circumstances. Their standard investor presentation, typically used in such meets, will be made available on the company’s investor relations website.

6
Analyst / Investor Meet (18 Aug 2025, 4:58 pm)

Marico Announces Non-Deal Roadshow in Paris & London for Investor Meetings (Sep 15-17, 2025)

Marico management to meet investors in Paris and London for a non-deal roadshow from Sept 15-17, 2025.

Marico Limited will hold one-on-one and group meetings with investors in Paris and London as part of a non-deal roadshow organized by Macquarie Capital Securities (India) Pvt. Ltd. from September 15 to September 17, 2025. The presentation materials used during these meets will be available on the company's website. This engagement aims to enhance communication with global investors without disclosing new price sensitive information.

The news from Marico Limited announces the schedule of analyst and investor meetings. Management will be conducting one-on-one and group meetings with investors in Paris and London between September 15, 2025, and September 17, 2025. This activity is part of a non-deal roadshow organized by Macquarie Capital Securities (India) Pvt. Ltd. The company has also made its standard investor presentation available on its website for reference. Marico has clarified that no unpublished price-sensitive information (UPSI) will be shared during these meetings, adhering to regulatory disclosure norms. The schedule is subject to change based on exigencies. This initiative underscores Marico's commitment to maintaining investor relations and providing visibility to its global investor base.

6
Company Update (13 Aug 2025, 6:37 pm)

Marico Limited Appoints Experienced Industry Veteran Bhaskar Bhat as Independent Director

Marico Limited appoints Bhaskar Bhat as Independent Director, subject to shareholder vote.

Marico Limited announced its Board approved the appointment of Mr. Bhaskar Bhat as Independent Director for a five-year term from October 1, 2025, contingent on shareholder approval via postal ballot. Mr. Bhat, a distinguished alumnus of IIT Madras and IIM Ahmedabad, boasts over four decades of corporate experience, having led Titan Company Limited as Managing Director for 17 years, significantly expanding its market presence and value.

Marico Limited officially informed the stock exchanges on August 13, 2025, about a key development concerning its board composition. The company's Board of Directors, through a resolution passed on the same day, approved the appointment of Mr. Bhaskar Bhat (DIN: 00148778) as an Additional Director in the capacity of Independent Director. This significant appointment is proposed for a term of five consecutive years, commencing on October 1, 2025, and concluding on September 30, 2030. The appointment is subject to the approval of the company's shareholders, which will be sought through a postal ballot process. The Nomination and Remuneration Committee has recommended Mr. Bhat for this role.

Mr. Bhaskar Bhat is a highly accomplished professional with over four decades of extensive experience in the corporate sector. His career highlights include a long and impactful association with the Tata Watch Project, which evolved into Titan Company Limited, starting in 1983. He held various significant roles within Titan, encompassing Sales & Marketing, Human Resources, and International Business, before retiring in September 2019. From April 2002 until his retirement, he served as the Managing Director of Titan Company Limited. Under his leadership, Titan Company Limited achieved remarkable growth, expanding its product portfolio into segments like Eyewear, Accessories, Fragrances, and Sarees, and saw its market capitalization grow to approximately $13 billion USD by 2019, making it the second largest company within the Tata Group.

Academically, Mr. Bhat is a distinguished alumnus of premier Indian institutions, holding a Mechanical Engineering degree from IIT Madras and completing his PGDBM from IIM Ahmedabad. Both institutions have recognized his contributions with Distinguished Alumnus Awards. Beyond his tenure at Titan, Mr. Bhat continues to contribute his expertise to corporate governance and strategy as an Independent Chairman of the Board of Kansai Nerolac Paints Limited. He also serves as an Independent Director on the boards of Metro Brands Limited and Lucas TVS Limited, among others. Furthermore, he is associated with non-profit organizations, being a Board Member of PANIIT Alumni Reach for Gram Udyogi Foundation and IITM Pravartak Technologies Foundation.

Marico Limited has affirmed that Mr. Bhaskar Bhat is not related to any of the existing Directors of the company and is not debarred from holding the office of Director by any regulatory authority. The company will communicate the details regarding the postal ballot process, including timelines and other requisite information, in due course to facilitate shareholder voting. This appointment is a strategic move to strengthen the board's expertise and governance framework.

2
Allotment of ESOP / ESPS (12 Aug 2025, 10:41 am)

Marico Limited Discloses Allotment of 69,397 Equity Shares Under ESOP Plan

Marico Limited allotted 69,397 equity shares under its ESOP 2016 plan, increasing its paid-up capital.

Marico Limited announced the allotment of 69,397 equity shares on August 12, 2025, under its Employee Stock Option Plan, 2016. This allotment has increased the company's paid-up share capital from approximately Rs. 129.78 crore to Rs. 129.79 crore. The shares were issued at various exercise prices, ranging from Rs. 346.04 to Rs. 545.34 per share, and will rank pari-passu with existing equity shares. The company clarified that this allotment is not material in nature.

This disclosure from Marico Limited details the allotment of 69,397 equity shares on August 12, 2025, under the Marico Employee Stock Option Plan, 2016. The allotment, made pursuant to the exercise of stock options by eligible employees, has led to an increase in the company's paid-up share capital from 1,29,78,25,359 equity shares to 1,29,78,94,756 equity shares, aggregating to Rs. 1,29,78,94,756/-. The exercise prices for these shares varied, with specific prices mentioned for different grants, including Rs. 346.04, Rs. 372.10, Rs. 520.96, and Rs. 545.34. The company has confirmed that these newly allotted shares will rank pari-passu with existing equity shares. Marico Limited explicitly stated in its filing that this allotment is "not material in nature" to the company. The filing adheres to Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information will also be available on the company's investor relations website.

9
Company Update (11 Aug 2025, 7:57 pm)

Marico Limited Q1 FY26 Earnings Call: Strong India Growth Amidst Copra Inflation, Positive International Outlook

Marico's Q1 FY26 earnings call highlights strong India growth, positive international performance, and strategies to manage copra price volatility.

Marico's Q1 FY26 earnings conference call highlighted robust performance with stable-to-improving demand in India, driven by premium categories and new business models. The company reported high-teen constant currency growth in its international business. Management detailed strategies for key segments: Parachute navigated copra hyperinflation with price hikes, Saffola oil saw mid-single-digit volume growth, Value-Added Hair Oils (VAHO) showed strong recovery with double-digit growth expected, and the Foods and Premium Personal Care (PPC) portfolios sustained accelerated growth. The company expects ~25% revenue growth for FY26 and double-digit profit CAGR over the next two years, driven by volume growth and effective management of input costs.

The transcript of Marico Limited's Q1 FY26 earnings conference call, held on August 4, 2025, details a strong operational start to the fiscal year. Management reported stable to improving demand trends in India, with premium categories outperforming mass segments and alternate channels like e-commerce and quick commerce leading growth. The India business achieved multi-year high revenue growth, supported by volume growth nearing double-digits and strategic pricing actions, especially in response to copra and edible oil inflation. The company's international business demonstrated high-teen constant currency growth, with robust performance in Bangladesh and MENA, and planned recovery in Vietnam.

Key segments discussed include:

  • Parachute: Navigated severe copra price inflation (effective 60% price increase) with minimal volume impact and market share gains, attributing resilience to brand equity and price inelasticity. Expects price stabilization and volume recovery.
  • Saffola Oil: Bounced back to mid-single-digit volume growth; launched cold-pressed oils.
  • Value-Added Hair Oils (VAHO): Showed a strong recovery, expecting double-digit value growth driven by mid and premium segments and Project SETU initiatives.
  • Foods Portfolio: Scaled as expected, with the core Saffola franchise growing double-digits and True Elements & Plix sustaining growth. Targeting over 25% growth for FY26.
  • Premium Personal Care (PPC): Digital-first portfolio showing strong momentum, targeting significant ARR growth and double-digit EBITDA margins by FY27.

Management highlighted strategies such as prioritizing volume-led growth over short-term margin optimization, re-pivoting advertising spends towards brand building in mid/premium segments, and streamlining non-media expenses. The company reiterated its medium-term ambition to reach ₹15,000 Cr revenue in two years and ₹20,000 Cr in five years, expecting a double-digit profit CAGR over the next two years. The call also addressed copra price volatility, attributing it to supply-demand gaps and weather patterns, noting a recent 12% correction from peaks and expressing confidence in managing future pricing and volumes.

6
AGM/EGM (8 Aug 2025, 6:43 pm)

Marico Limited's 37th AGM: FY25 Financials Adopted, ₹7 Final Dividend Declared, Director Reappointments Approved

Marico Limited's 37th AGM confirmed adoption of FY25 financials, declared ₹7 final dividend, and approved director reappointments.

Marico Limited held its 37th virtual AGM with 72 members. The meeting covered FY25 performance, double-digit revenue growth, and business outlooks. All resolutions, including the adoption of FY25 financials, ₹3.50 interim and ₹7 final dividends, director reappointments, and auditor ratifications, were passed.

Marico Limited conducted its 37th Annual General Meeting (AGM) virtually on August 8, 2025. The meeting, which commenced at 9:00 a.m. IST and concluded at 10:38 a.m. IST, was attended by 72 members (27 promoter/promoter group and 45 public). During the AGM, the Chairman, Mr. Harsh Mariwala, welcomed members and provided an overview of the company's seventh Integrated Annual Report themed "Future-ready. Agile. Resilient.", along with strategic imperatives and FY25 performance. The Managing Director & CEO, Mr. Saugata Gupta, briefed shareholders on the operational performance, demand trends in the FMCG sector, double-digit consolidated revenue growth for FY25, and the outlook for its foods and premium personal care businesses, alongside ESG initiatives. The Chief Financial Officer, Mr. Pawan Agrawal, also addressed queries. All resolutions presented, including the adoption of the Audited Financial Statements (Standalone & Consolidated) for the financial year ended March 31, 2025, the confirmation of an interim dividend of ₹3.50 per equity share and declaration of a final dividend of ₹7 per equity share for FY25, the re-appointment of directors, and ratification of cost and secretarial auditors, were passed with the requisite majority. The reports from the Statutory Auditor and Secretarial Auditor did not contain any adverse remarks.

3
AGM/EGM (8 Aug 2025, 6:38 pm)

Marico: AGM Approves FY25 Financials and Dividends; Resolution on Financial Limits Faces Dissent

Marico's 37th AGM passed all resolutions, including FY25 financials and dividends, with some dissent on financial limits.

At its 37th AGM on August 8, 2025, Marico Limited successfully passed all resolutions. Shareholders ratified the audited FY25 financial statements, confirmed the ₹3.50 interim dividend, and declared a ₹7 final dividend. Re-appointments of Mr. Harsh Mariwala and Mr. Saugata Gupta were approved. Notably, resolution 8 concerning enhanced limits under Section 186 saw around 60.8% of institutional votes cast against it, indicating shareholder concern on this specific matter.

Marico Limited held its 37th Annual General Meeting (AGM) on August 8, 2025, where all resolutions were duly passed by the members. The meeting confirmed the adoption of the company's audited standalone and consolidated financial statements for the fiscal year ended March 31, 2025. Shareholders also approved the confirmation of the interim dividend of ₹3.50 per equity share paid during the financial year and declared a final dividend of ₹7 per equity share for FY25. Key corporate governance matters included the re-appointment of Mr. Harsh Mariwala as a Director, his continuation as a Non-Executive Director, and the re-appointment of Mr. Saugata Gupta as Managing Director & Chief Executive Officer. The remuneration for Cost Auditors for FY26 was ratified, and Dr. K. R. Chandratre was appointed as the Secretarial Auditor for five years. A significant point of contention was Resolution 8, related to enhancing limits under Section 186 of the Companies Act, 2013, which received substantial opposition from institutional investors, with approximately 60.8% of their votes polled against it, although it passed overall due to broad support from other shareholder categories.

9
Company Update (5 Aug 2025, 4:21 pm)

Marico Limited Announces Strong Q1 FY26 Results: 16.13% YoY Revenue Growth, 33.09% PAT Growth

Marico's Q1 FY26 results show robust year-on-year growth in revenue and profit.

Marico Limited reported its consolidated financial results for the quarter ended June 30, 2025. Revenue from operations grew by 16.13% YoY to ₹12,528.16 lakh, while Profit After Tax (PAT) surged by 33.09% YoY to ₹672.86 lakh. Basic EPS rose to ₹1.16 from ₹0.87 year-on-year. The results signify strong operational performance and improved profitability for the quarter.

Marico Limited has announced its unaudited consolidated financial results for the quarter ended June 30, 2025. The company demonstrated strong year-on-year growth across key financial metrics.

Performance: Total income from operations for Q1 FY26 stood at ₹12,528.16 lakh, marking a significant 16.13% increase compared to ₹10,787.84 lakh in the corresponding quarter of the previous fiscal year (Q1 FY25). Profit After Tax (PAT) also saw substantial growth, rising by 33.09% YoY to ₹672.86 lakh from ₹505.56 lakh in Q1 FY25. The company's Profit Before Tax (after exceptional items) grew by 32.83% YoY to ₹951.66 lakh. Consequently, Earnings Per Share (EPS) for basic and diluted stood at ₹1.16, an increase from ₹0.87 in the prior year's quarter, reflecting a 33.33% YoY improvement. The PAT margin improved to approximately 5.37% in Q1 FY26 from 4.69% in Q1 FY25.

Financials: The company reported Equity Share Capital of ₹5,800.17 lakh. No other detailed balance sheet, cash flow, or ratio data is available in this extract.

Outlook & Discussion: No specific guidance or management commentary was provided in this results disclosure.

Comparative Lens: The results for Q1 FY26 show a marked improvement over Q1 FY25, with healthy double-digit growth in revenue and significantly higher growth in profitability and EPS.

Other Mentions: The document also contains separate notices regarding interest payment for Tata Communications Limited and a possession notice from IDBI Bank Limited, which are unrelated to Marico's financial results.

6
Audio Recording (4 Aug 2025, 9:42 pm)

Marico Announces Availability of Q1 FY26 Earnings Conference Call Recording

Marico Limited has made the audio recording of its Q1 FY26 earnings conference call available on its investor website.

Marico Limited has officially submitted an intimation to the stock exchanges regarding its recent earnings conference call. The audio recording of the call, which convened on August 4, 2025, to discuss the company's un-audited financial results and operational performance for the quarter ended June 30, 2025 (Q1 FY26), is now publicly accessible on Marico's official website under the investor documentation section. Furthermore, the company has assured that the formal transcript of this conference call will be furnished to the relevant stock exchanges in due course and will subsequently be published on their website. This announcement fulfills regulatory requirements under SEBI's Listing Obligations and Disclosure Requirements. However, this specific filing does not contain the actual financial performance figures, management guidance, or detailed outlook, which are to be obtained from the call recording or transcript.

Marico Limited has officially informed the stock exchanges about the availability of the audio recording for its earnings conference call.

  • Event & Period: The conference call was held on August 4, 2025, to discuss Marico's un-audited financial results and operations for the quarter ended June 30, 2025 (Q1 FY26).
  • Availability: The audio recording of the earnings call is now accessible on the company’s official website at https://marico.com/india/investors/documentation/quarterly-updates.
  • Future Disclosure: Marico also stated that the transcript of the conference call will be subsequently provided to the stock exchanges and published on their website.
  • Regulatory Compliance: This disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Financials & Guidance: This announcement solely pertains to the availability of the earnings call recording and does not include any specific financial performance data, such as revenue, profit, margins, EPS, management guidance, outlook, balance sheet figures, or cash flow statements. Investors are directed to the recording and transcript for these details.
  • Key Events: No orders, expansions, penalties, or product launches are mentioned in this notification.
8
Company Update (4 Aug 2025, 2:16 pm)

Marico Reports 23% YoY Revenue Growth in Q1 FY26, but EBITDA Margins Decline Amidst Input Cost Pressures

Marico's Q1 FY26 revenue up 23% YoY driven by India volume growth, but EBITDA margins declined due to input costs.

Marico announced Q1 FY26 revenue up 23% YoY to ₹3,259 Cr, with India volume growth at 9% and international CCG at 19%, both multi-quarter highs. The company noted accelerated growth in Foods and Premium Personal Care. However, EBITDA margins declined 360 bps to 20.1% due to significant commodity inflation and increased A&P spending, impacting profitability growth. PAT rose 9%. The outlook is cautiously optimistic, expecting demand to improve but acknowledging near-term input cost pressures.

Marico reported strong performance for Q1 FY26, with consolidated revenue from operations increasing by 23% year-on-year to ₹3,259 crore. This growth was driven by a healthy 9% volume growth in the India business and a robust 19% constant currency growth in its international operations, both marking multi-quarter highs. The India business revenue grew by 27% YoY to ₹2,495 crore, with strong market share and penetration gains across most categories on a MAT basis. The company's diversification strategy is gaining traction, with Foods posting approximately 20% value growth and Premium Personal Care, including digital-first brands, showing accelerated momentum, exiting the quarter at ₹850+ crore ARR. However, profitability faced pressure as EBITDA grew only 5% YoY to ₹655 crore, with EBITDA margins declining by 360 basis points to 20.1%. This compression was attributed to significant commodity inflation, particularly a 107% YoY increase in copra prices, which led to a ~530 bps contraction in gross margins, compounded by higher A&P spends (up 25% YoY). Profit After Tax (PAT) saw a 9% YoY increase to ₹504 crore. Key brands like Parachute Rigids saw a 1% volume decline but robust 31% revenue growth, demonstrating pricing power amidst inflation. Value-Added Hair Oils grew 13% in value, and Saffola Edible Oils posted mid-single digit volume growth with 28% revenue growth, alongside the launch of a new Cold Pressed Oils range. The international business showed resilience, with Bangladesh up 17% CCG and MENA up 42% CCG, though Vietnam experienced a muted quarter. Looking ahead, Marico anticipates gradual demand improvement, steady growth in core categories, and continued diversification. The company aims for Foods to reach ~8x FY20 revenues by FY27 and digital-first brands to scale significantly, targeting double-digit EBITDA margins for the latter by FY27. Management expects input cost headwinds to peak in H1 FY26 and ease thereafter, aiming for double-digit revenue growth and margin improvement in the medium term.

5
Company Update (4 Aug 2025, 2:11 pm)

Marico Limited Announces Intra-Group Restructuring: Integrating 'Just Herbs' Subsidiary via Voluntary Liquidation for Digital Strategy

Marico Limited is undertaking an intra-group restructuring by integrating its wholly-owned subsidiary, Apcos Naturals Private Limited, which operates the 'Just Herbs' brand, into the parent company. This integration will be executed through the voluntary liquidation of Apcos. The primary drivers for this restructuring are Marico's digital-first strategy, the goal of accelerating digital transformation, achieving operational synergies, optimizing costs, and simplifying its corporate group structure. Apcos Naturals is not a material subsidiary, and Marico anticipates that this move will not have a material impact on its consolidated financial statements. For the financial year ended March 31, 2025, Apcos reported a turnover of Rs. 98.79 crore, which represented 0.91% of Marico's overall consolidated turnover for the same period. The voluntary liquidation, which commenced on August 4, 2025, has secured the necessary board approvals and is subject to regulatory clearances. This consolidation is part of Marico's broader plan to enhance efficiency and digital capabilities, signalling a continued focus on strategic integration for growth.

Marico Limited has announced an intra-group restructuring to integrate Apcos Naturals, owner of the 'Just Herbs' brand, through voluntary liquidation. This aligns with Marico's digital-first strategy, aiming for digital transformation, operational synergies, cost optimisation, and structural simplification. Apcos' FY25 turnover was Rs. 98.79 crore (0.91% of consolidated turnover), with no material impact expected on Marico's consolidated financials or net worth. The voluntary liquidation process commenced on August 4, 2025, with board approvals already in place, and is subject to requisite statutory and regulatory clearances. The integration is intended to create efficiencies and support Marico's ongoing digital transformation efforts by consolidating operations under the parent entity, thereby simplifying the group structure and enhancing resource allocation.

Marico Limited has officially announced an intra-group restructuring on August 4, 2025, as per SEBI Listing Regulations. The company plans to integrate Apcos Naturals Private Limited, a wholly-owned subsidiary managing the 'Just Herbs' brand, into the parent entity. This integration will be carried out via the voluntary liquidation of Apcos, with its entire business undertaking being distributed to Marico on a going concern basis. The strategic rationale behind this move is to enhance Marico's digital-first strategy, accelerate its digital transformation journey, unlock operational synergies, achieve cost optimisation, and simplify its overall corporate structure. Marico has clarified that Apcos Naturals is not a material subsidiary and that the restructuring is not expected to result in any material impact on its consolidated financial statements or net worth. For the financial year ending March 31, 2025, Apcos recorded a turnover of Rs. 98.79 crore, which constituted approximately 0.91% of Marico's consolidated turnover for that fiscal year. The voluntary liquidation of Apcos commenced on August 4, 2025, following approvals from the respective Boards of Directors and shareholders of Apcos, as well as the Board of Directors of Marico. The process is subject to requisite statutory and regulatory approvals, after which Apcos will be dissolved by the Hon'ble National Company Law Tribunal (NCLT). No consideration is involved in this intra-group transaction, and Marico's shareholding pattern remains unaffected by this restructuring.

9
Board Meeting (4 Aug 2025, 2:02 pm)

Marico's Q1 FY26: Consolidated Revenue Jumps 23.3%, PAT Up 8.2%; Standalone PAT Soars 149.8% on High Other Income

Marico reported Q1 FY26 results, with consolidated revenue up 23.3% YoY to ₹3,259 Cr and PAT up 8.2% YoY to ₹513 Cr.

Marico posted robust Q1 FY26 results. Consolidated revenue grew 23.3% YoY to ₹3,259 Cr, with PAT up 8.2% YoY to ₹513 Cr. Standalone PAT dramatically surged 149.8% to ₹777 Cr, primarily due to a substantial increase in 'other income', likely linked to the acquisition of an additional stake in Plix. India segment revenue saw strong 27.2% YoY growth, while International revenue grew 12.2% YoY.

Marico Limited announced its unaudited consolidated and standalone financial results for the quarter ended June 30, 2025 (Q1 FY26) on August 4, 2025.

Consolidated Performance: The company reported a consolidated revenue from operations of ₹3,259 Cr, a significant increase of 23.3% compared to ₹2,643 Cr in Q1 FY25. Profit After Tax (PAT) grew by 8.2% YoY to ₹513 Cr from ₹474 Cr in the prior year. Consolidated EBITDA stood at approximately ₹711 Cr, up 7.2% YoY, with the EBITDA margin declining to 21.45% from 24.74% YoY. Basic Earnings Per Share (EPS) for the quarter was ₹3.90, an 8.3% increase from ₹3.60 in Q1 FY25.

Standalone Performance: The standalone results showed a dramatic surge, with revenue from operations at ₹2,281 Cr, up 20.9% YoY from ₹1,886 Cr. Standalone PAT leaped by 149.8% YoY to ₹777 Cr from ₹311 Cr. This exceptional growth was driven by a substantial increase in 'other income' to ₹474 Cr in Q1 FY26 from ₹18 Cr in Q1 FY25. Consequently, standalone EBITDA rose by 107.0% YoY to approximately ₹923 Cr, with EBITDA margins expanding significantly to 33.5% from 23.4% YoY. Standalone basic EPS was ₹6.01, up 149.4% YoY.

Segmental Performance: The India segment reported revenue of ₹2,495 Cr, a 27.2% YoY increase, while the International segment posted revenue of ₹764 Cr, up 12.2% YoY. Profit before tax for the India segment was ₹469 Cr (up 5.6% YoY), and for the International segment was ₹213 Cr (up 8.1% YoY).

Key Developments: The company disclosed that during the quarter, it acquired an additional 8.8% stake in Satiya Nutraceuticals (Plix) on a fully diluted basis. This acquisition is likely the reason for the significant jump in standalone 'other income'.

The financial results were reviewed by the Audit Committee and approved by the Board of Directors.

8
Result (4 Aug 2025, 1:56 pm)

Marico Limited Reports Strong Q1 FY26 Consolidated Revenue Growth of 23.31%; Standalone PAT Surges 149.84% Driven by Other Income

Marico Q1 FY26: Consolidated revenue up 23.31% YoY; standalone PAT surges 149.84% driven by other income.

Marico Limited posted its Q1 FY26 financial results, showing robust consolidated revenue growth of 23.31% YoY to ₹3,259 crore, driven by strong performance across its business segments. Consolidated Profit After Tax (PAT) increased by 8.23% YoY to ₹513 crore. However, consolidated PAT margins contracted YoY to 15.74%. Notably, standalone results revealed a dramatic surge in PAT by 149.84% YoY to ₹777 crore, primarily fueled by substantial "other income" of ₹474 crore, which is significantly higher than the consolidated figure. Standalone revenue grew 20.94% YoY. The India segment revenue grew 27.17% YoY, while international segment revenue saw a 12.19% YoY increase. The company also announced the acquisition of an additional 8.8% stake in Satiya Nutraceuticals (Plix), taking its total holding to 60%.

Marico Limited released its unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26) on August 4, 2025.

Quarterly Results (Consolidated):
The company reported a consolidated revenue from operations of ₹3,259 crore for Q1 FY26, marking a significant 23.31% year-on-year (YoY) increase from ₹2,643 crore in Q1 FY25. Consolidated Profit After Tax (PAT) for the quarter stood at ₹513 crore, an 8.23% YoY growth from ₹474 crore in the corresponding period last year. Basic Earnings Per Share (EPS) grew by 8.33% YoY to ₹3.90 from ₹3.60. The consolidated PAT margin declined to 15.74% from 17.93% YoY, indicating some pressure on profitability. Sequentially, consolidated revenue grew by 19.38% from ₹2,730 crore in Q4 FY25, and PAT saw a substantial 48.70% jump from ₹345 crore.

Quarterly Results (Standalone):
On a standalone basis, Marico reported revenue from operations of ₹2,281 crore, a YoY increase of 20.94% from ₹1,886 crore in Q1 FY25. The standalone PAT witnessed an exceptional surge of 149.84% YoY, reaching ₹777 crore compared to ₹311 crore in Q1 FY25. This robust PAT growth was primarily attributed to a significant rise in "Other income" to ₹474 crore, a stark contrast to the ₹56 crore reported on a consolidated basis. Consequently, standalone PAT margins expanded significantly to 34.06% from 16.49% YoY. Standalone Basic EPS grew by 149.38% YoY to ₹6.01.

Segmental Performance:
The India segment reported revenue of ₹2,495 crore in Q1 FY26, up 27.17% YoY from ₹1,962 crore in Q1 FY25. Profit Before Tax (PBT) for the India segment was ₹469 crore, a 5.63% YoY increase. The International segment posted revenue of ₹764 crore, up 12.19% YoY from ₹681 crore, with PBT rising 8.12% YoY to ₹213 crore.

Key Developments:
During the quarter ended June 30, 2025, Marico acquired an additional 8.8% stake in Satiya Nutraceuticals Private Limited (Plix) on a fully diluted basis from existing investors. This acquisition has increased Marico's total stake in Plix to 60% on a fully diluted basis.

Outlook and Discussion:
The provided documents do not contain specific forward-looking guidance from the management or details of an upcoming earnings call.